mental retardation: ['Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual is mentally retarded. IQ scores between 70 and 79 are in the borderline mentally retarded range. Scores below 67 are in the retarded range. (Joynt, Clinical Neurology, 1992, Ch55, p28)']
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1027 |
4. Check minimum number of eventsNone |
1027 |
5. Include endpointsNone |
1027 |
6. Filter based on genotype QC (FinnGen only) |
967 |
Control definitions (FinnGen only)
- Control exclude
- F5_MENTRET
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- F70-F79
- Name in latin
- Retardatio mentalis levis
Similar endpoints
↥List of similar endpoints to
Mild mental retardation
based on the number of shared cases.
Similar with more cases:
- Mental retardation
- Mental retardation, excluding more controls
- Mental retardation, wide definition
- Psychiatric diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 22488 | 9950 | 12449 |
| Only index persons | 19541 | 8687 | 10854 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.32 | 0.28 | 0.35 |
| Only index persons | 0.37 | 0.32 | 0.41 |
| Median age at first event (years) | |||
| Whole population | 18.73 | 21.41 | 16.40 |
| Only index persons | 18.04 | 20.26 | 16.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 967 | 493 | 474 |
| Unadjusted period prevalence (%) | 0.20 | 0.18 | 0.22 |
| Median age at first event (years) | 25.86 | 26.41 | 25.28 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1027
- Matched controls
- 10270
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
3851.4
322.3
294
*
F83
ICD-10 Finland
Mixed specific developmental disorders
38.5
307.7
217
71
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
14.9
307.7
366
367
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
12772.0
307.7
593
*
N05AX08
ATC
risperidone; systemic
12.3
296.6
360
432
F70.9
ICD-10 Finland
Mild mental retardation, Without mention of impairment of behaviour
3300.3
286.2
263
*
N03AG01
ATC
valproic acid; systemic, rectal
12.8
265.4
298
317
N05AH03
ATC
olanzapine; systemic
10.1
225.2
305
413
N05AA02
ATC
levomepromazine; systemic
15.3
207.5
196
156
F20.9
ICD-10 Finland
Schizophrenia, unspecified
20.3
194.3
155
89
N04AA02
ATC
biperiden; systemic
25.3
190.0
137
62
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
10.9
181.9
218
248
P85
ICPC
Mental retardation
1847.9
163.0
154
*
113
Kela drug reimbursment
Anxiety disorders associated with mental retardation
+∞
160.8
150
*
N05AC02
ATC
thioridazine; oral
19.2
156.4
127
75
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
7.0
152.3
280
521
N05AD01
ATC
haloperidol; systemic
18.9
151.9
124
74
N05AH02
ATC
clozapine; systemic
17.1
147.7
127
84
F29
ICD-10 Finland
Unspecified nonorganic psychosis
9.4
146.1
192
244
N05AF03
ATC
chlorprothixene; systemic
14.7
139.9
131
101
G40.9
ICD-10 Finland
Epilepsy, unspecified
11.5
138.1
153
154
N05BA06
ATC
lorazepam; systemic, sublingual
10.7
137.0
161
176
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
16.0
135.2
120
84
N05BA01
ATC
diazepam; systemic, rectal
6.0
131.5
290
637
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
19.2
125.6
101
58
N05AB03
ATC
perphenazine; systemic, rectal
11.2
124.7
140
143
P72
ICPC
Schizophrenia
13.9
121.7
117
94
3170A
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,EI KÄYTÄYTYM.HÄIRIÖTÄ]
+∞
114.8
108
*
N05AX12
ATC
aripiprazole; systemic
7.4
113.4
182
289
N05BA09
ATC
clobazam; oral
26.3
111.4
78
32
183
Kela drug reimbursment
Lamotrigin and topiramate
19.0
104.4
84
48
N05AF05
ATC
zuclopenthixol; systemic
26.1
104.1
73
30
A28
ICPC
Limited function/disability NOS
4.9
90.4
240
605
F70
ICD-10 Finland
Mild mental retardation
+∞
88.9
84
*
N05AH04
ATC
quetiapine; oral
3.8
86.5
364
1285
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
900.3
85.9
83
*
A06AD11
ATC
lactulose; oral
4.9
85.7
220
538
31199
ICD-8 Finland
Mild mental retardation, Other and unspecified
+∞
81.3
77
*
N03AF01
ATC
carbamazepine; oral, rectal
7.7
81.2
121
175
P99
ICPC
Psychological disorders other
7.7
80.3
119
171
R62.0
ICD-10 Finland
Delayed milestone
10.0
76.8
91
99
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
76.0
72
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
5.7
75.4
154
307
N03AF02
ATC
oxcarbazepine; oral
7.3
72.7
113
171
N05AA01
ATC
chlorpromazine; systemic, rectal
17.6
72.5
60
36
N03AX09
ATC
lamotrigine; oral
5.7
71.1
146
292
3170B
ICD-9 Finland
Mild mental retardation[LIEVÄ ÄLYLL.KEHITYSVAMMAISUUS,JOSSA KÄYTÄYTYM.HÄIRI]
+∞
68.5
65
*
N05CD07
ATC
temazepam; oral
5.0
67.1
159
360
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
8.9
64.6
83
100
OAB43, ,
SPAT
0.1
64.2
38
2893
188
Kela drug reimbursment
Psychosis requiring demanding treatment
19.4
63.4
50
27
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
17.5
60.3
50
30
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.9
59.3
203
607
N05CD08
ATC
midazolam; nasal, systemic
8.6
59.2
78
97
N06AB04
ATC
citalopram; systemic
3.3
57.0
276
1032
SPAT1234
SPAT
Support of social functional capacity
6.6
55.4
93
152
U04
ICPC
Incontinence urine
6.2
54.7
98
171
F71.1
ICD-10 Finland
Moderate mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
54.7
52
*
N03AX14
ATC
levetiracetam; systemic
7.5
54.5
81
116
EBA15
NOMESCO Finland
Extraction of multiple teeth
6.2
54.4
98
172
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.1
51.7
65
76
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
51.4
317
1353
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
+∞
50.4
48
*
31099
ICD-8 Finland
Borderline mental retardation, Other and unspecified
511.7
49.8
49
*
2989X
ICD-9 Finland
Other nonorganic psychoses, Unspecified psychosis
19.3
49.3
39
21
N05AD03
ATC
melperone; systemic
19.7
48.6
38
20
XA800
NOMESCO Finland
Neuropsychological investigation
4.6
46.9
121
291
SPAT1229
SPAT
Assessment of need for aid
5.3
46.6
99
202
SPAT1365
SPAT
Health check-up performed during first study year due to special need in students of upper secondary schools or vocational schools
16.9
46.3
39
24
P28
ICPC
Limited function/disability (P)
13.1
45.4
44
35
SPAT1301
SPAT
No procedures
2.6
44.9
395
1998
C03CA01
ATC
furosemide; systemic
2.9
44.1
253
1028
F80.1
ICD-10 Finland
Expressive language disorder
8.3
43.8
59
75
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
8.3
43.8
59
75
F22.0
ICD-10 Finland
Delusional disorder
13.3
42.8
41
32
N03AX11
ATC
topiramate; oral
6.2
42.8
76
131
N05BA04
ATC
oxazepam; oral
2.7
42.7
325
1525
F81.3
ICD-10 Finland
Mixed disorder of scholastic skills
9.9
42.7
50
53
SPAT1222
SPAT
Counselling/guidance promoting independent living
3.4
42.4
173
574
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
7.7
42.3
61
84
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
3.1
41.8
207
772
T36
ICD-10 Finland
Poisoning by systemic antibiotics
4.6
41.3
105
249
N88
ICPC
Epilepsy
13.0
41.1
40
32
F20
ICD-10 Finland
Schizophrenia
15.5
41.0
36
24
WYA20
NOMESCO Finland
Home visit
10.4
40.0
45
45
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.0
39.6
124
344
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
6.5
39.4
66
107
K03.66
ICD-10 Finland
Tooth plaque
3.1
39.3
189
691
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
10.6
38.9
43
42
F82
ICD-10 Finland
Specific developmental disorder of motor function
8.2
38.6
52
66
N05AN01
ATC
lithium; oral
6.0
38.6
70
123
A46
ICD-10 Finland
Erysipelas
3.2
38.4
177
631
Z72.8
ICD-10 Finland
Other problems related to lifestyle
15.3
38.4
34
23
P98
ICPC
Psychosis NOS/other
13.3
37.6
36
28
F84.9
ICD-10 Finland
Pervasive developmental disorder, unspecified
13.9
37.5
35
26
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
15.5
37.5
33
22
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
9.4
37.1
45
50
L28
ICPC
Limited function/disability (L)
3.0
37.1
197
761
EBA00
NOMESCO Finland
Extraction of tooth
2.3
37.0
528
3240
RL140, ,
NOMESCO Finland
14.8
36.6
33
23
H50.31
ICD-10 Finland
Intermittent exotropia
7.7
35.0
50
68
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
4.8
34.6
81
179
V628A
ICD-9 Finland
Other psychosocial circumstances, Other psychological or physical stress, not elsewhere classified
+∞
34.6
33
*
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.1
34.0
157
558
SPAT1254
SPAT
Administration of medicine
2.7
33.9
230
1007
F80.9
ICD-10 Finland
Developmental disorder of speech and language, unspecified
9.6
33.8
40
43
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.6
33.7
239
1069
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.5
33.6
126
394
F61.0
ICD-10 Finland
Mixed personality disorders
7.0
32.9
51
76
N03AE01
ATC
clonazepam; systemic
4.3
32.5
89
223
Z2446
NOMESCO Finland
Social worker
3.1
32.2
155
564
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
31.9
226
1007
G03DC03
ATC
lynestrenol; oral
6.7
31.8
51
79
K08.3
ICD-10 Finland
Retained dental root
3.6
31.2
110
330
A10BA02
ATC
metformin; oral
2.4
31.1
269
1314
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
30.8
216
957
RT150, ,
NOMESCO Finland
11.0
30.6
33
31
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.9
30.5
166
646
SPAT1262
SPAT
Handing over of treatment supplies
2.7
30.4
190
794
F79.1
ICD-10 Finland
Unspecified mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
30.4
29
*
K59.09
ICD-10 Finland
Constipation, unspecified
3.6
30.3
105
311
F60.8
ICD-10 Finland
Other specific personality disorders
11.8
30.1
31
27
29599
ICD-8 Finland
Schizophrenia, Unspecified type
70.1
30.1
34
5
M03BX02
ATC
tizanidine; oral
0.4
29.8
246
4363
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.5
29.7
112
351
SPAT1100
SPAT
Long-term monitoring of blood pressure
4.6
29.6
72
164
P29
ICPC
Psychological sympt/compl other
2.8
29.5
173
699
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
2.7
29.4
178
732
31109
ICD-8 Finland
Mild mental retardation, Following infections and intoxications, Unspecified
+∞
29.3
28
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
3.7
29.1
97
280
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
29.0
200
877
T90
ICPC
Diabetes non-insulin dependent
2.4
28.6
230
1083
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.0
28.5
140
514
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.8
28.4
159
627
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
31.9
28.3
37
12
F71.9
ICD-10 Finland
Moderate mental retardation, without mention of impairment of behaviour
+∞
28.3
27
*
N05AX13
ATC
paliperidone; systemic
9.7
28.1
33
35
SPAT1240
SPAT
Therapeutic discussion
2.7
27.9
179
757
OAA65, ,
SPAT
0.1
27.7
23
1508
N05BE01
ATC
buspirone; oral
4.9
27.2
62
134
N03AG04
ATC
vigabatrin; oral
63.8
27.1
31
5
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
27.0
335
1886
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.6
26.9
93
275
Z31.5
ICD-10 Finland
Genetic counselling
3.3
26.7
109
358
Z02.7
ICD-10 Finland
Issue of medical certificate
3.1
26.7
118
407
N03AX18
ATC
lacosamide; systemic
10.3
26.6
30
30
N05AL01
ATC
sulpiride; systemic
8.5
26.2
34
41
31100
ICD-8 Finland
Mild mental retardation, Following infections and intoxications, Post infectionem praenatalem
+∞
26.2
25
*
78159
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Laesio loquendi alia sive NUD
74.7
25.9
29
*
SPAT1263
SPAT
Sampling
2.0
25.8
469
3028
F99
ICD-10 Finland
Mental disorder, not otherwise specified
5.1
25.6
55
113
F20.5
ICD-10 Finland
Residual schizophrenia
29.2
25.5
34
12
103
Kela drug reimbursment
Diabetes, insulin-treated
2.3
25.4
254
1307
78020
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Convulsions
9.9
25.1
29
30
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
25.1
170
736
F10.20
ICD-10 Finland
Alcohol dependence currently independent
5.8
24.9
46
82
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
3.7
24.9
83
239
N05AF01
ATC
flupentixol; systemic
8.3
24.9
33
41
H13
ICPC
Plugged feeling ear
2.4
24.6
212
1023
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
24.5
130
496
M01AH05
ATC
etoricoxib; oral
0.5
24.4
269
4408
30180
ICD-8 Finland
Personality disorders, Immatura
31.9
23.8
31
10
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.1
23.6
51
105
K59.0
ICD-10 Finland
Constipation
3.6
23.6
82
243
WYA50
NOMESCO Finland
Student oral health check consistent with decree to assess need for oral health guidance and services
0.1
23.4
9
821
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.4
23.4
187
872
SCA02
NOMESCO Finland
Preventive oral health care
2.2
23.4
255
1355
SPAT1252
SPAT
Overall medication plan or its review
3.8
22.9
73
204
31009
ICD-8 Finland
Borderline mental retardation, Following infections and intoxications, Unspecified
235.0
22.7
23
*
G40.89
ICD-10 Finland
Other epilepsy
18.5
22.3
34
19
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
9.2
22.2
27
30
R1260
NOMESCO Finland
Evaluation of communicative skills
6.2
22.1
38
63
Z2445
NOMESCO Finland
Psychologist
2.9
22.1
109
399
N07BB01
ATC
disulfiram; oral
3.7
22.1
73
209
R11
ICD-10 Finland
Nausea and vomiting
2.6
22.1
140
585
H50.1
ICD-10 Finland
Divergent concomitant strabismus
8.7
22.0
28
33
N03AB02
ATC
phenytoin; systemic
8.3
21.8
29
36
N05AC01
ATC
periciazine; systemic
39.6
21.8
27
7
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.9
21.7
113
426
F72.0
ICD-10 Finland
Severe mental retardation, with the statement of no, or minimal, impairment of behaviour
224.6
21.7
22
*
RS222, ,
NOMESCO Finland
6.7
21.4
34
52
F81.9
ICD-10 Finland
Developmental disorder of scholastic skills, unspecified
7.7
21.3
30
40
Z29
ICPC
Social problem NOS
4.5
21.3
53
123
29999
ICD-8 Finland
Unspecified psychosis
34.6
21.2
27
8
OAA67, ,
SPAT
0.2
21.2
25
1294
R1210
NOMESCO Finland
Medical assessment of need and possibilities to rehabilitation
6.6
21.0
34
53
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
8.2
21.0
28
35
XF600, ,
SPAT
4.4
20.9
53
125
AA1AD
NOMESCO Finland
CT of head and brain
2.1
20.7
250
1373
-1, ,
ICPC
4.2
20.6
56
139
F80.2
ICD-10 Finland
Receptive language disorder
6.1
20.5
36
61
34599
ICD-8 Finland
Epilepsy, Other and unspecified
26.1
20.5
28
11
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.1
20.3
233
1254
2959C
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN]
49.1
20.2
24
5
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.9
20.2
102
378
OAB95, ,
SPAT
0.1
20.2
5
640
SPAT1167
SPAT
Insertion of urinary catheter
6.0
20.2
36
62
T82
ICPC
Obesity
3.5
20.0
70
208
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
7.4
20.0
29
40
181
Kela drug reimbursment
Retigabine and vigabatrin
58.7
20.0
23
*
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
3.2
20.0
82
270
K05.18
ICD-10 Finland
Chronic gingivitis
2.6
19.8
125
520
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
19.7
107
412
N06AB03
ATC
fluoxetine; oral
2.4
19.6
158
736
F20.0
ICD-10 Finland
Paranoid schizophrenia
15.0
19.5
32
22
R60.0
ICD-10 Finland
Localized oedema
2.6
19.3
120
495
SPAT1260
SPAT
Consultation of another employee
2.2
19.3
194
991
OAA62, ,
SPAT
0.1
19.2
6
643
S97
ICPC
Chronic ulcer skin
3.4
19.2
70
214
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
4.8
19.1
43
92
R32
ICD-10 Finland
Unspecified urinary incontinence
4.9
18.8
42
89
3199A
ICD-9 Finland
Unspecified mental retardation[MUU ÄLYLLINEN KEHITYSVAMMAISUUS,EI KÄYTTÄYTYMIHÄIRI]
+∞
18.8
18
*
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
6.9
18.8
29
43
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.9
18.7
93
342
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.5
18.6
36
67
R5110, ,
SPAT
2.9
18.6
91
331
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.8
18.6
404
2688
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
18.6
170
835
F21
ICD-10 Finland
Schizotypal disorder
18.0
18.3
28
16
3153A
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[KIELENKEHITYKSEN ERITYISVAIKEUS]
44.9
18.3
22
5
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
4.2
18.2
49
121
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.2
18.1
75
248
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
7.1
17.9
27
39
E86
ICD-10 Finland
Volume depletion
5.5
17.9
35
66
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
3.9
17.7
52
137
N06AB06
ATC
sertraline; oral
2.2
17.5
168
840
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
4.0
17.5
50
129
F84.0
ICD-10 Finland
Childhood autism
29.4
17.5
23
8
SPAT1139
SPAT
Nutrition survey
4.5
17.5
43
99
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
17.3
109
452
Z50.5
ICD-10 Finland
Speech therapy
4.0
17.3
50
130
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
17.3
260
1532
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
15.1
17.2
28
19
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.9
17.1
268
1601
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.3
17.1
136
629
3153X
ICD-9 Finland
Specific delays in development, Developmental speech or language disorder[PUHEEN KEHITYKSEN ERITYISVAIKEUS]
50.9
17.0
20
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
13.5
17.0
29
22
E66.01
ICD-10 Finland
Obesity due to excess calories
2.4
17.0
129
584
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
16.9
399
2701
X78
ICD-10 Finland
Intentional self-harm by sharp object
6.4
16.8
28
45
F20.3
ICD-10 Finland
Undifferentiated schizophrenia
15.4
16.7
27
18
H52.2
ICD-10 Finland
Astigmatism
3.9
16.6
50
134
SPF00
NOMESCO Finland
Reparation of dental prosthesis without impressions
5.7
16.6
31
56
R33
ICD-10 Finland
Retention of urine
3.2
16.6
69
229
3141A
ICD-9 Finland
Hyperkinetic syndrome of childhood, Hyperkinesis with developmental delay
172.7
16.5
17
*
F20.39
ICD-10 Finland
Undifferentiated schizophrenia UNS
13.7
16.5
28
21
A29
ICPC
General symptom/complaint other
2.2
16.5
155
768
F60.9
ICD-10 Finland
Personality disorder, unspecified
5.3
16.4
33
64
SPAT1251
SPAT
Organisation of medication
4.3
16.3
42
100
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
2.9
16.3
81
297
U07.2
ICD-10 Finland
COVID-19, virus not identified
0.3
16.2
64
1654
D12
ICPC
Constipation
3.6
15.9
52
148
3159X
ICD-9 Finland
Specific delays in development, Unspecified delay in development
61.0
15.8
18
*
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
33.9
15.8
20
6
31000
ICD-8 Finland
Borderline mental retardation, Following infections and intoxications, Post infectionem praenatalem
+∞
15.7
15
*
L17
ICPC
Foot/toe symptom/complaint
1.8
15.7
337
2211
EBA30
NOMESCO Finland
Extraction of root of tooth
3.1
15.6
66
221
G40.10
ICD-10 Finland
Simple partial seizures
14.0
15.6
26
19
7834D
ICD-9 Finland
Symptoms concerning nutrition, metabolism and development, Lack of expected normal physiological development[LAPSEN NORMAALIN KEHITTYMISEN HIDASTUMINEN]
162.4
15.5
16
*
R5130, ,
SPAT
162.4
15.5
16
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.3
15.5
37
1246
OAB48, ,
SPAT
0.3
15.5
40
1289
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.0
15.5
207
1168
J96.1
ICD-10 Finland
Chronic respiratory failure
6.8
15.4
24
36
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
15.1
234
1385
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.9
15.1
235
1394
R1240
NOMESCO Finland
Social assessment of need and possibilities of rehabilitation
6.6
15.0
24
37
A10BB01
ATC
glibenclamide; oral
5.3
14.9
30
58
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
14.9
176
949
R4120, ,
SPAT
6.9
14.9
23
34
SPAT1216
SPAT
Assessment of functional ability
2.3
14.9
126
597
2959A
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,TARKEMMIN MÄÄRITTELEMÄT]
32.2
14.8
19
6
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.3
14.8
56
175
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
14.8
207
1184
OAA80, ,
SPAT
0.1
14.8
11
811
SDA02
NOMESCO Finland
Periodontal treatment, brief
1.7
14.8
416
2933
S09
ICPC
Infected finger/toe
3.5
14.7
51
151
34408
ICD-8 Finland
Other cerebral paralysis, Alia definita
+∞
14.6
14
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.3
14.5
112
510
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.3
14.5
39
1232
RS312, ,
NOMESCO Finland
36.6
14.5
18
5
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.3
14.4
37
1202
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
3.5
14.4
50
148
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.9
14.4
70
254
OAB50, ,
SPAT
2.6
14.4
90
372
N06AB05
ATC
paroxetine; oral
2.9
14.4
71
260
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
11.6
14.3
26
23
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.8
14.3
242
1471
WYA30, ,
SPAT
6.3
14.2
24
39
N06AA04
ATC
clomipramine; systemic
5.2
14.2
29
57
SPAT1244
SPAT
Occupational therapy
12.2
14.1
25
21
F28
ICD-10 Finland
Other nonorganic psychotic disorders
14.7
14.1
23
16
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.7
14.1
317
2095
SPAT1312
SPAT
General health counselling
1.7
14.0
371
2563
F20.10
ICD-10 Finland
Raise schizophrenia continuously
16.0
14.0
22
14
SPAT1310
SPAT
Counselling related to known health issue
1.7
13.9
334
2245
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
13.9
124
600
Z03
ICPC
Housing/neighbourhood problem
17.8
13.9
21
12
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
4.3
13.8
36
87
SAA03
NOMESCO Finland
Extended examination of mouth
1.7
13.7
508
3823
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.5
13.7
92
393
A41.9
ICD-10 Finland
Sepsis, unspecified
3.5
13.7
47
138
ZY010
NOMESCO Finland
Hospital outpatient
2.4
13.7
100
444
R55
ICD-10 Finland
Syncope and collapse
2.3
13.7
106
483
SPAT1101
SPAT
Orthostatic test
4.4
13.7
34
79
F71
ICD-10 Finland
Moderate mental retardation
+∞
13.6
13
*
F79
ICD-10 Finland
Unspecified mental retardation
+∞
13.6
13
*
31599
ICD-8 Finland
Unspecified mental retardation, Other and unspecified
+∞
13.6
13
*
F20.8
ICD-10 Finland
Other schizophrenia
16.5
13.5
21
13
N03AX23
ATC
brivaracetam; systemic
16.5
13.5
21
13
A01
ICPC
Pain general/multiple sites
2.3
13.4
111
520
W19
ICD-10 Finland
Unspecified fall
2.2
13.4
123
602
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.2
13.4
120
582
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.8
13.2
24
42
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
40.6
13.2
16
*
G21.1
ICD-10 Finland
Other drug-induced secondary parkinsonism
40.6
13.2
16
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
3.9
13.2
38
99
S06
ICPC
Rash localized
2.7
13.1
73
285
N06AA09
ATC
amitriptyline; systemic
2.6
13.0
79
322
M01AB05
ATC
diclofenac; systemic, rectal
0.6
12.9
325
4488
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.3
12.9
50
159
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.7
12.9
30
66
M41.4
ICD-10 Finland
Neuromuscular scoliosis
50.7
12.9
15
*
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
2.5
12.8
80
330
N03AX22
ATC
perampanel; oral
15.7
12.6
20
13
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
3.1
12.6
52
172
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.2
12.5
111
535
SPAT1281
SPAT
Other administrative function
2.3
12.5
99
455
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
12.5
205
1229
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
12.5
114
556
3459X
ICD-9 Finland
Epilepsy, unspecified
24.6
12.5
17
7
G21.0
ICD-10 Finland
Malignant neuroleptic syndrome
131.6
12.5
13
*
WVA20, ,
SPAT
3.0
12.5
57
200
ZY000
NOMESCO Finland
Hospital inpatient
4.1
12.4
34
85
S76
ICPC
Skin infection other
2.7
12.4
66
251
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.7
12.3
68
264
N03AX15
ATC
zonisamide; oral
14.5
12.3
20
14
R1250
NOMESCO Finland
Evaluation of functional capability
3.7
12.2
39
109
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
38.0
12.2
15
*
R50.9
ICD-10 Finland
Fever, unspecified
1.8
12.2
196
1167
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
2.9
12.2
56
197
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.4
12.2
43
129
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
12.6
12.1
21
17
H81
ICPC
Excessive ear wax
2.0
12.1
152
834
Z10.0
ICD-10 Finland
Occupational health examination
0.2
12.1
14
750
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
3.1
12.1
51
171
29580
ICD-8 Finland
Schizophrenia, Other
21.6
12.0
17
8
G40
ICD-10 Finland
Epilepsy
5.7
12.0
22
39
G41.9
ICD-10 Finland
Status epilepticus, unspecified
13.6
12.0
20
15
SPAT1245
SPAT
Provision of support and information to patient’s family members
3.5
11.9
40
116
K05.1
ICD-10 Finland
Chronic gingivitis
2.3
11.9
90
406
L89
ICD-10 Finland
Decubitus ulcer and pressure area
5.4
11.9
23
43
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
2.4
11.8
84
368
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
4.4
11.7
29
67
IGV01
NOMESCO Finland
Psychiatric network contact
3.3
11.7
44
137
R39.1
ICD-10 Finland
Other difficulties with micturition
3.7
11.7
37
103
N28
ICPC
Limited function/disability (N)
5.6
11.7
22
40
N05AL05
ATC
amisulpride; oral
30.4
11.7
15
5
SPAT1396
SPAT
Meeting with multidisciplinary group of experts
3.8
11.6
35
94
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.5
11.6
40
118
R45.1
ICD-10 Finland
Restlessness and agitation
19.2
11.6
17
9
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
11.6
462
3492
Z00.0
ICD-10 Finland
General medical examination
1.8
11.6
217
1351
S72.0
ICD-10 Finland
Fracture of neck of femur
4.3
11.6
30
72
N05BA02
ATC
chlordiazepoxide; systemic
4.3
11.6
30
72
SPAT1325
SPAT
Vaccination
1.6
11.5
334
2337
P27
ICPC
Fear of mental disorder
3.9
11.5
34
90
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.1
11.5
115
581
2956C
ICD-9 Finland
Schizophrenic psychoses, Residual schizophrenia[RESIDUAALINEN SKITSOFRENIA,KROONINEN]
+∞
11.5
11
*
SPAT1305
SPAT
Counselling and guidance related to physical exercise
2.2
11.4
97
459
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
4.2
11.4
30
73
S22
ICPC
Nail symptom/complaint
2.3
11.4
87
394
R41.0
ICD-10 Finland
Disorientation, unspecified
4.0
11.3
32
82
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.7
11.3
62
240
K02.1
ICD-10 Finland
Caries of dentine
1.6
11.3
662
5459
G80.9
ICD-10 Finland
Cerebral palsy, unspecified
35.4
11.3
14
*
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
9.7
11.3
22
23
KAY40, ,
NOMESCO Finland
0.0
11.2
*
273
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
2.4
11.2
78
339
J01CF05
ATC
flucloxacillin; systemic
2.3
11.2
90
417
R60.9
ICD-10 Finland
Oedema, unspecified
2.9
11.2
51
179
N06AX16
ATC
venlafaxine; oral
1.9
11.1
153
865
H01
ICPC
Ear pain/earache
1.8
11.1
183
1095
NB6AA
NOMESCO Finland
Humerus X-ray examination
4.0
11.1
31
79
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
11.0
210
1312
R1410
NOMESCO Finland
Drawing up a rehabilitation plan
5.8
11.0
20
35
A10BB12
ATC
glimepiride; oral
3.0
11.0
48
164
D01AC02
ATC
miconazole; topical
2.5
11.0
71
298
A10BH01
ATC
sitagliptin; oral
2.4
11.0
75
323
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
11.0
70
292
29500
ICD-8 Finland
Schizophrenia, Simple type
43.8
10.9
13
*
34532
ICD-8 Finland
Epilepsy, Partialis (focalis) generalisata
43.8
10.9
13
*
IGY02, ,
SPAT
3.8
10.9
33
89
H03AA01
ATC
levothyroxine sodium; systemic
1.8
10.9
187
1134
Z28
ICPC
Limited function/disability (Z)
12.1
10.9
19
16
N30.0
ICD-10 Finland
Acute cystitis
1.9
10.9
158
910
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.9
10.8
137
753
A10AE04
ATC
insulin glargine; parenteral
2.2
10.8
94
449
Y0209
ICD-8 Finland
Examination of the nervous system and sensory organs, Nervous system
10.7
10.8
20
19
U07
ICPC
Urine symptom/complaint other
2.3
10.8
85
390
IHZ04, ,
SPAT
3.6
10.8
36
104
30041
ICD-8 Finland
Neuroses, Depressiva
9.7
10.8
21
22
SPAT1154
SPAT
Insertion or removal of subcutaneous medicine capsule
5.0
10.8
23
47
R01AD58
ATC
fluticasone, combinations; nasal
0.5
10.8
106
1935
N05AE03
ATC
sertindole; oral
18.0
10.7
16
9
H47.2
ICD-10 Finland
Optic atrophy
18.0
10.7
16
9
R1100
NOMESCO Finland
General evaluation of the need for rehabilitation
3.1
10.7
44
145
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
13.1
10.7
18
14
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.7
10.6
233
1512
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
3.8
10.6
32
86
Q93.5
ICD-10 Finland
Other deletions of part of a chromosome
60.6
10.6
12
*
H52.0
ICD-10 Finland
Hypermetropia
3.1
10.6
44
146
N06AA12
ATC
doxepin; systemic
2.9
10.6
50
179
Z3226
NOMESCO Finland
Physiotherapist
1.8
10.6
193
1191
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
10.5
158
918
29560
ICD-8 Finland
Residual schizophrenia
+∞
10.4
10
*
30199
ICD-8 Finland
Personality disorders, Unspecified
+∞
10.4
10
*
F78.0
ICD-10 Finland
Other mental retardation, with the statement of no, or minimal, impairment of behaviour
+∞
10.4
10
*
3046, ,
Kela drug reimbursment
+∞
10.4
10
*
SPAT1097
SPAT
Recording of ECG
2.0
10.4
111
575
F20.38
ICD-10 Finland
Undifferentiated schizophrenia other definite
16.2
10.4
16
10
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
12.2
10.4
18
15
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
3.3
10.4
39
122
2959E
ICD-9 Finland
Schizophrenic psychoses, Unspecified schizophrenia[ERILAISTUMATON SKITSOFRENIA,KROONINEN AKUUTTI VAIHE]
32.9
10.3
13
*
S74
ICPC
Dermatophytosis
3.7
10.3
32
88
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
4.5
10.3
25
57
G80.1
ICD-10 Finland
Spastic diplegic cerebral palsy
19.0
10.3
15
8
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
19.0
10.3
15
8
XX4AW, ,
NOMESCO Finland
4.8
10.3
23
49
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
3.9
10.3
30
79
4122
FHL
Tympanostomy (tympanic tube)
3.9
10.3
30
79
3451A
ICD-9 Finland
Epilepsy, Generalised convulsive epilepsy
23.6
10.3
14
6
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
3.9
10.2
29
75
H53.0
ICD-10 Finland
Amblyopia ex anopsia
3.9
10.2
29
75
K04.1
ICD-10 Finland
Necrosis of pulp
2.0
10.1
122
659
RT160, ,
NOMESCO Finland
8.0
10.1
22
28
N06AX03
ATC
mianserin; oral
2.9
10.1
48
172
R4120
NOMESCO Finland
Occupational therapy
2.3
10.1
76
342
N05AE04
ATC
ziprasidone; systemic
8.6
10.1
21
25
F80.8
ICD-10 Finland
Other developmental disorders of speech and language
8.6
10.1
21
25
Z3231
NOMESCO Finland
Registered nurse
1.6
10.1
292
2033
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
10.2
10.0
19
19
J01CE08
ATC
benzathine benzylpenicillin; parenteral
10.2
10.0
19
19
N05BA05
ATC
potassium clorazepate; oral
10.2
10.0
19
19
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
10.2
10.0
19
19
N02AJ06
ATC
codeine and paracetamol; systemic
0.6
10.0
199
2974
S29
ICPC
Skin symptom/complaint other
1.7
10.0
212
1361
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
2.5
10.0
61
249
WX725
NOMESCO Finland
Noninvasive ventilation
2.6
10.0
60
243
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
3.6
10.0
32
90
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.7
10.0
54
208
S10
ICPC
Boil/carbuncle
2.4
10.0
68
293
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.7
10.0
232
1528
F42.1
ICD-10 Finland
Predominantly compulsive acts [obsessional rituals]
5.2
9.9
20
39
XQ855, ,
SPAT
5.0
9.8
21
43
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
9.8
203
1295
A99
ICPC
Disease/condition unspecnature/site
2.0
9.7
108
567
OAB72, ,
SPAT
3.9
9.7
28
73
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
9.7
93
462
SPAT1307
SPAT
Psychosocial counselling and guidance
2.0
9.7
104
539
P15
ICPC
Chronic alcohol abuse
2.9
9.7
44
154
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
4.2
9.7
25
60
WW200, ,
SPAT
1.6
9.7
272
1877
H50.30
ICD-10 Finland
Intermittent esotropy
5.4
9.7
19
36
F20.1
ICD-10 Finland
Hebephrenic schizophrenia
55.5
9.7
11
*
W78
ICPC
Pregnancy
0.3
9.7
35
960
G04BD04
ATC
oxybutynin; oral, transdermal
2.7
9.6
51
194
R56.0
ICD-10 Finland
Febrile convulsions
4.4
9.6
24
56
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.3
9.6
21
753
SPAT1285
SPAT
Provision of consultation response
2.6
9.6
57
230
S01.0
ICD-10 Finland
Open wound of scalp
2.2
9.6
78
363
P17
ICPC
Tobacco abuse
4.5
9.6
23
52
F91.9
ICD-10 Finland
Conduct disorder, unspecified
11.5
9.6
17
15
G40.00
ICD-10 Finland
Benign childhood epilepsy with centrotemporal EEG spikes
11.5
9.6
17
15
2988A
ICD-9 Finland
Other nonorganic psychoses, Other and unspecified reactive psychosis
15.2
9.5
15
10
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
15.2
9.5
15
10
F10.24
ICD-10 Finland
Alcohol depence active use
3.9
9.4
27
70
F10.25
ICD-10 Finland
Alcohol dependence continuous use
3.9
9.4
27
70
R02
ICPC
Shortness of breath/dyspnoea
1.9
9.4
129
727
G80.8
ICD-10 Finland
Other cerebral palsy
100.9
9.4
10
*
SDA03
NOMESCO Finland
Periodontal treatment
1.5
9.4
413
3147
IEV99, ,
SPAT
17.7
9.4
14
8
N03AD01
ATC
ethosuximide; oral
17.7
9.4
14
8
WZC00
NOMESCO Finland
Treatment plan or consultation
1.5
9.4
400
3028
F72.1
ICD-10 Finland
Severe mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
9.4
9
*
Q85.1
ICD-10 Finland
Tuberous sclerosis
+∞
9.4
9
*
N03AX24
ATC
cannabidiol; oral
+∞
9.4
9
*
N03AX17
ATC
stiripentol; oral
+∞
9.4
9
*
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
3.3
9.4
34
104
F23.91
ICD-10 Finland
Acute and transient psychosis, unspecified without acute stress factor
21.9
9.4
13
6
N30.9
ICD-10 Finland
Cystitis, unspecified
2.3
9.4
69
308
7803A
ICD-9 Finland
General symptoms, Convulsions
5.0
9.3
20
41
KMAK, ,
NOMESCO Finland
1.5
9.3
467
3657
X84
ICD-10 Finland
Intentional self-harm by unspecified means
8.8
9.3
19
22
F20.34
ICD-10 Finland
Undifferentiated schizophrenia with partial recurrence
10.8
9.3
17
16
R95
ICPC
Chron obstructive pulmonary disease
3.9
9.3
27
71
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
7.4
9.2
21
29
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.3
9.2
23
766
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.2
221
1464
A08
ICPC
Swelling
2.7
9.2
50
193
U05
ICPC
Urination problems other
2.7
9.2
50
193
R53
ICD-10 Finland
Malaise and fatigue
1.6
9.1
244
1660
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
2.3
9.1
68
305
H01AC01
ATC
somatropin; parenteral
3.8
9.1
27
72
S42.2
ICD-10 Finland
Fracture of upper end of humerus
2.8
9.1
44
160
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.7
9.1
168
1038
H65.3
ICD-10 Finland
Chronic mucoid otitis media
2.4
9.1
63
274
RL130, ,
NOMESCO Finland
7.1
9.0
21
30
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.4
9.0
54
1190
P50
ICPC
Psychological, Medication/prescr/renewal
10.1
9.0
17
17
Z01.2
ICD-10 Finland
Dental examination
1.5
9.0
543
4404
29510
ICD-8 Finland
Schizophrenia, Hebephrenic type
37.0
9.0
11
*
SPAT1243
SPAT
Psychiatric/psychological examination
2.6
9.0
50
195
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
9.0
404
3087
A10BD07
ATC
metformin and sitagliptin; systemic
3.1
8.9
37
123
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.3
8.9
22
736
SPAT1284
SPAT
Extensive health certificate
3.1
8.9
36
118
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
8.0
8.9
19
24
37301
ICD-8 Finland
Strabismus, Concomitans divergens
8.0
8.9
19
24
SPAT1304
SPAT
Counselling and guidance related to ageing
2.8
8.9
44
162
SPAT1255
SPAT
Intravenous administration of medicine
2.5
8.9
55
227
UKC02
NOMESCO Finland
Cystoscopy
1.9
8.8
108
586
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
3.8
8.8
26
69
SCA01
NOMESCO Finland
Preventive oral health care, short
1.5
8.8
442
3451
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.3
8.8
66
297
OAB93, ,
SPAT
0.2
8.8
8
408
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.8
8.8
148
890
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
7.3
8.8
20
28
D01AE15
ATC
terbinafine; topical
2.4
8.7
61
266
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.9
8.7
118
663
RT490, ,
NOMESCO Finland
14.2
8.7
14
10
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.5
8.7
54
223
R01AD12
ATC
fluticasone furoate; nasal
0.6
8.7
161
2466
SCF02
NOMESCO Finland
Preventive oral care by dental hygienist
2.3
8.7
64
286
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
8.6
76
366
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
3.7
8.6
27
75
ICB03, ,
SPAT
8.3
8.6
18
22
WZC30, ,
SPAT
2.1
8.6
83
414
J01DB01
ATC
cefalexin; oral
1.6
8.6
813
7217
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
11.7
8.6
15
13
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.3
8.5
30
837
Z91.5
ICD-10 Finland
Personal history of self-harm
10.1
8.5
16
16
R01AD09
ATC
mometasone; nasal
0.6
8.5
251
3450
SPAT1360
SPAT
Extensive global examination
2.3
8.5
63
282
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.9
8.5
113
631
R62.9
ICD-10 Finland
Lack of expected normal physiological development, unspecified
27.8
8.5
11
*
30799
ICD-8 Finland
Transient situational disturbances
27.8
8.5
11
*
34510
ICD-8 Finland
Epilepsy, """"Grand mal""""
27.8
8.5
11
*
G04BD07
ATC
tolterodine; oral
3.0
8.5
37
127
N03AF03
ATC
rufinamide; oral
90.8
8.4
9
*
F20.31
ICD-10 Finland
Undifferentiated schizophrenia periodically with gradual deterioration
90.8
8.4
9
*
SCA03
NOMESCO Finland
Preventive oral health care, extensive
2.1
8.4
79
390
F20.04
ICD-10 Finland
Paranoid schizophrenia with partial recurrence
6.8
8.4
20
30
CEC10
NOMESCO Finland
Recession and resection of extraocular muscle
4.9
8.4
18
37
OAB91, ,
SPAT
0.2
8.4
10
524
ZYC01
NOMESCO Finland
Remote contact by phone
2.1
8.3
79
391
3180A
ICD-9 Finland
Other specified mental retardation, Moderate mental retardation[KESKIVAIKEA ÄLYLL KEHITYSVAMMAISUUS,EI KÄYTÄYT.HÄIR]
+∞
8.3
8
*
31299
ICD-8 Finland
Moderate mental retardation, Other and unspecified
+∞
8.3
8
*
IDY03
NOMESCO Finland
Systematic individual therapy, cognitive-behavioural
0.1
8.3
5
338
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.3
8.3
62
278
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
8.6
8.3
17
20
L14
ICPC
Leg/thigh symptom/complaint
2.0
8.3
86
440
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
3.2
8.3
33
107
L16
ICPC
Ankle symptom/complaint
1.8
8.3
146
888
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
8.2
751
6571
F22.9
ICD-10 Finland
Persistent delusional disorder, unspecified
14.6
8.2
13
9
F61
ICD-10 Finland
Mixed and other personality disorders
14.6
8.2
13
9
F89
ICD-10 Finland
Unspecified disorder of psychological development
7.6
8.2
18
24
E66.2
ICD-10 Finland
Extreme obesity with alveolar hypoventilation
7.6
8.2
18
24
UDC00
NOMESCO Finland
Ear microscopy
2.1
8.2
81
408
E66.9
ICD-10 Finland
Obesity, unspecified
2.6
8.2
48
193
S01
ICPC
Pain/tenderness of skin
2.4
8.2
55
236
WZC00, ,
SPAT
1.7
8.2
167
1059
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.2
8.2
68
320
WX730
NOMESCO Finland
Conventional respirator
4.8
8.1
18
38
F40.2
ICD-10 Finland
Specific (isolated) phobias
4.8
8.1
18
38
T07
ICPC
Weight gain
3.3
8.1
30
93
S94
ICPC
Ingrowing nail
3.4
8.1
28
83
C09AA02
ATC
enalapril; systemic
1.8
8.1
123
716
G80.0
ICD-10 Finland
Spastic quadriplegic cerebral palsy
33.6
8.1
10
*
30920
ICD-8 Finland
Mental disorders not specified as psychotic associated with physical conditions, Brain trauma
33.6
8.1
10
*
ADB00
NOMESCO Finland
Implantation of vagus nerve stimulating device
17.3
8.1
12
7
F20.01
ICD-10 Finland
Paranoid schizophrenia periodically with gradual deterioration
17.3
8.1
12
7
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
8.1
142
864
A97
ICPC
No disease
1.6
8.0
228
1570
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
8.0
90
475
R73.9
ICD-10 Finland
Hyperglycaemia, unspecified
2.9
8.0
36
126
I50.9
ICD-10 Finland
Heart failure, unspecified
2.1
7.9
74
364
C03EB01
ATC
furosemide and potassium-sparing agents; systemic
3.8
7.9
24
65
E000003, ,
ATC
2.4
7.9
54
233
WX704
NOMESCO Finland
Intubation
2.1
7.9
79
399
P76
ICPC
Depressive disorder
2.0
7.9
92
491
Q21.10
ICD-10 Finland
Persistent ostium secundum
4.0
7.9
22
56
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
6.2
7.9
20
33
A10BK03
ATC
empagliflozin; oral
2.0
7.9
83
428
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
7.9
68
325
IEV99
NOMESCO Finland
Other psychiatric network intervention
3.3
7.8
29
90
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
2.1
7.8
75
373
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.8
7.8
23
61
R81
ICPC
Pneumonia
2.7
7.8
40
150
L84
ICD-10 Finland
Corns and callosities
2.9
7.8
35
122
RT420, ,
NOMESCO Finland
10.9
7.8
14
13
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
9.5
7.8
15
16
WX003
NOMESCO Finland
Sedation or analgesia orally, rectally or intramuscularly without general anesthesia
3.7
7.8
24
66
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
4.2
7.8
20
48
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.9
7.7
97
531
A10AD01
ATC
insulin (human); parenteral
3.9
7.7
22
57
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
0.6
7.7
188
2711
29899
ICD-8 Finland
Other psychoses, Reactive psychosis, unspecified
45.3
7.7
9
*
30050
ICD-8 Finland
Neuroses, Neurasthenia
45.3
7.7
9
*
K07
ICPC
Swollen ankles/oedema
2.8
7.7
37
134
DFF20
NOMESCO Finland
Audiometry for children
6.0
7.7
20
34
R5140, ,
SPAT
4.4
7.7
19
44
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
3.4
7.7
27
81
J01FA10
ATC
azithromycin; systemic
0.7
7.7
430
5248
SPD01
NOMESCO Finland
Mucosa-supported complete denture
7.5
7.7
17
23
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
7.5
7.7
17
23
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.6
7.7
42
163
F10.09
ICD-10 Finland
Alcohol intoxication UNS
3.1
7.7
32
107
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
3.8
7.7
23
62
SPE01
NOMESCO Finland
Mucosa-supported partial denture
3.8
7.7
23
62
GD1AA, ,
SPAT
0.5
7.6
56
1144
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.0
7.6
85
447
F60.1
ICD-10 Finland
Schizoid personality disorder
18.5
7.6
11
6
SGB10
NOMESCO Finland
Root filling of tooth with one root canal
1.8
7.6
110
631
5210A
ICD-9 Finland
Diseases of hard tissues of teeth, Dental caries
25.2
7.6
10
*
RS220, ,
NOMESCO Finland
3.5
7.6
25
72
WYA20, ,
SPAT
8.9
7.6
15
17
OAA64, ,
SPAT
0.2
7.5
13
537
SAA02
NOMESCO Finland
Basic examination of mouth
1.5
7.5
767
6789
A10AD05
ATC
insulin aspart; parenteral
4.3
7.5
19
45
F98.00
ICD-10 Finland
Nonorganic enuresis nocturna
3.7
7.5
23
63
TDA90, ,
SPAT
2.2
7.5
59
272
A12BA01
ATC
potassium chloride; oral
3.6
7.4
24
68
79309
ICD-8 Finland
Observation, without need for further medical care, Casus mentales alii sive NUD
80.7
7.4
8
*
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
80.7
7.4
8
*
J01CR50
ATC
combinations of penicillins; systemic
80.7
7.4
8
*
4304
FHL
Tooth or tooth extraction under general anesthesia
80.7
7.4
8
*
J01DA01
ATC
[U] cefalexin
1.4
7.4
515
4232
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
0.6
7.4
123
1951
R13
ICD-10 Finland
Dysphagia
2.2
7.4
61
286
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
7.7
7.4
16
21
R44.0
ICD-10 Finland
Auditory hallucinations
7.7
7.4
16
21
TPH07
NOMESCO Finland
Cathetrisation of artery
1.9
7.4
94
517
R03AK03
ATC
[U] fenoterol and ipratropium bromide
3.0
7.4
31
104
N05AB02
ATC
fluphenazine; systemic
13.5
7.4
12
9
3000A
ICD-9 Finland
Neurotic disorders, Anxiety states[TARKEMMIN MÄÄRITTELEMÄTÖN AHDISTUNEISUUSHÄIRIÖ]
13.5
7.4
12
9
F43.00
ICD-10 Finland
Acute stress reaction mild
2.9
7.4
33
115
Q38.1
ICD-10 Finland
Ankyloglossia
4.1
7.4
20
50
SFA10
NOMESCO Finland
One-surface restoration
1.4
7.4
581
4885
30000
ICD-8 Finland
Neuroses, Anxiety neurosis
8.4
7.3
15
18
J01AA04
ATC
lymecycline; systemic
0.4
7.3
38
888
G80.3
ICD-10 Finland
Dyskinetic cerebral palsy
+∞
7.3
7
*
78151
ICD-8 Finland
Other symptoms referable to nervous system and special senses, Aphasia
+∞
7.3
7
*
F78.1
ICD-10 Finland
Other mental retardation, significant impairment of behaviour requiring attention or treatment
+∞
7.3
7
*
F07.9
ICD-10 Finland
Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction
+∞
7.3
7
*
H47.7
ICD-10 Finland
Disorder of visual pathways, unspecified
+∞
7.3
7
*
F43.24
ICD-10 Finland
Adaptive disorder with behavioral disorder
+∞
7.3
7
*
30040
ICD-8 Finland
Neuroses, Neurotico-depressiva
9.4
7.3
14
15
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
4.2
7.3
19
46
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.3
7.3
22
662
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.8
7.3
35
127
L60.0
ICD-10 Finland
Ingrowing nail
2.2
7.3
61
288
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.8
7.3
103
587
NFB20
NOMESCO Finland
Primary partial prosthetic replacement of hip joint using cement, other or unspecified
5.8
7.2
19
33
ZXY49
NOMESCO Finland
Other health care provider
5.8
7.2
19
33
F20.32
ICD-10 Finland
Undifferentiated schizophrenia stable periodically
15.9
7.2
11
7
F20.6
ICD-10 Finland
Simple schizophrenia
15.9
7.2
11
7
NG1BG, ,
SPAT
0.1
7.2
*
283
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
7.2
118
702
A04
ICPC
Weakness/tiredness general
1.6
7.2
165
1076
EJC20
NOMESCO Finland
Operation on frenulum of tongue
4.5
7.2
17
38
S00.0
ICD-10 Finland
Superficial injury of scalp
3.2
7.2
28
90
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
1.9
7.2
98
552
E0000UV, ,
ATC
1.4
7.2
417
3312
H61.2
ICD-10 Finland
Impacted cerumen
2.1
7.2
71
358
2951C
ICD-9 Finland
Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]
30.2
7.2
9
*
ICB06, ,
NOMESCO Finland
3.2
7.2
27
85
F23.9
ICD-10 Finland
Acute and transient psychotic disorder, unspecified
20.2
7.1
10
5
C07AB02
ATC
metoprolol; systemic
1.8
7.1
120
720
TJD20
NOMESCO Finland
Change of gastrostomy tube
8.0
7.1
15
19
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.9
7.1
32
112
F06.7
ICD-10 Finland
Mild cognitive disorder
3.8
7.1
21
56
DM1QA, ,
SPAT
0.1
7.1
*
257
R42
ICD-10 Finland
Dizziness and giddiness
1.6
7.1
171
1129
F20.02
ICD-10 Finland
Paranoid schizophrenia stable periodically
12.1
7.1
12
10
A11CC03
ATC
alfacalcidol; systemic
3.1
7.1
29
96
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
7.0
179
1197
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
3.0
7.0
30
102
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.6
7.0
39
153
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
7.0
726
8014
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.9
7.0
83
447
WVA30, ,
SPAT
2.2
6.9
60
287
H04
ICPC
Ear discharge
2.7
6.9
37
142
I50.0
ICD-10 Finland
Congestive heart failure
2.6
6.9
39
154
R06AX27
ATC
desloratadine; oral
0.6
6.9
177
2535
F05.9
ICD-10 Finland
Delirium, unspecified
4.0
6.9
19
48
H60.1
ICD-10 Finland
Cellulitis of external ear
4.0
6.9
19
48
KAY20, ,
NOMESCO Finland
0.0
6.9
*
171
MA5AE
NOMESCO Finland
Morphology ultrasound screening, weeks 18+0 to 21+6 of gestation
0.2
6.9
8
356
SPAT1104
SPAT
Monitoring of emergency patient
2.2
6.9
55
255
602
Kela drug reimbursment
Children's severe malnutrition
3.3
6.9
25
77
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
6.9
70
357
H43.8
ICD-10 Finland
Other disorders of vitreous body
0.2
6.8
9
369
MA3AE
NOMESCO Finland
Combined first trimester screening
0.2
6.8
7
334
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
2.6
6.8
39
155
IFA99, ,
SPAT
6.8
6.8
16
24
E66.8
ICD-10 Finland
Other obesity
2.2
6.8
57
269
C09AA05
ATC
ramipril; oral
1.6
6.8
154
1000
ZXA10
NOMESCO Finland
Bilateral
1.6
6.8
153
992
S31.1
ICD-10 Finland
Open wound of abdominal wall
11.0
6.8
12
11
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
5.7
6.8
18
32
ND2AA, ,
SPAT
0.2
6.8
8
349
30610
ICD-8 Finland
Special symptoms not elsewhere classified, Specific learning disturbance
40.3
6.8
8
*
A90
ICPC
Congenital anomaly NOS/multiple
40.3
6.8
8
*
52100
ICD-8 Finland
Disease of hard tissues of teeth, Dental caries
40.3
6.8
8
*
2971A
ICD-9 Finland
Paranoid states, Paranoia
40.3
6.8
8
*
7455A
ICD-9 Finland
Bulbus cordis anomalies and anomalies of cardiac septal closure, Ostium secundum type atrial septal defect
40.3
6.8
8
*
Z93.1
ICD-10 Finland
Gastrostomy status
40.3
6.8
8
*
3016A
ICD-9 Finland
Personality disorders, Dependent personality disorder
40.3
6.8
8
*
F20.20
ICD-10 Finland
Catatonic schizophrenia continuously
40.3
6.8
8
*
30010
ICD-8 Finland
Neuroses, Hysterical neurosis
40.3
6.8
8
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.6
6.8
37
144
WX892
NOMESCO Finland
Monitored bed care
2.0
6.8
70
359
SPAT1197
SPAT
Extensive health check-up of expecting family
0.4
6.7
29
736
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
3.4
6.7
23
68
E66.00
ICD-10 Finland
Metabolic syndrome
2.2
6.7
52
238
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.5
6.7
298
2245
K02.9
ICD-10 Finland
Dental caries, unspecified
3.0
6.7
28
94
2953C
ICD-9 Finland
Schizophrenic psychoses, Paranoid type[PARANOIDISTYYPPINEN SKITSOFRENIA,KROONINEN]
22.7
6.7
9
*
L30.3
ICD-10 Finland
Infective dermatitis
2.5
6.7
39
157
A41.8
ICD-10 Finland
Other specified sepsis
3.8
6.7
20
54
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
3.8
6.7
20
54
R73.0
ICD-10 Finland
Abnormal glucose tolerance test
3.1
6.7
27
89
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
6.7
211
1483
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
3.6
6.6
21
59
SPAT1241
SPAT
Extensive assessment of psychosocial situation
3.6
6.6
21
59
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.8
6.6
90
507
H26.02
ICD-10 Finland
Presenil cataract
3.3
6.6
24
74
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.2
6.6
10
446
L57.0
ICD-10 Finland
Actinic keratosis
0.2
6.5
7
322
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
2.5
6.5
38
153
D06
ICPC
Abdominal pain localized other
1.8
6.5
89
502
SPAT1235
SPAT
Mental health, emotional support
6.2
6.5
16
26
L03.9
ICD-10 Finland
Cellulitis, unspecified
3.2
6.5
25
80
U06
ICPC
Haematuria
3.2
6.5
25
80
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
2.9
6.5
30
107
199
Kela drug reimbursment
Rufinamide
70.3
6.4
7
*
34519
ICD-8 Finland
Epilepsy, Generalisata convulsiva NUD
70.3
6.4
7
*
SGA02
NOMESCO Finland
Opening and preparing the root canals
1.7
6.4
121
749
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
7.5
6.4
14
19
30899
ICD-8 Finland
Behaviour disorders of childhood
14.4
6.4
10
7
F25
ICD-10 Finland
Schizoaffective disorders
14.4
6.4
10
7
-1, ,
NOMESCO Finland
1.4
6.4
401
3212
R03BB04
ATC
tiotropium bromide; inhalant
2.0
6.4
63
318
A02BA04
ATC
nizatidine; systemic
2.2
6.3
49
224
A10AB05
ATC
insulin aspart; parenteral
1.9
6.3
79
432
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
8.2
6.3
13
16
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
5.6
6.3
17
31
S21
ICPC
Skin texture symptom/complaint
1.6
6.3
143
929
J01EA01
ATC
trimethoprim; systemic
1.6
6.3
182
1252
Z72.0
ICD-10 Finland
Tobacco use
2.9
6.3
29
103
2961C
ICD-9 Finland
Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]
9.3
6.3
12
13
F60.0
ICD-10 Finland
Paranoid personality disorder
9.3
6.3
12
13
S82.6
ICD-10 Finland
Fracture of lateral malleolus
2.1
6.3
58
285
4451
FHL
Guitar cutting
2.4
6.3
41
174
G40.59
ICD-10 Finland
Other special epileptic syndromes
18.1
6.3
9
5
E70.0
ICD-10 Finland
Classical phenylketonuria
+∞
6.3
6
*
1530, ,
Kela drug reimbursment
+∞
6.3
6
*
F70.8
ICD-10 Finland
Mild mental retardation, Other impairments of behaviour
+∞
6.3
6
*
Q04.3
ICD-10 Finland
Other reduction deformities of brain
+∞
6.3
6
*
F06.2
ICD-10 Finland
Organic delusional [schizophrenia-like] disorder
26.8
6.2
8
*
K11.72
ICD-10 Finland
Xerostomia
26.8
6.2
8
*
G41.2
ICD-10 Finland
Complex partial status epilepticus
26.8
6.2
8
*
F23.00
ICD-10 Finland
Acute polymorphic psychosis without actual schizophrenic disease picture without acute stress factor
26.8
6.2
8
*
XF600
NOMESCO Finland
Bloodpressure measurement
1.9
6.2
80
442
S06.0
ICD-10 Finland
Concussion
1.7
6.2
119
740
JDB10
NOMESCO Finland
Percutaneous gastrostomy
5.1
6.2
18
36
A07AA09
ATC
vancomycin; oral
5.1
6.2
18
36
U29
ICPC
Urinary symptom/complaint other
2.8
6.2
29
104
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
3.2
6.2
24
77
SFA30
NOMESCO Finland
Three-surface restoration
1.4
6.2
364
2878
R01AD59
ATC
mometasone, combinations; nasal
0.3
6.2
12
460
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
3.6
6.2
20
57
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.2
6.2
23
72
P19
ICPC
Drug abuse
3.4
6.2
21
62
Z51.88
ICD-10 Finland
Other specified medical care
3.4
6.2
21
62
SPAT1303
SPAT
Counselling and guidance related to growth and development
2.2
6.2
49
227
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.0
6.2
63
322
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
3.0
6.1
26
88
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
7.7
6.1
13
17
N06BA04
ATC
methylphenidate; oral
1.8
6.1
86
489
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.0
6.1
66
344
H02AB09
ATC
hydrocortisone; systemic
2.5
6.1
38
158
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.7
6.1
104
627
WX402
NOMESCO Finland
General anaesthesia
1.5
6.1
216
1553
30300
ICD-8 Finland
Alcoholism, Episodic excessive drinking
8.7
6.1
12
14
RK320, ,
NOMESCO Finland
6.7
6.0
14
21
2780A
ICD-9 Finland
Obesity and other hyperalimentation, Obesity
10.1
6.0
11
11
A10BJ05
ATC
dulaglutide; parenteral
3.3
6.0
22
68
F40.9
ICD-10 Finland
Phobic anxiety disorder, unspecified
5.2
6.0
17
33
EB1VA, ,
NOMESCO Finland
1.6
6.0
167
1138
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
risperidone; oral, parenteral
N05AX08 [21604559]
N05AX08 [21604559]
2.9e+00
3.0e+00
3.6e+00
—
3.4e+00
3.4e+00
3.2e+00
cases:8.99%
controls:0.52%
cases:7.45%
controls:0.39%
cases:3.48%
controls:0.10%
—
—
cases:2.99%
controls:0.10%
cases:9.55%
controls:0.35%
cases:16.30%
controls:0.81%
72
41
729
7790
60
31
745
7837
28
8
777
7860
—
24
8
779
7858
75
27
710
7717
118
58
606
7108
valproic acid; oral, parenteral, rectal
N03AG01 [21604422]
N03AG01 [21604422]
2.6e+00
3.0e+00
2.8e+00
—
3.4e+00
3.3e+00
3.2e+00
cases:10.49%
controls:0.86%
cases:9.69%
controls:0.53%
cases:3.48%
controls:0.23%
—
—
cases:3.74%
controls:0.13%
cases:11.85%
controls:0.50%
cases:16.99%
controls:0.81%
84
67
717
7764
78
42
727
7826
28
18
777
7850
—
30
10
773
7856
93
39
692
7705
123
58
601
7108
Unspecified nonorganic psychosis
F29 [45533099]
F29 [45533099]
2.3e+00
3.0e+00
3.5e+00
1.0e+50
2.9e+00
3.2e+00
3.2e+00
cases:5.12%
controls:0.55%
cases:5.09%
controls:0.28%
cases:2.86%
controls:0.09%
cases:3.73%
controls:0.00%
cases:1.87%
controls:0.10%
cases:5.86%
controls:0.25%
cases:10.22%
controls:0.47%
41
43
760
7788
41
22
764
7846
23
7
782
7861
30
0
775
7868
15
8
788
7858
46
19
739
7725
74
34
650
7132
Mixed specific developmental disorders
F83 [45595922]
F83 [45595922]
3.3e+00
3.4e+00
3.7e+00
1.0e+50
2.8e+00
2.2e+00
1.7e+00
cases:13.61%
controls:0.59%
cases:10.68%
controls:0.39%
cases:4.22%
controls:0.11%
cases:2.61%
controls:0.00%
cases:1.62%
controls:0.10%
cases:2.93%
controls:0.34%
cases:4.01%
controls:0.73%
109
46
692
7785
86
31
719
7837
34
9
771
7859
21
0
784
7868
13
8
790
7858
23
26
762
7718
29
52
695
7114
perphenazine; oral, parenteral, rectal
N05AB03 [21604502]
N05AB03 [21604502]
2.7e+00
3.2e+00
—
—
3.2e+00
3.4e+00
3.5e+00
cases:3.75%
controls:0.26%
cases:2.73%
controls:0.11%
—
—
—
—
cases:1.49%
controls:0.06%
cases:3.69%
controls:0.13%
cases:4.83%
controls:0.15%
30
20
771
7811
22
9
783
7859
—
—
12
5
791
7861
29
10
756
7734
35
11
689
7155
olanzapine; oral, parenteral
N05AH03 [21604543]
N05AH03 [21604543]
2.3e+00
2.6e+00
2.9e+00
—
2.4e+00
3.0e+00
2.8e+00
cases:5.74%
controls:0.63%
cases:5.71%
controls:0.44%
cases:2.86%
controls:0.17%
—
—
cases:2.37%
controls:0.22%
cases:8.54%
controls:0.48%
cases:14.09%
controls:0.96%
46
49
755
7782
46
35
759
7833
23
13
782
7855
—
19
17
784
7849
67
37
718
7707
102
69
622
7097
Inpatient Hospital
21 [8717]
21 [8717]
8.8e-01
1.4e+00
2.0e+00
6.2e+00
2.0e+00
1.6e+00
1.1e+00
cases:45.69%
controls:25.94%
cases:26.34%
controls:7.91%
cases:7.70%
controls:1.14%
cases:31.06%
controls:0.09%
cases:7.97%
controls:1.17%
cases:26.75%
controls:6.95%
cases:45.30%
controls:20.96%
366
2031
435
5800
212
622
593
7246
62
90
743
7778
250
7
555
7861
64
92
739
7774
210
538
575
7206
328
1502
396
5664
Psychiatry
26 [38004469]
26 [38004469]
1.9e+00
2.5e+00
2.6e+00
—
2.7e+00
3.0e+00
2.3e+00
cases:24.22%
controls:4.53%
cases:22.73%
controls:2.30%
cases:12.55%
controls:1.04%
—
—
cases:12.95%
controls:0.99%
cases:29.94%
controls:2.17%
cases:38.12%
controls:5.60%
194
355
607
7476
183
181
622
7687
101
82
704
7786
—
104
78
699
7788
235
168
550
7576
276
401
448
6765
topiramate; oral
N03AX11 [21604433]
N03AX11 [21604433]
2.2e+00
2.7e+00
2.4e+00
—
2.6e+00
2.3e+00
2.4e+00
cases:2.37%
controls:0.26%
cases:2.24%
controls:0.15%
cases:0.99%
controls:0.09%
—
—
cases:0.87%
controls:0.06%
cases:1.91%
controls:0.19%
cases:3.45%
controls:0.32%
19
20
782
7811
18
12
787
7856
8
7
797
7861
—
7
5
796
7861
15
15
770
7729
25
23
699
7143
Epilepsy, unspecified
G40.9 [45562083]
G40.9 [45562083]
2.4e+00
2.9e+00
—
1.0e+50
3.2e+00
3.2e+00
2.9e+00
cases:4.99%
controls:0.46%
cases:2.86%
controls:0.17%
—
—
cases:2.11%
controls:0.00%
cases:1.49%
controls:0.06%
cases:3.44%
controls:0.14%
cases:6.08%
controls:0.35%
40
36
761
7795
23
13
782
7855
—
17
0
788
7868
12
5
791
7861
27
11
758
7733
44
25
680
7141
clozapine; oral, parenteral
N05AH02 [21604542]
N05AH02 [21604542]
2.0e+00
2.1e+00
2.0e+00
—
1.7e+00
2.6e+00
3.4e+00
cases:2.25%
controls:0.31%
cases:2.11%
controls:0.27%
cases:1.61%
controls:0.22%
—
—
cases:1.25%
controls:0.23%
cases:3.44%
controls:0.26%
cases:7.60%
controls:0.28%
18
24
783
7807
17
21
788
7847
13
17
792
7851
—
10
18
793
7848
27
20
758
7724
55
20
669
7146
Paediatric neurology
421 [44777781]
421 [44777781]
1.9e+00
2.0e+00
2.7e+00
—
3.4e+00
2.1e+00
1.7e+00
cases:19.48%
controls:3.61%
cases:14.91%
controls:2.40%
cases:5.96%
controls:0.42%
—
—
cases:8.47%
controls:0.31%
cases:12.99%
controls:1.78%
cases:11.74%
controls:2.43%
156
283
645
7548
120
189
685
7679
48
33
757
7835
—
68
24
735
7842
102
138
683
7606
85
174
639
6992
lamotrigine; oral
N03AX09 [21604431]
N03AX09 [21604431]
2.4e+00
2.7e+00
3.0e+00
—
—
3.0e+00
2.3e+00
cases:4.87%
controls:0.46%
cases:2.86%
controls:0.20%
cases:1.24%
controls:0.06%
—
—
—
—
cases:3.31%
controls:0.17%
cases:4.83%
controls:0.52%
39
36
762
7795
23
16
782
7852
10
5
795
7863
—
—
26
13
759
7731
35
37
689
7129
aripiprazole; oral, parenteral
N05AX12 [21604562]
N05AX12 [21604562]
1.8e+00
2.1e+00
2.3e+00
—
2.0e+00
2.6e+00
2.5e+00
cases:3.62%
controls:0.59%
cases:2.73%
controls:0.34%
cases:1.12%
controls:0.11%
—
—
cases:1.12%
controls:0.15%
cases:3.69%
controls:0.30%
cases:6.77%
controls:0.59%
29
46
772
7785
22
27
783
7841
9
9
796
7859
—
9
12
794
7854
29
23
756
7721
49
42
675
7124
levomepromazine; oral, parenteral
N05AA02 [21604493]
N05AA02 [21604493]
2.7e+00
3.7e+00
—
—
—
3.6e+00
3.2e+00
cases:5.37%
controls:0.37%
cases:3.98%
controls:0.10%
—
—
—
—
—
—
cases:4.46%
controls:0.13%
cases:8.56%
controls:0.38%
43
29
758
7802
32
8
773
7860
—
—
—
35
10
750
7734
62
27
662
7139
Severe psychotic and other severe mental disorders
112 [2001600112]
112 [2001600112]
2.8e+00
2.9e+00
—
—
1.0e+50
3.9e+00
3.2e+00
cases:6.62%
controls:0.43%
cases:2.73%
controls:0.15%
—
—
—
—
cases:1.87%
controls:0.00%
cases:3.69%
controls:0.08%
cases:7.18%
controls:0.31%
53
34
748
7797
22
12
783
7856
—
—
15
0
788
7866
29
6
756
7738
52
22
672
7144
quetiapine; oral
N05AH04 [21604544]
N05AH04 [21604544]
1.5e+00
2.1e+00
2.2e+00
—
2.4e+00
2.3e+00
2.0e+00
cases:8.99%
controls:2.06%
cases:8.20%
controls:1.09%
cases:3.35%
controls:0.39%
—
—
cases:4.23%
controls:0.42%
cases:11.21%
controls:1.23%
cases:16.71%
controls:2.67%
72
161
729
7670
66
86
739
7782
27
31
778
7837
—
34
33
769
7833
88
95
697
7649
121
191
603
6975
clonazepam; oral, parenteral
N03AE01 [21604415]
N03AE01 [21604415]
2.3e+00
2.6e+00
2.6e+00
—
—
2.8e+00
2.0e+00
cases:3.37%
controls:0.33%
cases:2.36%
controls:0.18%
cases:0.99%
controls:0.08%
—
—
—
—
cases:2.68%
controls:0.17%
cases:3.31%
controls:0.45%
27
26
774
7805
19
14
786
7854
8
6
797
7862
—
—
21
13
764
7731
24
32
700
7134
Child and Adolescent Psychiatry
OMOP4821986 [45756756]
OMOP4821986 [45756756]
1.3e+00
1.4e+00
1.7e+00
4.0e+00
1.6e+00
1.3e+00
8.7e-01
cases:9.74%
controls:2.95%
cases:7.33%
controls:1.87%
cases:3.35%
controls:0.65%
cases:3.85%
controls:0.08%
cases:3.49%
controls:0.70%
cases:5.99%
controls:1.69%
cases:6.08%
controls:2.65%
78
231
723
7600
59
147
746
7721
27
51
778
7817
31
6
774
7862
28
55
775
7811
47
131
738
7613
44
190
680
6976
Emergency Room Visit
ER [9203]
ER [9203]
5.6e-01
1.0e+00
2.0e+00
4.8e+00
1.5e+00
1.2e+00
8.4e-01
cases:39.95%
controls:27.57%
cases:21.12%
controls:8.66%
cases:7.58%
controls:1.11%
cases:7.45%
controls:0.06%
cases:5.35%
controls:1.22%
cases:22.04%
controls:7.88%
cases:43.37%
controls:24.80%
320
2159
481
5672
170
681
635
7187
61
87
744
7781
60
5
745
7863
43
96
760
7770
173
610
612
7134
314
1777
410
5389
Limited function/disability NOS
A28 [2002000162]
A28 [2002000162]
1.4e+00
1.8e+00
2.3e+00
—
2.6e+00
2.3e+00
1.6e+00
cases:2.50%
controls:0.65%
cases:1.61%
controls:0.28%
cases:1.24%
controls:0.13%
—
—
cases:1.37%
controls:0.10%
cases:2.17%
controls:0.23%
cases:3.73%
controls:0.81%
20
51
781
7780
13
22
792
7846
10
10
795
7858
—
11
8
792
7858
17
18
768
7726
27
58
697
7108
Complex partial epileptic seizure with secondary generalization
G40.22 [2000502141]
G40.22 [2000502141]
2.4e+00
2.1e+00
—
1.0e+50
2.5e+00
2.4e+00
2.4e+00
cases:2.37%
controls:0.23%
cases:1.37%
controls:0.17%
—
—
cases:0.75%
controls:0.00%
cases:0.75%
controls:0.06%
cases:1.27%
controls:0.12%
cases:2.21%
controls:0.21%
19
18
782
7813
11
13
794
7855
—
6
0
799
7868
6
5
797
7861
10
9
775
7735
16
15
708
7151
lorazepam; oral, parenteral, sublingual
N05BA06 [21604571]
N05BA06 [21604571]
2.6e+00
2.7e+00
—
—
—
3.0e+00
3.3e+00
cases:3.50%
controls:0.28%
cases:3.11%
controls:0.22%
—
—
—
—
—
—
cases:3.95%
controls:0.21%
cases:8.29%
controls:0.35%
28
22
773
7809
25
17
780
7851
—
—
—
31
16
754
7728
60
25
664
7141
oxcarbazepine; oral
N03AF02 [21604418]
N03AF02 [21604418]
2.0e+00
2.1e+00
2.6e+00
—
1.7e+00
2.3e+00
2.4e+00
cases:4.62%
controls:0.66%
cases:3.48%
controls:0.43%
cases:0.99%
controls:0.08%
—
—
cases:0.87%
controls:0.17%
cases:3.31%
controls:0.34%
cases:4.70%
controls:0.45%
37
52
764
7779
28
34
777
7834
8
6
797
7862
—
7
13
796
7853
26
26
759
7718
34
32
690
7134
methylphenidate; oral
N06BA04 [21604757]
N06BA04 [21604757]
1.9e+00
1.7e+00
2.7e+00
—
2.3e+00
1.6e+00
1.2e+00
cases:4.49%
controls:0.72%
cases:3.23%
controls:0.60%
cases:1.61%
controls:0.11%
—
—
cases:1.74%
controls:0.18%
cases:3.06%
controls:0.65%
cases:4.28%
controls:1.38%
36
56
765
7775
26
47
779
7821
13
9
792
7859
—
14
14
789
7852
24
50
761
7694
31
99
693
7067
Undifferentiated schizophrenia continuous
F20.30 [2000501944]
F20.30 [2000501944]
2.3e+00
2.7e+00
—
1.0e+50
—
2.8e+00
3.4e+00
cases:1.62%
controls:0.17%
cases:1.49%
controls:0.10%
—
—
cases:1.99%
controls:0.00%
—
—
cases:1.91%
controls:0.12%
cases:4.28%
controls:0.15%
13
13
788
7818
12
8
793
7860
—
16
0
789
7868
—
15
9
770
7735
31
11
693
7155
lithium; oral
N05AN01 [21604556]
N05AN01 [21604556]
2.6e+00
2.4e+00
—
—
—
3.2e+00
3.0e+00
cases:2.25%
controls:0.18%
cases:1.24%
controls:0.11%
—
—
—
—
—
—
cases:1.78%
controls:0.08%
cases:2.76%
controls:0.14%
18
14
783
7817
10
9
795
7859
—
—
—
14
6
771
7738
20
10
704
7156
olanzapine and samidorphan
N05AH53 [955100]
N05AH53 [955100]
2.5e+00
2.8e+00
—
—
—
3.1e+00
2.7e+00
cases:1.50%
controls:0.13%
cases:0.99%
controls:0.06%
—
—
—
—
—
—
cases:1.40%
controls:0.06%
cases:2.76%
controls:0.18%
12
10
789
7821
8
5
797
7863
—
—
—
11
5
774
7739
20
13
704
7153
diazepam; oral, parenteral, rectal
N05BA01 [21604566]
N05BA01 [21604566]
2.0e+00
2.3e+00
1.9e+00
—
1.0e+00
2.5e+00
2.2e+00
cases:10.36%
controls:1.55%
cases:5.34%
controls:0.58%
cases:1.74%
controls:0.25%
—
—
cases:0.62%
controls:0.23%
cases:6.50%
controls:0.56%
cases:12.85%
controls:1.58%
83
121
718
7710
43
46
762
7822
14
20
791
7848
—
5
18
798
7848
51
43
734
7701
93
113
631
7053
levetiracetam; oral, parenteral
N03AX14 [21604436]
N03AX14 [21604436]
2.0e+00
1.8e+00
2.0e+00
—
—
2.4e+00
2.7e+00
cases:3.00%
controls:0.42%
cases:1.86%
controls:0.32%
cases:0.87%
controls:0.11%
—
—
—
—
cases:2.42%
controls:0.23%
cases:3.31%
controls:0.22%
24
33
777
7798
15
25
790
7843
7
9
798
7859
—
—
19
18
766
7726
24
16
700
7150
sertraline; oral
N06AB06 [21604714]
N06AB06 [21604714]
1.4e+00
1.6e+00
2.4e+00
—
2.3e+00
1.6e+00
1.6e+00
cases:4.62%
controls:1.23%
cases:3.35%
controls:0.67%
cases:1.24%
controls:0.11%
—
—
cases:1.00%
controls:0.10%
cases:3.44%
controls:0.71%
cases:7.87%
controls:1.67%
37
96
764
7735
27
53
778
7815
10
9
795
7859
—
8
8
795
7858
27
55
758
7689
57
120
667
7046
carbamazepine; oral, rectal
N03AF01 [21604417]
N03AF01 [21604417]
2.0e+00
2.2e+00
2.6e+00
—
—
2.0e+00
2.1e+00
cases:3.00%
controls:0.43%
cases:2.73%
controls:0.31%
cases:0.99%
controls:0.08%
—
—
—
—
cases:2.29%
controls:0.31%
cases:3.31%
controls:0.42%
24
34
777
7797
22
24
783
7844
8
6
797
7862
—
—
18
24
767
7720
24
30
700
7136
thioridazine; oral
N05AC02 [21604512]
N05AC02 [21604512]
3.7e+00
—
—
—
—
3.6e+00
3.6e+00
cases:3.00%
controls:0.08%
—
—
—
—
—
—
—
—
cases:2.29%
controls:0.06%
cases:2.90%
controls:0.08%
24
6
777
7825
—
—
—
—
18
5
767
7739
21
6
703
7160
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 [2000502142]
G40.29 [2000502142]
2.2e+00
3.2e+00
—
1.0e+50
—
2.7e+00
2.7e+00
cases:2.00%
controls:0.23%
cases:1.49%
controls:0.06%
—
—
cases:1.24%
controls:0.00%
—
—
cases:1.53%
controls:0.10%
cases:2.21%
controls:0.15%
16
18
785
7813
12
5
793
7863
—
10
0
795
7868
—
12
8
773
7736
16
11
708
7155
Home Visit
OMOP4822459 [581476]
OMOP4822459 [581476]
1.2e+00
1.8e+00
2.0e+00
—
2.0e+00
2.0e+00
1.7e+00
cases:7.37%
controls:2.32%
cases:6.21%
controls:1.07%
cases:2.11%
controls:0.28%
—
—
cases:2.24%
controls:0.32%
cases:7.26%
controls:1.08%
cases:17.40%
controls:3.66%
59
182
742
7649
50
84
755
7784
17
22
788
7846
—
18
25
785
7841
57
84
728
7660
126
262
598
6904
General Practice
1 [38004446]
1 [38004446]
9.0e-01
1.7e+00
2.4e+00
—
2.5e+00
1.7e+00
1.3e+00
cases:18.60%
controls:8.49%
cases:12.30%
controls:2.47%
cases:3.35%
controls:0.31%
—
—
cases:3.99%
controls:0.33%
cases:12.87%
controls:2.58%
cases:24.31%
controls:8.04%
149
665
652
7166
99
194
706
7674
27
24
778
7844
—
32
26
771
7840
101
200
684
7544
176
576
548
6590
citalopram; oral, parenteral
N06AB04 [21604712]
N06AB04 [21604712]
1.7e+00
1.8e+00
2.0e+00
—
1.8e+00
1.7e+00
1.6e+00
cases:9.86%
controls:2.04%
cases:6.46%
controls:1.09%
cases:1.61%
controls:0.23%
—
—
cases:1.74%
controls:0.31%
cases:5.73%
controls:1.05%
cases:9.67%
controls:2.12%
79
160
722
7671
52
86
753
7782
13
18
792
7850
—
14
24
789
7842
45
81
740
7663
70
152
654
7014
Epilepsy
G40 [45595935]
G40 [45595935]
2.5e+00
2.9e+00
—
—
—
2.3e+00
2.8e+00
cases:3.50%
controls:0.31%
cases:1.37%
controls:0.08%
—
—
—
—
—
—
cases:1.40%
controls:0.14%
cases:3.04%
controls:0.18%
28
24
773
7807
11
6
794
7862
—
—
—
11
11
774
7733
22
13
702
7153
Outpatient Visit
OP [9202]
OP [9202]
6.6e-01
7.4e-01
1.1e+00
4.9e+00
1.3e+00
8.8e-01
6.9e-01
cases:72.16%
controls:57.35%
cases:57.27%
controls:38.98%
cases:23.23%
controls:9.43%
cases:35.78%
controls:0.39%
cases:25.65%
controls:8.89%
cases:59.62%
controls:37.93%
cases:77.76%
controls:63.69%
578
4491
223
3340
461
3067
344
4801
187
742
618
7126
288
31
517
7837
206
699
597
7167
468
2937
317
4807
563
4564
161
2602
Valproate [Moles/volume] in Serum or Plasma
14946-8 [3009466]
14946-8 [3009466]
2.1e+00
2.6e+00
—
—
—
2.8e+00
2.6e+00
cases:2.75%
controls:0.33%
cases:1.61%
controls:0.13%
—
—
—
—
—
—
cases:1.91%
controls:0.12%
cases:4.42%
controls:0.33%
22
26
779
7805
13
10
792
7858
—
—
—
15
9
770
7735
32
24
692
7142
Paranoid schizophrenia continuous
F20.00 [2000501920]
F20.00 [2000501920]
2.2e+00
2.0e+00
—
—
—
2.7e+00
3.0e+00
cases:1.62%
controls:0.19%
cases:1.24%
controls:0.17%
—
—
—
—
—
—
cases:2.04%
controls:0.14%
cases:4.14%
controls:0.21%
13
15
788
7816
10
13
795
7855
—
—
—
16
11
769
7733
30
15
694
7151
buspirone; oral
N05BE01 [21604601]
N05BE01 [21604601]
2.4e+00
2.2e+00
—
—
—
2.9e+00
2.4e+00
cases:1.62%
controls:0.15%
cases:0.99%
controls:0.11%
—
—
—
—
—
—
cases:1.40%
controls:0.08%
cases:1.93%
controls:0.18%
13
12
788
7819
8
9
797
7859
—
—
—
11
6
774
7738
14
13
710
7153
Mental and behavioural disorders due to use of alcohol, Harmful use
F10.1 [45595844]
F10.1 [45595844]
2.1e+00
3.1e+00
—
1.0e+50
—
2.4e+00
1.9e+00
cases:2.87%
controls:0.36%
cases:1.37%
controls:0.06%
—
—
cases:0.87%
controls:0.00%
—
—
cases:1.40%
controls:0.13%
cases:3.87%
controls:0.59%
23
28
778
7803
11
5
794
7863
—
7
0
798
7868
—
11
10
774
7734
28
42
696
7124
chlorprothixene; oral, parenteral
N05AF03 [21604533]
N05AF03 [21604533]
3.0e+00
—
—
—
—
3.5e+00
3.0e+00
cases:2.75%
controls:0.14%
—
—
—
—
—
—
—
—
cases:2.04%
controls:0.06%
cases:5.11%
controls:0.27%
22
11
779
7820
—
—
—
—
16
5
769
7739
37
19
687
7147
disulfiram; oral
N07BB01 [21604821]
N07BB01 [21604821]
2.0e+00
2.3e+00
—
—
—
2.8e+00
2.4e+00
cases:1.87%
controls:0.27%
cases:1.49%
controls:0.15%
—
—
—
—
—
—
cases:1.66%
controls:0.10%
cases:3.18%
controls:0.29%
15
21
786
7810
12
12
793
7856
—
—
—
13
8
772
7736
23
21
701
7145
ANTIHYPERTENSIVE_DRUG - yes
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
ANTIHYPERTENSIVE_DRUG-1 [2002330215]
2.1e+00
2.6e+00
—
—
—
2.4e+00
2.2e+00
cases:1.00%
controls:0.13%
cases:0.87%
controls:0.06%
—
—
—
—
—
—
cases:1.02%
controls:0.09%
cases:1.38%
controls:0.15%
8
10
793
7821
7
5
798
7863
—
—
—
8
7
777
7737
10
11
714
7155
temazepam; oral
N05CD07 [21604642]
N05CD07 [21604642]
1.3e+00
1.6e+00
2.3e+00
—
—
2.1e+00
2.0e+00
cases:4.74%
controls:1.29%
cases:2.86%
controls:0.60%
cases:1.12%
controls:0.11%
—
—
—
—
cases:4.33%
controls:0.53%
cases:9.67%
controls:1.48%
38
101
763
7730
23
47
782
7821
9
9
796
7859
—
—
34
41
751
7703
70
106
654
7060
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
4.6e-01
6.9e-01
1.4e+00
3.9e+00
1.6e+00
7.8e-01
5.0e-01
cases:22.60%
controls:15.60%
cases:18.14%
controls:10.02%
cases:7.33%
controls:1.96%
cases:3.11%
controls:0.06%
cases:7.72%
controls:1.70%
cases:18.98%
controls:9.72%
cases:29.97%
controls:20.54%
181
1222
620
6609
146
788
659
7080
59
154
746
7714
25
5
780
7863
62
134
741
7732
149
753
636
6991
217
1472
507
5694
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
X69 [45585661]
X69 [45585661]
1.8e+00
2.5e+00
1.0e+50
—
—
2.8e+00
2.2e+00
cases:2.00%
controls:0.34%
cases:0.75%
controls:0.06%
cases:0.75%
controls:0.00%
—
—
—
—
cases:1.27%
controls:0.08%
cases:3.18%
controls:0.35%
16
27
785
7804
6
5
799
7863
6
0
799
7868
—
—
10
6
775
7738
23
25
701
7141
Poisoning by systemic antibiotics
T36 [45756588]
T36 [45756588]
1.7e+00
2.3e+00
1.0e+50
—
—
3.0e+00
2.3e+00
cases:2.62%
controls:0.47%
cases:1.12%
controls:0.11%
cases:0.75%
controls:0.00%
—
—
—
—
cases:1.78%
controls:0.09%
cases:3.73%
controls:0.40%
21
37
780
7794
9
9
796
7859
6
0
799
7868
—
—
14
7
771
7737
27
29
697
7137
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
4.5e-01
6.8e-01
1.4e+00
3.9e+00
1.6e+00
7.7e-01
4.9e-01
cases:22.47%
controls:15.60%
cases:18.14%
controls:10.10%
cases:7.33%
controls:2.00%
cases:2.98%
controls:0.06%
cases:7.60%
controls:1.69%
cases:18.98%
controls:9.76%
cases:29.83%
controls:20.64%
180
1222
621
6609
146
795
659
7073
59
157
746
7711
24
5
781
7863
61
133
742
7733
149
756
636
6988
216
1479
508
5687
venlafaxine; oral
N06AX16 [21604745]
N06AX16 [21604745]
1.0e+00
1.5e+00
1.9e+00
—
1.7e+00
1.6e+00
1.4e+00
cases:3.62%
controls:1.33%
cases:3.35%
controls:0.78%
cases:1.74%
controls:0.25%
—
—
cases:1.37%
controls:0.25%
cases:4.20%
controls:0.84%
cases:6.35%
controls:1.72%
29
104
772
7727
27
61
778
7807
14
20
791
7848
—
11
20
792
7846
33
65
752
7679
46
123
678
7043
Mixed personality disorders
F61.0 [2000502024]
F61.0 [2000502024]
3.1e+00
—
—
1.0e+50
—
2.5e+00
3.6e+00
cases:1.62%
controls:0.08%
—
—
—
—
cases:1.12%
controls:0.00%
—
—
cases:0.76%
controls:0.06%
cases:2.90%
controls:0.08%
13
6
788
7825
—
—
9
0
796
7868
—
6
5
779
7739
21
6
703
7160
midazolam; nasal, oral, parenteral, sublingual
N05CD08 [21604643]
N05CD08 [21604643]
1.6e+00
1.9e+00
—
—
—
2.7e+00
2.8e+00
cases:2.12%
controls:0.42%
cases:1.49%
controls:0.22%
—
—
—
—
—
—
cases:2.17%
controls:0.14%
cases:3.31%
controls:0.21%
17
33
784
7798
12
17
793
7851
—
—
—
17
11
768
7733
24
15
700
7151
Depressive episode, unspecified
F32.9 [45571760]
F32.9 [45571760]
1.6e+00
2.2e+00
2.1e+00
—
1.7e+00
1.7e+00
1.3e+00
cases:6.12%
controls:1.24%
cases:3.48%
controls:0.38%
cases:0.75%
controls:0.09%
—
—
cases:0.62%
controls:0.11%
cases:3.31%
controls:0.59%
cases:6.63%
controls:1.90%
49
97
752
7734
28
30
777
7838
6
7
799
7861
—
5
9
798
7857
26
46
759
7698
48
136
676
7030
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
1.3e+00
1.7e+00
2.7e+00
1.0e+50
2.3e+00
2.0e+00
1.4e+00
cases:8.74%
controls:2.67%
cases:4.10%
controls:0.79%
cases:1.12%
controls:0.08%
cases:0.99%
controls:0.00%
cases:0.62%
controls:0.06%
cases:3.44%
controls:0.46%
cases:4.97%
controls:1.31%
70
209
731
7622
33
62
772
7806
9
6
796
7862
8
0
797
7868
5
5
798
7861
27
36
758
7708
36
94
688
7072
Disturbance of activity and attention
F90.0 [45542870]
F90.0 [45542870]
1.8e+00
1.6e+00
1.6e+00
—
1.7e+00
1.2e+00
1.2e+00
cases:4.37%
controls:0.75%
cases:3.48%
controls:0.75%
cases:1.37%
controls:0.27%
—
—
cases:1.12%
controls:0.22%
cases:2.42%
controls:0.76%
cases:5.11%
controls:1.62%
35
59
766
7772
28
59
777
7809
11
21
794
7847
—
9
17
794
7849
19
59
766
7685
37
116
687
7050
Neurology
13 [38004458]
13 [38004458]
9.6e-01
1.4e+00
2.0e+00
1.0e+50
1.7e+00
1.7e+00
1.2e+00
cases:11.24%
controls:4.61%
cases:8.07%
controls:2.15%
cases:3.11%
controls:0.43%
cases:7.70%
controls:0.00%
cases:2.62%
controls:0.51%
cases:10.06%
controls:2.05%
cases:17.68%
controls:5.96%
90
361
711
7470
65
169
740
7699
25
34
780
7834
62
0
743
7868
21
40
782
7826
79
159
706
7585
128
427
596
6739
Mixed anxiety and depressive disorder
F41.2 [45566845]
F41.2 [45566845]
1.2e+00
1.9e+00
2.8e+00
—
1.8e+00
1.8e+00
1.1e+00
cases:2.87%
controls:0.84%
cases:2.24%
controls:0.34%
cases:1.24%
controls:0.08%
—
—
cases:0.62%
controls:0.10%
cases:2.29%
controls:0.40%
cases:4.56%
controls:1.51%
23
66
778
7765
18
27
787
7841
10
6
795
7862
—
5
8
798
7858
18
31
767
7713
33
108
691
7058
Counselling and guidance which enhance independent living
R2130 [2001310196]
R2130 [2001310196]
1.4e+00
1.3e+00
2.6e+00
1.0e+50
2.5e+00
1.1e+00
1.0e+00
cases:5.87%
controls:1.48%
cases:1.99%
controls:0.57%
cases:0.99%
controls:0.08%
cases:1.24%
controls:0.00%
cases:1.12%
controls:0.09%
cases:1.53%
controls:0.49%
cases:2.76%
controls:1.00%
47
116
754
7715
16
45
789
7823
8
6
797
7862
10
0
795
7868
9
7
794
7859
12
38
773
7706
20
72
704
7094
Recurrent depressive disorder, unspecified
F33.9 [45581458]
F33.9 [45581458]
2.5e+00
2.5e+00
—
1.0e+50
—
2.2e+00
1.7e+00
cases:1.37%
controls:0.11%
cases:0.75%
controls:0.06%
—
—
cases:0.87%
controls:0.00%
—
—
cases:0.89%
controls:0.10%
cases:2.07%
controls:0.39%
11
9
790
7822
6
5
799
7863
—
7
0
798
7868
—
7
8
778
7736
15
28
709
7138
lactulose; oral
A06AD11 [21600571]
A06AD11 [21600571]
1.7e+00
2.1e+00
—
—
—
2.7e+00
2.3e+00
cases:3.12%
controls:0.61%
cases:1.99%
controls:0.25%
—
—
—
—
—
—
cases:3.06%
controls:0.21%
cases:4.83%
controls:0.49%
25
48
776
7783
16
20
789
7848
—
—
—
24
16
761
7728
35
35
689
7131
Emotionally unstable personality disorder, impulsive
F60.30 [2000502022]
F60.30 [2000502022]
1.9e+00
2.3e+00
—
—
—
2.5e+00
2.0e+00
cases:1.25%
controls:0.19%
cases:0.87%
controls:0.09%
—
—
—
—
—
—
cases:1.27%
controls:0.10%
cases:2.07%
controls:0.29%
10
15
791
7816
7
7
798
7861
—
—
—
10
8
775
7736
15
21
709
7145
Fall on same level from slipping, tripping and stumbling
W01 [45756243]
W01 [45756243]
8.6e-01
1.1e+00
1.9e+00
1.0e+50
2.0e+00
1.7e+00
1.1e+00
cases:5.24%
controls:2.30%
cases:1.86%
controls:0.65%
cases:0.87%
controls:0.13%
cases:0.87%
controls:0.00%
cases:0.75%
controls:0.10%
cases:3.57%
controls:0.67%
cases:7.18%
controls:2.62%
42
180
759
7651
15
51
790
7817
7
10
798
7858
7
0
798
7868
6
8
797
7858
28
52
757
7692
52
188
672
6978
Severe depressive episode without psychotic symptoms
F32.2 [45557202]
F32.2 [45557202]
1.3e+00
1.8e+00
2.4e+00
—
—
1.9e+00
1.1e+00
cases:1.87%
controls:0.51%
cases:1.49%
controls:0.25%
cases:1.24%
controls:0.11%
—
—
—
—
cases:1.91%
controls:0.30%
cases:2.49%
controls:0.81%
15
40
786
7791
12
20
793
7848
10
9
795
7859
—
—
15
23
770
7721
18
58
706
7108
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
6.7e-01
9.7e-01
2.8e+00
—
1.8e+00
1.4e+00
7.8e-01
cases:4.37%
controls:2.29%
cases:2.61%
controls:1.00%
cases:1.24%
controls:0.08%
—
—
cases:1.12%
controls:0.18%
cases:4.59%
controls:1.20%
cases:8.98%
controls:4.33%
35
179
766
7652
21
79
784
7789
10
6
795
7862
—
9
14
794
7852
36
93
749
7651
65
310
659
6856
Internal Medicine
11 [38004456]
11 [38004456]
6.0e-01
6.9e-01
1.2e+00
3.4e+00
8.7e-01
9.0e-01
7.5e-01
cases:20.22%
controls:12.25%
cases:10.06%
controls:5.31%
cases:3.60%
controls:1.13%
cases:2.24%
controls:0.08%
cases:2.37%
controls:1.00%
cases:11.97%
controls:5.26%
cases:25.41%
controls:13.84%
162
959
639
6872
81
418
724
7450
29
89
776
7779
18
6
787
7862
19
79
784
7787
94
407
691
7337
184
992
540
6174
Functional capacity evaluation
443351003 [40481051]
443351003 [40481051]
1.3e+00
1.8e+00
2.3e+00
—
—
1.6e+00
1.3e+00
cases:2.87%
controls:0.82%
cases:1.99%
controls:0.32%
cases:0.75%
controls:0.08%
—
—
—
—
cases:1.91%
controls:0.37%
cases:3.59%
controls:0.98%
23
64
778
7767
16
25
789
7843
6
6
799
7862
—
—
15
29
770
7715
26
70
698
7096
Pneumonia, unspecified
J18.9 [45601123]
J18.9 [45601123]
1.1e+00
1.5e+00
2.8e+00
1.0e+50
—
1.5e+00
1.4e+00
cases:5.12%
controls:1.70%
cases:1.74%
controls:0.39%
cases:0.99%
controls:0.06%
cases:0.75%
controls:0.00%
—
—
cases:1.91%
controls:0.43%
cases:6.08%
controls:1.65%
41
133
760
7698
14
31
791
7837
8
5
797
7863
6
0
799
7868
—
15
33
770
7711
44
118
680
7048
Mixed disorder of scholastic skills
F81.3 [45605515]
F81.3 [45605515]
2.7e+00
2.9e+00
2.6e+00
—
—
2.0e+00
1.8e+00
cases:2.37%
controls:0.17%
cases:1.99%
controls:0.11%
cases:0.87%
controls:0.06%
—
—
—
—
cases:0.64%
controls:0.09%
cases:0.69%
controls:0.11%
19
13
782
7818
16
9
789
7859
7
5
798
7863
—
—
5
7
780
7737
5
8
719
7158
Epilepsy and comparable convulsive disorders
111 [2001600111]
111 [2001600111]
1.9e+00
3.0e+00
—
—
—
—
3.3e+00
cases:3.62%
controls:0.56%
cases:1.24%
controls:0.06%
—
—
—
—
—
—
—
—
cases:3.18%
controls:0.13%
29
44
772
7787
10
5
795
7863
—
—
—
—
23
9
701
7157
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
6.2e-01
1.1e+00
2.6e+00
—
2.3e+00
1.2e+00
7.8e-01
cases:4.24%
controls:2.34%
cases:2.48%
controls:0.80%
cases:1.24%
controls:0.09%
—
—
cases:0.75%
controls:0.08%
cases:2.55%
controls:0.76%
cases:5.94%
controls:2.82%
34
183
767
7648
20
63
785
7805
10
7
795
7861
—
6
6
797
7860
20
59
765
7685
43
202
681
6964
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
1.7e+00
2.2e+00
—
—
—
2.3e+00
1.9e+00
cases:1.50%
controls:0.28%
cases:1.37%
controls:0.15%
—
—
—
—
—
—
cases:1.27%
controls:0.13%
cases:1.24%
controls:0.20%
12
22
789
7809
11
12
794
7856
—
—
—
10
10
775
7734
9
14
715
7152
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 [45534452]
R41.8 [45534452]
1.7e+00
2.4e+00
—
—
—
2.0e+00
1.9e+00
cases:1.12%
controls:0.22%
cases:1.49%
controls:0.14%
—
—
—
—
—
—
cases:0.89%
controls:0.12%
cases:2.21%
controls:0.32%
9
17
792
7814
12
11
793
7857
—
—
—
7
9
778
7735
16
23
708
7143
mirtazapine; oral
N06AX11 [21604740]
N06AX11 [21604740]
9.2e-01
1.5e+00
1.7e+00
—
1.5e+00
1.4e+00
9.1e-01
cases:6.49%
controls:2.68%
cases:5.47%
controls:1.26%
cases:1.99%
controls:0.36%
—
—
cases:1.49%
controls:0.34%
cases:5.22%
controls:1.33%
cases:9.39%
controls:4.02%
52
210
749
7621
44
99
761
7769
16
28
789
7840
—
12
27
791
7839
41
103
744
7641
68
288
656
6878
Simple partial seizures with secondary generalization
G40.12 [2000502137]
G40.12 [2000502137]
2.6e+00
—
—
1.0e+50
—
2.6e+00
2.7e+00
cases:1.25%
controls:0.09%
—
—
—
—
cases:0.75%
controls:0.00%
—
—
cases:1.02%
controls:0.08%
cases:1.38%
controls:0.10%
10
7
791
7824
—
—
6
0
799
7868
—
8
6
777
7738
10
7
714
7159
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 [3004529]
19258-3 [3004529]
1.5e+00
2.5e+00
—
—
—
2.2e+00
1.6e+00
cases:1.25%
controls:0.29%
cases:1.12%
controls:0.09%
—
—
—
—
—
—
cases:1.15%
controls:0.13%
cases:2.90%
controls:0.60%
10
23
791
7808
9
7
796
7861
—
—
—
9
10
776
7734
21
43
703
7123
Psychologist
Z2445 [2001311558]
Z2445 [2001311558]
1.5e+00
2.0e+00
2.6e+00
—
1.9e+00
1.3e+00
1.7e+00
cases:4.24%
controls:0.97%
cases:2.86%
controls:0.41%
cases:1.86%
controls:0.14%
—
—
cases:0.75%
controls:0.11%
cases:1.02%
controls:0.27%
cases:1.80%
controls:0.33%
34
76
767
7755
23
32
782
7836
15
11
790
7857
—
6
9
797
7857
8
21
777
7723
13
24
711
7142
mianserin; oral
N06AX03 [21604732]
N06AX03 [21604732]
1.6e+00
1.9e+00
—
—
—
1.9e+00
2.2e+00
cases:1.25%
controls:0.24%
cases:0.87%
controls:0.13%
—
—
—
—
—
—
cases:0.89%
controls:0.13%
cases:1.80%
controls:0.20%
10
19
791
7812
7
10
798
7858
—
—
—
7
10
778
7734
13
14
711
7152
Physical Medicine And Rehabilitation
25 [38004468]
25 [38004468]
6.3e-01
1.5e+00
1.8e+00
—
2.6e+00
1.1e+00
4.3e-01
cases:6.87%
controls:3.79%
cases:6.09%
controls:1.46%
cases:1.61%
controls:0.27%
—
—
cases:2.24%
controls:0.18%
cases:4.33%
controls:1.42%
cases:6.91%
controls:4.61%
55
297
746
7534
49
115
756
7753
13
21
792
7847
—
18
14
785
7852
34
110
751
7634
50
330
674
6836
oxazepam; oral
N05BA04 [21604569]
N05BA04 [21604569]
1.0e+00
1.3e+00
2.2e+00
—
1.1e+00
1.7e+00
1.5e+00
cases:6.62%
controls:2.53%
cases:4.10%
controls:1.17%
cases:1.74%
controls:0.20%
—
—
cases:1.00%
controls:0.33%
cases:5.73%
controls:1.15%
cases:11.33%
controls:2.87%
53
198
748
7633
33
92
772
7776
14
16
791
7852
—
8
26
795
7840
45
89
740
7655
82
206
642
6960
potassium chloride; oral
A12BA01 [21600877]
A12BA01 [21600877]
1.6e+00
2.0e+00
—
—
—
2.3e+00
1.6e+00
cases:1.87%
controls:0.38%
cases:1.12%
controls:0.15%
—
—
—
—
—
—
cases:1.78%
controls:0.18%
cases:2.49%
controls:0.49%
15
30
786
7801
9
12
796
7856
—
—
—
14
14
771
7730
18
35
706
7131
Social worker
Z2446 [2001311559]
Z2446 [2001311559]
1.5e+00
1.8e+00
—
1.0e+50
—
2.3e+00
2.0e+00
cases:5.24%
controls:1.28%
cases:3.11%
controls:0.53%
—
—
cases:1.49%
controls:0.00%
—
—
cases:1.78%
controls:0.18%
cases:3.04%
controls:0.42%
42
100
759
7731
25
42
780
7826
—
12
0
793
7868
—
14
14
771
7730
22
30
702
7136
Treatment of a patient needing special arrangements
WYA30 [2001310874]
WYA30 [2001310874]
1.8e+00
1.7e+00
—
—
—
1.9e+00
2.1e+00
cases:4.74%
controls:0.82%
cases:1.37%
controls:0.24%
—
—
—
—
—
—
cases:1.78%
controls:0.27%
cases:7.60%
controls:1.05%
38
64
763
7767
11
19
794
7849
—
—
—
14
21
771
7723
55
75
669
7091
macrogol; oral
A06AD15 [21600575]
A06AD15 [21600575]
1.3e+00
1.9e+00
—
—
—
2.3e+00
2.1e+00
cases:3.12%
controls:0.89%
cases:2.48%
controls:0.39%
—
—
—
—
—
—
cases:2.68%
controls:0.28%
cases:6.35%
controls:0.85%
25
70
776
7761
20
31
785
7837
—
—
—
21
22
764
7722
46
61
678
7105
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
1.1e+00
8.7e-01
1.6e+00
—
2.0e+00
1.0e+00
9.0e-01
cases:21.72%
controls:8.70%
cases:8.70%
controls:3.85%
cases:2.36%
controls:0.50%
—
—
cases:3.24%
controls:0.44%
cases:9.30%
controls:3.56%
cases:18.23%
controls:8.28%
174
681
627
7150
70
303
735
7565
19
39
786
7829
—
26
35
777
7831
73
276
712
7468
132
593
592
6573
Incontinence urine
U04 [2002001139]
U04 [2002001139]
1.9e+00
2.6e+00
—
—
—
—
2.8e+00
cases:0.87%
controls:0.13%
cases:0.87%
controls:0.06%
—
—
—
—
—
—
—
—
cases:2.90%
controls:0.18%
7
10
794
7821
7
5
798
7863
—
—
—
—
21
13
703
7153
Astigmatism
H52.2 [45547934]
H52.2 [45547934]
1.4e+00
2.0e+00
—
—
—
2.0e+00
1.9e+00
cases:1.50%
controls:0.36%
cases:1.12%
controls:0.15%
—
—
—
—
—
—
cases:1.15%
controls:0.15%
cases:2.21%
controls:0.35%
12
28
789
7803
9
12
796
7856
—
—
—
9
12
776
7732
16
25
708
7141
Inpatient Visit
IP [9201]
IP [9201]
5.9e-01
9.4e-01
1.4e+00
—
2.4e+00
1.3e+00
7.1e-01
cases:11.86%
controls:6.97%
cases:5.09%
controls:2.05%
cases:1.24%
controls:0.31%
—
—
cases:1.99%
controls:0.19%
cases:6.24%
controls:1.78%
cases:9.67%
controls:5.01%
95
546
706
7285
41
161
764
7707
10
24
795
7844
—
16
15
787
7851
49
138
736
7606
70
359
654
6807
escitalopram; oral
N06AB10 [21604718]
N06AB10 [21604718]
9.1e-01
1.2e+00
1.7e+00
—
1.4e+00
1.2e+00
9.1e-01
cases:4.87%
controls:2.02%
cases:3.85%
controls:1.18%
cases:1.99%
controls:0.37%
—
—
cases:1.37%
controls:0.36%
cases:4.46%
controls:1.41%
cases:7.46%
controls:3.15%
39
158
762
7673
31
93
774
7775
16
29
789
7839
—
11
28
792
7838
35
109
750
7635
54
226
670
6940
empagliflozin; oral
A10BK03 [1123740]
A10BK03 [1123740]
1.9e+00
1.9e+00
1.9e+00
—
—
1.6e+00
8.5e-01
cases:1.37%
controls:0.22%
cases:1.37%
controls:0.22%
cases:0.87%
controls:0.13%
—
—
—
—
cases:1.40%
controls:0.28%
cases:1.52%
controls:0.66%
11
17
790
7814
11
17
794
7851
7
10
798
7858
—
—
11
22
774
7722
11
47
713
7119
No procedures
SPAT1301 [2001700402]
SPAT1301 [2001700402]
5.6e-01
1.1e+00
2.0e+00
—
1.7e+00
1.1e+00
6.7e-01
cases:7.24%
controls:4.25%
cases:3.23%
controls:1.12%
cases:1.12%
controls:0.15%
—
—
cases:1.00%
controls:0.18%
cases:3.44%
controls:1.15%
cases:8.84%
controls:4.72%
58
333
743
7498
26
88
779
7780
9
12
796
7856
—
8
14
795
7852
27
89
758
7655
64
338
660
6828
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
2.9e-01
5.2e-01
1.2e+00
3.1e+00
1.4e+00
6.1e-01
3.6e-01
cases:21.97%
controls:17.43%
cases:16.77%
controls:10.66%
cases:5.71%
controls:1.80%
cases:1.99%
controls:0.09%
cases:6.85%
controls:1.86%
cases:16.18%
controls:9.48%
cases:27.90%
controls:21.31%
176
1365
625
6466
135
839
670
7029
46
142
759
7726
16
7
789
7861
55
146
748
7720
127
734
658
7010
202
1527
522
5639
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
2.5e-01
4.5e-01
9.8e-01
3.5e+00
1.3e+00
5.3e-01
3.0e-01
cases:20.10%
controls:16.38%
cases:14.91%
controls:10.08%
cases:5.09%
controls:1.97%
cases:2.86%
controls:0.09%
cases:7.10%
controls:1.97%
cases:15.54%
controls:9.76%
cases:27.49%
controls:21.87%
161
1283
640
6548
120
793
685
7075
41
155
764
7713
23
7
782
7861
57
155
746
7711
122
756
663
6988
199
1567
525
5599
General psychiatric examination, not elsewhere classified
Z00.4 [45605094]
Z00.4 [45605094]
1.0e+00
1.7e+00
2.5e+00
—
—
1.1e+00
7.2e-01
cases:5.12%
controls:1.90%
cases:3.35%
controls:0.62%
cases:1.24%
controls:0.10%
—
—
—
—
cases:1.91%
controls:0.67%
cases:4.42%
controls:2.20%
41
149
760
7682
27
49
778
7819
10
8
795
7860
—
—
15
52
770
7692
32
158
692
7008
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
R5110 [2001310246]
R5110 [2001310246]
1.8e+00
2.0e+00
—
—
—
2.0e+00
1.3e+00
cases:4.00%
controls:0.72%
cases:1.24%
controls:0.18%
—
—
—
—
—
—
cases:1.27%
controls:0.18%
cases:3.04%
controls:0.81%
32
56
769
7775
10
14
795
7854
—
—
—
10
14
775
7730
22
58
702
7108
Emotionally unstable personality disorder, borderline condition
F60.31 [2000502023]
F60.31 [2000502023]
2.4e+00
2.6e+00
—
1.0e+50
—
—
2.0e+00
cases:1.25%
controls:0.11%
cases:0.87%
controls:0.06%
—
—
cases:0.99%
controls:0.00%
—
—
—
—
cases:1.52%
controls:0.21%
10
9
791
7822
7
5
798
7863
—
8
0
797
7868
—
—
11
15
713
7151
Receptive language disorder
F80.2 [45576561]
F80.2 [45576561]
2.4e+00
2.3e+00
—
—
—
—
2.3e+00
cases:2.00%
controls:0.19%
cases:0.75%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.08%
16
15
785
7816
6
6
799
7862
—
—
—
—
6
6
718
7160
Care involving use of other rehabilitation procedures
Z50.8 [45556842]
Z50.8 [45556842]
1.6e+00
1.5e+00
—
1.0e+50
—
2.3e+00
1.6e+00
cases:4.00%
controls:0.83%
cases:1.37%
controls:0.32%
—
—
cases:0.62%
controls:0.00%
—
—
cases:1.91%
controls:0.19%
cases:2.49%
controls:0.53%
32
65
769
7766
11
25
794
7843
—
5
0
800
7868
—
15
15
770
7729
18
38
706
7128
Mental disorder, not otherwise specified
F99 [45605525]
F99 [45605525]
2.6e+00
—
—
—
—
2.5e+00
1.8e+00
cases:1.37%
controls:0.10%
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.06%
cases:1.10%
controls:0.18%
11
8
790
7823
—
—
—
—
6
5
779
7739
8
13
716
7153
Schizophrenia
P72 [2002000866]
P72 [2002000866]
2.0e+00
1.9e+00
—
—
—
2.0e+00
2.8e+00
cases:1.12%
controls:0.15%
cases:0.62%
controls:0.09%
—
—
—
—
—
—
cases:0.76%
controls:0.10%
cases:2.07%
controls:0.13%
9
12
792
7819
5
7
800
7861
—
—
—
6
8
779
7736
15
9
709
7157
Schizophrenia, unspecified
F20.9 [45576533]
F20.9 [45576533]
3.0e+00
—
—
1.0e+50
—
—
3.8e+00
cases:1.50%
controls:0.08%
—
—
—
—
cases:0.99%
controls:0.00%
—
—
—
—
cases:4.83%
controls:0.11%
12
6
789
7825
—
—
8
0
797
7868
—
—
35
8
689
7158
lynestrenol
G03AC02 [21602498]
G03AC02 [21602498]
2.3e+00
2.0e+00
—
—
—
2.0e+00
2.4e+00
cases:1.25%
controls:0.13%
cases:0.99%
controls:0.14%
—
—
—
—
—
—
cases:0.64%
controls:0.09%
cases:1.80%
controls:0.17%
10
10
791
7821
8
11
797
7857
—
—
—
5
7
780
7737
13
12
711
7154
lynestrenol; oral
G03DC03 [21602554]
G03DC03 [21602554]
2.3e+00
2.0e+00
—
—
—
2.0e+00
2.4e+00
cases:1.25%
controls:0.13%
cases:0.99%
controls:0.14%
—
—
—
—
—
—
cases:0.64%
controls:0.09%
cases:1.80%
controls:0.17%
10
10
791
7821
8
11
797
7857
—
—
—
5
7
780
7737
13
12
711
7154
Bicarbonate [Moles/volume] in Venous blood
14627-4 [3027273]
14627-4 [3027273]
1.3e+00
2.0e+00
—
—
—
1.7e+00
1.6e+00
cases:1.37%
controls:0.37%
cases:0.87%
controls:0.11%
—
—
—
—
—
—
cases:1.02%
controls:0.19%
cases:2.90%
controls:0.63%
11
29
790
7802
7
9
798
7859
—
—
—
8
15
777
7729
21
45
703
7121
Neuropsychological investigation
XA800 [2001300412]
XA800 [2001300412]
2.4e+00
2.5e+00
—
—
—
8.1e-01
1.6e+00
cases:6.12%
controls:0.56%
cases:3.48%
controls:0.29%
—
—
—
—
—
—
cases:0.64%
controls:0.28%
cases:1.93%
controls:0.40%
49
44
752
7787
28
23
777
7845
—
—
—
5
22
780
7722
14
29
710
7137
Lithium [Moles/volume] in Serum or Plasma
14334-7 [3024666]
14334-7 [3024666]
1.9e+00
2.3e+00
—
—
—
—
2.2e+00
cases:0.87%
controls:0.13%
cases:0.75%
controls:0.08%
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.11%
7
10
794
7821
6
6
799
7862
—
—
—
—
7
8
717
7158
Outpatient Hospital
22 [8756]
22 [8756]
6.5e-01
8.8e-01
1.5e+00
—
1.6e+00
1.1e+00
7.1e-01
cases:29.96%
controls:18.24%
cases:12.30%
controls:5.49%
cases:3.11%
controls:0.72%
—
—
cases:3.24%
controls:0.70%
cases:11.59%
controls:4.38%
cases:25.41%
controls:14.29%
240
1428
561
6403
99
432
706
7436
25
57
780
7811
—
26
55
777
7811
91
339
694
7405
184
1024
540
6142
Other healthcare associate professional
Z3229 [2001311561]
Z3229 [2001311561]
7.9e-01
1.5e+00
—
—
2.6e+00
1.4e+00
1.4e+00
cases:3.00%
controls:1.38%
cases:2.11%
controls:0.47%
—
—
—
—
cases:1.00%
controls:0.08%
cases:1.02%
controls:0.25%
cases:2.90%
controls:0.71%
24
108
777
7723
17
37
788
7831
—
—
8
6
795
7860
8
19
777
7725
21
51
703
7115
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
F33.10 [2000501984]
1.4e+00
2.1e+00
—
—
—
1.6e+00
1.3e+00
cases:1.62%
controls:0.41%
cases:1.37%
controls:0.18%
—
—
—
—
—
—
cases:1.27%
controls:0.27%
cases:2.21%
controls:0.61%
13
32
788
7799
11
14
794
7854
—
—
—
10
21
775
7723
16
44
708
7122
Anxiety disorder, unspecified
F41.9 [45542849]
F41.9 [45542849]
1.5e+00
1.7e+00
1.8e+00
—
—
1.8e+00
1.2e+00
cases:4.49%
controls:1.03%
cases:2.11%
controls:0.38%
cases:0.75%
controls:0.13%
—
—
—
—
cases:2.55%
controls:0.43%
cases:5.52%
controls:1.69%
36
81
765
7750
17
30
788
7838
6
10
799
7858
—
—
20
33
765
7711
40
121
684
7045
Type 2 diabetes mellitus, without complications
E11.9 [45561952]
E11.9 [45561952]
8.4e-01
9.7e-01
—
1.0e+50
2.3e+00
1.1e+00
1.0e+00
cases:3.25%
controls:1.43%
cases:1.99%
controls:0.76%
—
—
cases:1.61%
controls:0.00%
cases:0.87%
controls:0.09%
cases:2.17%
controls:0.72%
cases:5.66%
controls:2.09%
26
112
775
7719
16
60
789
7808
—
13
0
792
7868
7
7
796
7859
17
56
768
7688
41
150
683
7016
fluoxetine; oral
N06AB03 [21604711]
N06AB03 [21604711]
1.6e+00
1.5e+00
—
—
1.5e+00
1.7e+00
1.3e+00
cases:6.62%
controls:1.39%
cases:3.11%
controls:0.69%
—
—
—
—
cases:1.00%
controls:0.22%
cases:3.44%
controls:0.62%
cases:5.11%
controls:1.45%
53
109
748
7722
25
54
780
7814
—
—
8
17
795
7849
27
48
758
7696
37
104
687
7062
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
1.9e-01
3.8e-01
9.3e-01
3.0e+00
9.5e-01
4.7e-01
3.5e-01
cases:18.60%
controls:15.89%
cases:16.77%
controls:12.10%
cases:6.34%
controls:2.59%
cases:2.61%
controls:0.13%
cases:6.35%
controls:2.56%
cases:16.69%
controls:11.13%
cases:26.24%
controls:20.12%
149
1244
652
6587
135
952
670
6916
51
204
754
7664
21
10
784
7858
51
201
752
7665
131
862
654
6882
190
1442
534
5724
Supine thorax X-ray examination
GD1QA [2001303648]
GD1QA [2001303648]
1.1e+00
2.1e+00
—
—
-1.0e+50
2.1e+00
1.9e+00
cases:1.25%
controls:0.42%
cases:0.75%
controls:0.09%
—
—
—
—
cases:0.00%
controls:0.06%
cases:2.04%
controls:0.25%
cases:3.04%
controls:0.49%
10
33
791
7798
6
7
799
7861
—
—
0
5
803
7861
16
19
769
7725
22
35
702
7131
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
3.6e-01
3.7e-01
5.5e-01
3.3e+00
6.5e-01
3.9e-01
4.9e-01
cases:52.31%
controls:43.34%
cases:47.08%
controls:38.14%
cases:24.35%
controls:15.63%
cases:19.01%
controls:0.85%
cases:26.15%
controls:15.55%
cases:50.06%
controls:40.55%
cases:68.51%
controls:57.09%
419
3394
382
4437
379
3001
426
4867
196
1230
609
6638
153
67
652
7801
210
1223
593
6643
393
3140
392
4604
496
4091
228
3075
clobazam; oral
N05BA09 [21604574]
N05BA09 [21604574]
2.7e+00
3.4e+00
—
—
—
—
—
cases:2.37%
controls:0.17%
cases:2.24%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
19
13
782
7818
18
6
787
7862
—
—
—
—
—
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
2.5e-01
3.9e-01
8.6e-01
3.3e+00
1.0e+00
4.2e-01
2.1e-01
cases:25.84%
controls:21.40%
cases:23.23%
controls:16.94%
cases:8.32%
controls:3.69%
cases:3.73%
controls:0.14%
cases:9.22%
controls:3.61%
cases:22.55%
controls:16.01%
cases:34.53%
controls:29.93%
207
1676
594
6155
187
1333
618
6535
67
290
738
7578
30
11
775
7857
74
284
729
7582
177
1240
608
6504
250
2145
474
5021
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
2.5e-01
4.0e-01
8.6e-01
3.3e+00
1.0e+00
4.2e-01
2.1e-01
cases:25.84%
controls:21.39%
cases:23.23%
controls:16.92%
cases:8.32%
controls:3.69%
cases:3.73%
controls:0.14%
cases:9.22%
controls:3.61%
cases:22.42%
controls:15.97%
cases:34.53%
controls:29.91%
207
1675
594
6156
187
1331
618
6537
67
290
738
7578
30
11
775
7857
74
284
729
7582
176
1237
609
6507
250
2143
474
5023
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
2.5e-01
4.0e-01
8.6e-01
3.3e+00
1.0e+00
4.2e-01
2.1e-01
cases:25.84%
controls:21.39%
cases:23.23%
controls:16.90%
cases:8.32%
controls:3.69%
cases:3.73%
controls:0.14%
cases:9.22%
controls:3.61%
cases:22.42%
controls:16.01%
cases:34.39%
controls:29.85%
207
1675
594
6156
187
1330
618
6538
67
290
738
7578
30
11
775
7857
74
284
729
7582
176
1240
609
6504
249
2139
475
5027
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
2.5e-01
3.9e-01
8.6e-01
3.3e+00
9.9e-01
4.2e-01
2.1e-01
cases:25.84%
controls:21.39%
cases:23.23%
controls:16.94%
cases:8.32%
controls:3.69%
cases:3.73%
controls:0.14%
cases:9.22%
controls:3.62%
cases:22.42%
controls:16.00%
cases:34.53%
controls:29.91%
207
1675
594
6156
187
1333
618
6535
67
290
738
7578
30
11
775
7857
74
285
729
7581
176
1239
609
6505
250
2143
474
5023
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
2.4e-01
3.9e-01
8.6e-01
3.3e+00
1.0e+00
4.1e-01
2.1e-01
cases:25.84%
controls:21.48%
cases:23.23%
controls:16.94%
cases:8.32%
controls:3.71%
cases:3.73%
controls:0.14%
cases:9.22%
controls:3.61%
cases:22.42%
controls:16.05%
cases:34.53%
controls:30.03%
207
1682
594
6149
187
1333
618
6535
67
292
738
7576
30
11
775
7857
74
284
729
7582
176
1243
609
6501
250
2152
474
5014
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
2.4e-01
3.9e-01
8.7e-01
3.3e+00
9.9e-01
4.1e-01
2.2e-01
cases:25.72%
controls:21.35%
cases:23.11%
controls:16.87%
cases:8.32%
controls:3.67%
cases:3.73%
controls:0.14%
cases:9.09%
controls:3.60%
cases:22.29%
controls:15.95%
cases:34.53%
controls:29.84%
206
1672
595
6159
186
1327
619
6541
67
289
738
7579
30
11
775
7857
73
283
730
7583
175
1235
610
6509
250
2138
474
5028
Emergency Medicine
93 [38004510]
93 [38004510]
4.8e-01
9.7e-01
2.0e+00
—
1.1e+00
9.3e-01
5.3e-01
cases:11.99%
controls:7.75%
cases:9.44%
controls:3.81%
cases:3.98%
controls:0.57%
—
—
cases:1.74%
controls:0.60%
cases:10.19%
controls:4.29%
cases:20.17%
controls:12.95%
96
607
705
7224
76
300
729
7568
32
45
773
7823
—
14
47
789
7819
80
332
705
7412
146
928
578
6238
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
2.4e-01
3.9e-01
8.6e-01
3.3e+00
9.9e-01
4.2e-01
2.3e-01
cases:25.84%
controls:21.45%
cases:23.23%
controls:16.97%
cases:8.32%
controls:3.70%
cases:3.60%
controls:0.14%
cases:9.22%
controls:3.62%
cases:22.42%
controls:16.00%
cases:34.94%
controls:29.97%
207
1680
594
6151
187
1335
618
6533
67
291
738
7577
29
11
776
7857
74
285
729
7581
176
1239
609
6505
253
2148
471
5018
oxybutynin; oral, transdermal
G04BD04 [21602637]
G04BD04 [21602637]
1.7e+00
—
—
—
—
2.1e+00
2.0e+00
cases:1.00%
controls:0.18%
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.09%
cases:1.10%
controls:0.15%
8
14
793
7817
—
—
—
—
6
7
779
7737
8
11
716
7155
Intermittent exotropia
H50.31 [2000502353]
H50.31 [2000502353]
1.8e+00
1.5e+00
—
—
—
2.0e+00
2.1e+00
cases:1.75%
controls:0.31%
cases:0.75%
controls:0.17%
—
—
—
—
—
—
cases:1.02%
controls:0.14%
cases:1.80%
controls:0.22%
14
24
787
7807
6
13
799
7855
—
—
—
8
11
777
7733
13
16
711
7150
Adaptation disorder with mixed anxiety and depression
F43.22 [2000502003]
F43.22 [2000502003]
1.5e+00
2.1e+00
—
1.0e+50
—
2.0e+00
1.7e+00
cases:0.75%
controls:0.17%
cases:0.75%
controls:0.09%
—
—
cases:0.62%
controls:0.00%
—
—
cases:0.76%
controls:0.10%
cases:1.80%
controls:0.33%
6
13
795
7818
6
7
799
7861
—
5
0
800
7868
—
6
8
779
7736
13
24
711
7142
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
4.9e-01
6.6e-01
1.6e+00
—
1.5e+00
8.9e-01
7.1e-01
cases:10.99%
controls:7.02%
cases:6.21%
controls:3.32%
cases:2.11%
controls:0.44%
—
—
cases:1.99%
controls:0.44%
cases:7.01%
controls:3.01%
cases:15.47%
controls:8.29%
88
550
713
7281
50
261
755
7607
17
35
788
7833
—
16
35
787
7831
55
233
730
7511
112
594
612
6572
metoprolol; oral, parenteral
C07AB02 [21601684]
C07AB02 [21601684]
9.3e-01
1.1e+00
8.3e-01
—
1.5e+00
1.1e+00
1.1e+00
cases:3.87%
controls:1.57%
cases:3.73%
controls:1.23%
cases:0.87%
controls:0.38%
—
—
cases:1.25%
controls:0.29%
cases:3.69%
controls:1.27%
cases:5.52%
controls:1.90%
31
123
770
7708
30
97
775
7771
7
30
798
7838
—
10
23
793
7843
29
98
756
7646
40
136
684
7030
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
8.3e-01
4.4e-01
—
—
2.6e+00
1.3e+00
1.0e+00
cases:3.87%
controls:1.72%
cases:1.12%
controls:0.72%
—
—
—
—
cases:0.87%
controls:0.06%
cases:1.66%
controls:0.48%
cases:4.70%
controls:1.79%
31
135
770
7696
9
57
796
7811
—
—
7
5
796
7861
13
37
772
7707
34
128
690
7038
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
1.2e+00
1.5e+00
1.5e+00
—
1.4e+00
1.6e+00
1.4e+00
cases:4.49%
controls:1.37%
cases:3.98%
controls:0.94%
cases:0.87%
controls:0.20%
—
—
cases:1.12%
controls:0.28%
cases:4.20%
controls:0.89%
cases:6.63%
controls:1.72%
36
107
765
7724
32
74
773
7794
7
16
798
7852
—
9
22
794
7844
33
69
752
7675
48
123
676
7043
Nursing episode
950 [44777714]
950 [44777714]
2.1e+00
—
—
—
—
2.1e+00
1.4e+00
cases:1.37%
controls:0.17%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.13%
cases:2.49%
controls:0.60%
11
13
790
7818
—
—
—
—
8
10
777
7734
18
43
706
7123
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
F70.1 [45552501]
F70.1 [45552501]
—
1.0e+50
—
1.0e+50
1.0e+50
—
5.6e+00
—
—
cases:0.75%
controls:0.00%
—
—
cases:18.14%
controls:0.00%
cases:5.60%
controls:0.00%
—
—
cases:16.44%
controls:0.07%
—
6
0
799
7868
—
146
0
659
7868
45
0
758
7866
—
119
5
605
7161
Clinical Cytogenetics and Genomics
OMOP4822000 [32411]
OMOP4822000 [32411]
9.7e-01
1.1e+00
—
1.0e+50
—
2.2e+00
1.3e+00
cases:4.99%
controls:1.95%
cases:1.61%
controls:0.55%
—
—
cases:0.75%
controls:0.00%
—
—
cases:1.53%
controls:0.17%
cases:3.45%
controls:0.93%
40
153
761
7678
13
43
792
7825
—
6
0
799
7868
—
12
13
773
7731
25
67
699
7099
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
G40.19 [2000502138]
G40.19 [2000502138]
2.8e+00
—
—
—
—
—
2.8e+00
cases:1.25%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.07%
10
6
791
7825
—
—
—
—
—
8
5
716
7161
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.2 [45591172]
G40.2 [45591172]
2.8e+00
—
—
—
—
—
2.8e+00
cases:1.62%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.07%
13
8
788
7823
—
—
—
—
—
8
5
716
7161
Albumin [Presence] in Urine by Test strip
50949-7 [3029937]
50949-7 [3029937]
6.8e-01
9.7e-01
1.2e+00
—
2.0e+00
1.0e+00
8.2e-01
cases:5.37%
controls:2.78%
cases:3.11%
controls:1.19%
cases:0.75%
controls:0.22%
—
—
cases:0.87%
controls:0.11%
cases:2.93%
controls:1.06%
cases:8.84%
controls:4.10%
43
218
758
7613
25
94
780
7774
6
17
799
7851
—
7
9
796
7857
23
82
762
7662
64
294
660
6872
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
2.5e-01
7.0e-01
1.0e+00
1.4e+00
8.1e-01
7.0e-01
7.5e-01
cases:85.27%
controls:81.83%
cases:79.75%
controls:66.15%
cases:50.56%
controls:26.97%
cases:5.09%
controls:1.25%
cases:45.21%
controls:26.76%
cases:80.64%
controls:67.45%
cases:94.34%
controls:88.71%
683
6408
118
1423
642
5205
163
2663
407
2122
398
5746
41
98
764
7770
363
2105
440
5761
633
5223
152
2521
683
6357
41
809
Other and unspecified convulsions
R56.8 [45602033]
R56.8 [45602033]
1.8e+00
1.2e+00
—
—
—
1.7e+00
1.9e+00
cases:4.37%
controls:0.74%
cases:0.87%
controls:0.25%
—
—
—
—
—
—
cases:1.15%
controls:0.22%
cases:3.31%
controls:0.49%
35
58
766
7773
7
20
798
7848
—
—
—
9
17
776
7727
24
35
700
7131
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
3.9e-01
4.8e-01
2.0e+00
—
1.7e+00
1.1e+00
6.3e-01
cases:4.00%
controls:2.75%
cases:2.24%
controls:1.40%
cases:1.74%
controls:0.24%
—
—
cases:1.00%
controls:0.18%
cases:3.44%
controls:1.21%
cases:6.35%
controls:3.49%
32
215
769
7616
18
110
787
7758
14
19
791
7849
—
8
14
795
7852
27
94
758
7650
46
250
678
6916
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 [2001310176]
R1230 [2001310176]
2.4e+00
3.0e+00
1.0e+50
—
—
—
5.3e-01
cases:2.37%
controls:0.22%
cases:2.48%
controls:0.13%
cases:1.12%
controls:0.00%
—
—
—
—
—
—
cases:0.83%
controls:0.49%
19
17
782
7814
20
10
785
7858
9
0
796
7868
—
—
—
6
35
718
7131
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 [40763086]
60026-2 [40763086]
6.5e-01
9.6e-01
1.2e+00
—
2.0e+00
1.0e+00
7.8e-01
cases:6.87%
controls:3.69%
cases:4.22%
controls:1.66%
cases:0.75%
controls:0.23%
—
—
cases:1.00%
controls:0.14%
cases:4.33%
controls:1.59%
cases:11.60%
controls:5.65%
55
289
746
7542
34
131
771
7737
6
18
799
7850
—
8
11
795
7855
34
123
751
7621
84
405
640
6761
colecalciferol; oral
A11CC05 [21600820]
A11CC05 [21600820]
—
—
—
—
—
3.3e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.06%
cases:1.80%
controls:0.22%
—
—
—
—
—
13
5
772
7739
13
16
711
7150
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
1.4e-01
1.5e+00
—
—
—
2.2e+00
1.6e+00
cases:1.25%
controls:1.09%
cases:1.12%
controls:0.25%
—
—
—
—
—
—
cases:1.02%
controls:0.12%
cases:2.90%
controls:0.59%
10
85
791
7746
9
20
796
7848
—
—
—
8
9
777
7735
21
42
703
7124
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
3.8e-01
5.5e-01
1.7e+00
—
1.3e+00
9.1e-01
8.1e-01
cases:9.24%
controls:6.54%
cases:5.84%
controls:3.44%
cases:3.11%
controls:0.58%
—
—
cases:1.74%
controls:0.47%
cases:6.88%
controls:2.89%
cases:12.98%
controls:6.24%
74
512
727
7319
47
271
758
7597
25
46
780
7822
—
14
37
789
7829
54
224
731
7520
94
447
630
6719
Erysipelas
A46 [45561706]
A46 [45561706]
1.6e+00
9.5e-01
—
—
—
2.4e+00
1.3e+00
cases:2.75%
controls:0.59%
cases:0.62%
controls:0.24%
—
—
—
—
—
—
cases:1.91%
controls:0.17%
cases:2.90%
controls:0.84%
22
46
779
7785
5
19
800
7849
—
—
—
15
13
770
7731
21
60
703
7106
Severe depressive episode with psychotic symptoms
F32.3 [45600739]
F32.3 [45600739]
2.1e+00
—
—
1.0e+50
1.0e+50
—
3.1e+00
cases:1.37%
controls:0.17%
—
—
—
—
cases:1.24%
controls:0.00%
cases:0.87%
controls:0.00%
—
—
cases:2.35%
controls:0.11%
11
13
790
7818
—
—
10
0
795
7868
7
0
796
7866
—
17
8
707
7158
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
1.3e-01
3.0e-01
8.8e-01
3.2e+00
9.5e-01
3.4e-01
8.8e-02
cases:19.48%
controls:17.56%
cases:16.89%
controls:13.07%
cases:6.21%
controls:2.68%
cases:2.48%
controls:0.10%
cases:6.72%
controls:2.72%
cases:16.18%
controls:12.09%
cases:25.28%
controls:23.65%
156
1375
645
6456
136
1028
669
6840
50
211
755
7657
20
8
785
7860
54
214
749
7652
127
936
658
6808
183
1695
541
5471
EKG study
11524-6 [3013512]
11524-6 [3013512]
5.1e-01
1.0e+00
2.1e+00
—
1.7e+00
1.1e+00
7.6e-01
cases:3.12%
controls:1.90%
cases:2.48%
controls:0.93%
cases:0.75%
controls:0.09%
—
—
cases:0.87%
controls:0.17%
cases:3.18%
controls:1.10%
cases:6.22%
controls:3.00%
25
149
776
7682
20
73
785
7795
6
7
799
7861
—
7
13
796
7853
25
85
760
7659
45
215
679
6951
pH of Urine
2756-5 [3015736]
2756-5 [3015736]
5.5e-01
8.5e-01
—
—
1.9e+00
1.1e+00
5.4e-01
cases:6.37%
controls:3.78%
cases:4.72%
controls:2.07%
—
—
—
—
cases:1.12%
controls:0.17%
cases:4.97%
controls:1.77%
cases:10.91%
controls:6.66%
51
296
750
7535
38
163
767
7705
—
—
9
13
794
7853
39
137
746
7607
79
477
645
6689
Sampling
SPAT1263 [2001700364]
SPAT1263 [2001700364]
5.7e-01
8.0e-01
—
—
1.7e+00
1.1e+00
6.9e-01
cases:8.86%
controls:5.20%
cases:4.10%
controls:1.88%
—
—
—
—
cases:1.37%
controls:0.25%
cases:5.10%
controls:1.69%
cases:11.88%
controls:6.34%
71
407
730
7424
33
148
772
7720
—
—
11
20
792
7846
40
131
745
7613
86
454
638
6712
Treatment of chronic ulcer or burn
SPAT1148 [2001700249]
SPAT1148 [2001700249]
1.7e+00
1.9e+00
—
—
—
1.1e+00
1.2e+00
cases:2.50%
controls:0.45%
cases:1.12%
controls:0.17%
—
—
—
—
—
—
cases:0.64%
controls:0.21%
cases:2.62%
controls:0.78%
20
35
781
7796
9
13
796
7855
—
—
—
5
16
780
7728
19
56
705
7110
Psychological sympt/compl other
P29 [2002000823]
P29 [2002000823]
1.4e+00
2.1e+00
—
—
-1.0e+50
9.1e-01
1.4e+00
cases:2.62%
controls:0.66%
cases:1.49%
controls:0.19%
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.89%
controls:0.36%
cases:4.70%
controls:1.17%
21
52
780
7779
12
15
793
7853
—
—
0
6
803
7860
7
28
778
7716
34
84
690
7082
Schizoaffective disorder, unspecified
F25.9 [45605490]
F25.9 [45605490]
2.3e+00
—
—
1.0e+50
—
—
2.5e+00
cases:0.87%
controls:0.09%
—
—
—
—
cases:0.62%
controls:0.00%
—
—
—
—
cases:1.52%
controls:0.13%
7
7
794
7824
—
—
5
0
800
7868
—
—
11
9
713
7157
Home visit
WYA20 [2001310873]
WYA20 [2001310873]
2.5e+00
—
—
—
—
—
2.3e+00
cases:0.75%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.08%
6
5
795
7826
—
—
—
—
—
6
6
718
7160
Specific developmental disorder of motor function
F82 [45605516]
F82 [45605516]
2.6e+00
2.2e+00
—
—
—
—
1.5e+00
cases:2.87%
controls:0.23%
cases:1.12%
controls:0.13%
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.18%
23
18
778
7813
9
10
796
7858
—
—
—
—
6
13
718
7153
metformin; oral
A10BA02 [21600747]
A10BA02 [21600747]
6.7e-01
9.7e-01
1.4e+00
—
6.1e-01
6.8e-01
9.6e-01
cases:5.24%
controls:2.76%
cases:5.84%
controls:2.29%
cases:2.24%
controls:0.53%
—
—
cases:1.37%
controls:0.75%
cases:4.71%
controls:2.45%
cases:8.98%
controls:3.63%
42
216
759
7615
47
180
758
7688
18
42
787
7826
—
11
59
792
7807
37
190
748
7554
65
260
659
6906
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 [3008486]
14920-3 [3008486]
3.6e-01
6.5e-01
9.4e-01
—
1.8e+00
5.3e-01
4.1e-01
cases:15.11%
controls:11.02%
cases:10.81%
controls:5.97%
cases:2.24%
controls:0.89%
—
—
cases:3.24%
controls:0.53%
cases:9.68%
controls:5.94%
cases:20.58%
controls:14.71%
121
863
680
6968
87
470
718
7398
18
70
787
7798
—
26
42
777
7824
76
460
709
7284
149
1054
575
6112
Counselling/guidance promoting independent living
SPAT1222 [2001700323]
SPAT1222 [2001700323]
1.3e+00
1.5e+00
2.1e+00
—
—
1.9e+00
1.5e+00
cases:2.12%
controls:0.59%
cases:0.99%
controls:0.22%
cases:0.62%
controls:0.08%
—
—
—
—
cases:1.78%
controls:0.27%
cases:3.45%
controls:0.80%
17
46
784
7785
8
17
797
7851
5
6
800
7862
—
—
14
21
771
7723
25
57
699
7109
atomoxetine; oral
N06BA09 [21604762]
N06BA09 [21604762]
2.1e+00
—
—
—
—
—
2.6e+00
cases:0.75%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.10%
6
7
795
7824
—
—
—
—
—
9
7
715
7159
Obesity due to excess calories
E66.01 [2000501501]
E66.01 [2000501501]
1.3e+00
8.7e-01
1.6e+00
—
-1.0e+50
1.8e+00
1.6e+00
cases:3.00%
controls:0.83%
cases:1.12%
controls:0.47%
cases:0.62%
controls:0.13%
—
—
cases:0.00%
controls:0.09%
cases:2.17%
controls:0.37%
cases:4.42%
controls:0.92%
24
65
777
7766
9
37
796
7831
5
10
800
7858
—
0
7
803
7859
17
29
768
7715
32
66
692
7100
ipratropium bromide; inhalant
R03BB01 [21603293]
R03BB01 [21603293]
1.4e+00
2.5e+00
—
—
—
—
2.2e+00
cases:0.62%
controls:0.15%
cases:0.75%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.14%
5
12
796
7819
6
5
799
7863
—
—
—
—
9
10
715
7156
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
2.5e-01
4.7e-01
1.5e+00
—
1.2e+00
9.4e-01
8.4e-01
cases:7.87%
controls:6.24%
cases:5.09%
controls:3.25%
cases:2.61%
controls:0.57%
—
—
cases:1.62%
controls:0.47%
cases:6.24%
controls:2.53%
cases:11.88%
controls:5.51%
63
489
738
7342
41
256
764
7612
21
45
784
7823
—
13
37
790
7829
49
196
736
7548
86
395
638
6771
sodium picosulfate; oral
A06AB08 [21600545]
A06AB08 [21600545]
2.0e+00
—
—
—
—
—
2.6e+00
cases:0.75%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.10%
6
8
795
7823
—
—
—
—
—
9
7
715
7159
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 [3009201]
3016-3 [3009201]
4.0e-01
6.2e-01
9.5e-01
—
1.6e+00
5.1e-01
3.7e-01
cases:18.60%
controls:13.26%
cases:13.54%
controls:7.78%
cases:2.61%
controls:1.03%
—
—
cases:4.11%
controls:0.83%
cases:11.97%
controls:7.58%
cases:24.86%
controls:18.56%
149
1038
652
6793
109
612
696
7256
21
81
784
7787
—
33
65
770
7801
94
587
691
7157
180
1330
544
5836
Psychological disorders other
P99 [2002000880]
P99 [2002000880]
1.3e+00
—
—
—
—
2.2e+00
2.3e+00
cases:0.87%
controls:0.23%
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.10%
cases:2.62%
controls:0.27%
7
18
794
7813
—
—
—
—
7
8
778
7736
19
19
705
7147
Specific gravity of Urine by Refractometry
5810-7 [3019150]
5810-7 [3019150]
7.8e-01
9.6e-01
—
—
2.1e+00
8.7e-01
6.1e-01
cases:4.74%
controls:2.23%
cases:2.86%
controls:1.12%
—
—
—
—
cases:0.75%
controls:0.09%
cases:2.42%
controls:1.03%
cases:7.18%
controls:4.05%
38
175
763
7656
23
88
782
7780
—
—
6
7
797
7859
19
80
766
7664
52
290
672
6876
Bacteria identified in Urine by Culture
630-4 [3026008]
630-4 [3026008]
8.2e-01
1.2e+00
1.5e+00
—
1.8e+00
1.5e+00
9.4e-01
cases:5.87%
controls:2.68%
cases:3.23%
controls:0.99%
cases:0.87%
controls:0.20%
—
—
cases:0.62%
controls:0.10%
cases:4.08%
controls:0.98%
cases:8.98%
controls:3.71%
47
210
754
7621
26
78
779
7790
7
16
798
7852
—
5
8
798
7858
32
76
753
7668
65
266
659
6900
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.2e-01
2.1e-01
6.9e-01
2.8e+00
8.8e-01
2.6e-01
7.7e-02
cases:28.09%
controls:25.64%
cases:27.08%
controls:23.13%
cases:12.42%
controls:6.65%
cases:5.47%
controls:0.34%
cases:13.57%
controls:6.11%
cases:27.77%
controls:22.91%
cases:38.26%
controls:36.46%
225
2008
576
5823
218
1820
587
6048
100
523
705
7345
44
27
761
7841
109
481
694
7385
218
1774
567
5970
277
2613
447
4553
Moderate depressive episode without somatic syndrome
F32.10 [2000501980]
F32.10 [2000501980]
1.3e+00
1.6e+00
1.8e+00
—
1.4e+00
1.6e+00
8.5e-01
cases:3.12%
controls:0.88%
cases:2.24%
controls:0.48%
cases:0.75%
controls:0.13%
—
—
cases:0.62%
controls:0.15%
cases:2.04%
controls:0.44%
cases:2.49%
controls:1.07%
25
69
776
7762
18
38
787
7830
6
10
799
7858
—
5
12
798
7854
16
34
769
7710
18
77
706
7089
Therapeutic discussion
SPAT1240 [2001700341]
SPAT1240 [2001700341]
6.0e-01
1.6e+00
—
—
—
1.5e+00
1.3e+00
cases:2.50%
controls:1.39%
cases:2.24%
controls:0.47%
—
—
—
—
—
—
cases:1.91%
controls:0.44%
cases:5.11%
controls:1.49%
20
109
781
7722
18
37
787
7831
—
—
—
15
34
770
7710
37
107
687
7059
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
3.3e-01
5.9e-01
1.2e+00
—
1.1e+00
6.3e-01
4.5e-01
cases:20.85%
controls:15.87%
cases:12.55%
controls:7.37%
cases:3.35%
controls:1.07%
—
—
cases:3.24%
controls:1.06%
cases:14.52%
controls:8.33%
cases:30.94%
controls:22.16%
167
1243
634
6588
101
580
704
7288
27
84
778
7784
—
26
83
777
7783
114
645
671
7099
224
1588
500
5578
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
5.5e-01
7.5e-01
1.7e+00
1.0e+50
4.6e-01
7.3e-01
5.5e-01
cases:6.62%
controls:3.93%
cases:4.47%
controls:2.16%
cases:1.12%
controls:0.20%
cases:3.35%
controls:0.00%
cases:0.62%
controls:0.39%
cases:4.59%
controls:2.26%
cases:10.50%
controls:6.34%
53
308
748
7523
36
170
769
7698
9
16
796
7852
27
0
778
7868
5
31
798
7835
36
175
749
7569
76
454
648
6712
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
3.9e-01
6.2e-01
1.1e+00
—
1.2e+00
6.2e-01
3.3e-01
cases:23.10%
controls:16.91%
cases:20.25%
controls:12.05%
cases:7.33%
controls:2.57%
—
—
cases:7.47%
controls:2.30%
cases:20.25%
controls:12.07%
cases:30.52%
controls:23.96%
185
1324
616
6507
163
948
642
6920
59
202
746
7666
—
60
181
743
7685
159
935
626
6809
221
1717
503
5449
Otolaryngology
4 [38004449]
4 [38004449]
4.0e-01
6.4e-01
9.0e-01
2.6e+00
5.8e-01
4.7e-01
5.5e-01
cases:14.11%
controls:9.88%
cases:6.96%
controls:3.77%
cases:1.37%
controls:0.56%
cases:0.87%
controls:0.06%
cases:0.75%
controls:0.42%
cases:5.22%
controls:3.32%
cases:14.23%
controls:8.71%
113
774
688
7057
56
297
749
7571
11
44
794
7824
7
5
798
7863
6
33
797
7833
41
257
744
7487
103
624
621
6542
paroxetine; oral
N06AB05 [21604713]
N06AB05 [21604713]
1.5e+00
1.4e+00
—
—
—
1.3e+00
1.4e+00
cases:2.00%
controls:0.47%
cases:1.24%
controls:0.32%
—
—
—
—
—
—
cases:1.15%
controls:0.31%
cases:2.21%
controls:0.57%
16
37
785
7794
10
25
795
7843
—
—
—
9
24
776
7720
16
41
708
7125
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
7.6e-01
6.5e-01
1.6e+00
—
9.0e-01
1.0e+00
8.2e-01
cases:7.62%
controls:3.72%
cases:3.60%
controls:1.91%
cases:2.61%
controls:0.55%
—
—
cases:1.25%
controls:0.51%
cases:4.59%
controls:1.74%
cases:9.67%
controls:4.51%
61
291
740
7540
29
150
776
7718
21
43
784
7825
—
10
40
793
7826
36
135
749
7609
70
323
654
6843
Delayed milestone
R62.0 [45597195]
R62.0 [45597195]
2.2e+00
1.9e+00
—
—
—
—
-1.0e+50
cases:4.24%
controls:0.47%
cases:1.12%
controls:0.17%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.10%
34
37
767
7794
9
13
796
7855
—
—
—
—
0
7
724
7159
Genetic counselling
Z31.5 [45590715]
Z31.5 [45590715]
8.7e-01
1.1e+00
—
—
—
1.8e+00
1.4e+00
cases:3.25%
controls:1.39%
cases:1.37%
controls:0.44%
—
—
—
—
—
—
cases:0.89%
controls:0.14%
cases:2.62%
controls:0.66%
26
109
775
7722
11
35
794
7833
—
—
—
7
11
778
7733
19
47
705
7119
Chronic ulcer skin
S97 [2002001061]
S97 [2002001061]
2.2e+00
—
—
—
—
—
1.9e+00
cases:1.00%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
cases:1.80%
controls:0.27%
8
9
793
7822
—
—
—
—
—
13
19
711
7147
nizatidine; oral, parenteral
A02BA04 [21600085]
A02BA04 [21600085]
8.0e-01
2.5e+00
—
—
—
—
1.6e+00
cases:0.62%
controls:0.28%
cases:0.75%
controls:0.06%
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.22%
5
22
796
7809
6
5
799
7863
—
—
—
—
8
16
716
7150
Obesity
T82 [2002001125]
T82 [2002001125]
1.6e+00
—
—
—
—
2.1e+00
1.9e+00
cases:0.75%
controls:0.15%
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.09%
cases:1.80%
controls:0.27%
6
12
795
7819
—
—
—
—
6
7
779
7737
13
19
711
7147
Bipolar affective disorder, unspecified
F31.9 [45571758]
F31.9 [45571758]
2.2e+00
—
—
1.0e+50
—
—
1.9e+00
cases:1.00%
controls:0.11%
—
—
—
—
cases:0.75%
controls:0.00%
—
—
—
—
cases:1.10%
controls:0.17%
8
9
793
7822
—
—
6
0
799
7868
—
—
8
12
716
7154
cloZAPine [Moles/volume] in Serum or Plasma
14656-3 [3000081]
14656-3 [3000081]
1.3e+00
—
—
—
—
1.9e+00
2.2e+00
cases:0.75%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.02%
controls:0.15%
cases:2.35%
controls:0.28%
6
16
795
7815
—
—
—
—
8
12
777
7732
17
20
707
7146
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
5.6e-01
8.8e-01
1.8e+00
—
—
1.6e+00
9.5e-01
cases:7.62%
controls:4.49%
cases:3.23%
controls:1.36%
cases:0.75%
controls:0.13%
—
—
—
—
cases:3.31%
controls:0.66%
cases:6.63%
controls:2.68%
61
352
740
7479
26
107
779
7761
6
10
799
7858
—
—
26
51
759
7693
48
192
676
6974
Acute tubulo-interstitial nephritis
N10 [45543856]
N10 [45543856]
9.5e-01
1.4e+00
—
—
—
1.9e+00
1.1e+00
cases:2.12%
controls:0.83%
cases:0.75%
controls:0.19%
—
—
—
—
—
—
cases:1.78%
controls:0.26%
cases:2.49%
controls:0.82%
17
65
784
7766
6
15
799
7853
—
—
—
14
20
771
7724
18
59
706
7107
Pediatric Medicine
37 [38004477]
37 [38004477]
3.0e-01
3.1e-01
1.5e-01
3.6e+00
4.3e-01
2.1e-01
4.4e-01
cases:21.47%
controls:16.84%
cases:13.04%
controls:9.95%
cases:3.23%
controls:2.78%
cases:4.35%
controls:0.13%
cases:3.99%
controls:2.62%
cases:10.83%
controls:8.95%
cases:15.33%
controls:10.44%
172
1319
629
6512
105
783
700
7085
26
219
779
7649
35
10
770
7858
32
206
771
7660
85
693
700
7051
111
748
613
6418
Limited function/disability (L)
L28 [2002000647]
L28 [2002000647]
9.5e-01
1.5e+00
—
—
—
1.4e+00
1.1e+00
cases:1.50%
controls:0.59%
cases:1.12%
controls:0.25%
—
—
—
—
—
—
cases:1.40%
controls:0.36%
cases:3.45%
controls:1.13%
12
46
789
7785
9
20
796
7848
—
—
—
11
28
774
7716
25
81
699
7085
ferrous glycine sulfate; oral
B03AA01 [21601080]
B03AA01 [21601080]
1.0e+00
1.4e+00
—
—
—
1.8e+00
2.2e+00
cases:1.37%
controls:0.51%
cases:0.62%
controls:0.15%
—
—
—
—
—
—
cases:1.15%
controls:0.19%
cases:2.49%
controls:0.29%
11
40
790
7791
5
12
800
7856
—
—
—
9
15
776
7729
18
21
706
7145
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
7.4e-01
1.0e+00
1.4e+00
1.0e+50
1.3e+00
1.2e+00
9.7e-01
cases:6.99%
controls:3.47%
cases:3.85%
controls:1.42%
cases:0.75%
controls:0.18%
cases:0.87%
controls:0.00%
cases:0.62%
controls:0.17%
cases:3.18%
controls:0.98%
cases:6.63%
controls:2.61%
56
272
745
7559
31
112
774
7756
6
14
799
7854
7
0
798
7868
5
13
798
7853
25
76
760
7668
48
187
676
6979
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
8.5e-01
8.1e-01
1.4e+00
—
—
1.2e+00
1.0e+00
cases:7.12%
controls:3.17%
cases:3.11%
controls:1.41%
cases:0.99%
controls:0.25%
—
—
—
—
cases:3.44%
controls:1.05%
cases:7.60%
controls:2.80%
57
248
744
7583
25
111
780
7757
8
20
797
7848
—
—
27
81
758
7663
55
201
669
6965
Bacterial pneumonia, unspecified
J15.9 [45557621]
J15.9 [45557621]
1.8e+00
—
—
—
—
—
2.1e+00
cases:2.12%
controls:0.34%
—
—
—
—
—
—
—
—
—
—
cases:2.35%
controls:0.31%
17
27
784
7804
—
—
—
—
—
17
22
707
7144
General evaluation of the need for rehabilitation
R1100 [2001310172]
R1100 [2001310172]
1.8e+00
—
—
—
—
2.1e+00
2.0e+00
cases:1.75%
controls:0.28%
—
—
—
—
—
—
—
—
cases:0.64%
controls:0.08%
cases:1.38%
controls:0.18%
14
22
787
7809
—
—
—
—
5
6
780
7738
10
13
714
7153
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
6.5e-01
9.0e-01
—
—
—
1.3e+00
1.0e+00
cases:8.86%
controls:4.83%
cases:3.73%
controls:1.55%
—
—
—
—
—
—
cases:2.80%
controls:0.77%
cases:6.35%
controls:2.39%
71
378
730
7453
30
122
775
7746
—
—
—
22
60
763
7684
46
171
678
6995
Counselling and guidance related to nutrition and weight management
SPAT1306 [2001700407]
SPAT1306 [2001700407]
1.3e+00
1.2e+00
—
—
—
1.5e+00
1.1e+00
cases:3.00%
controls:0.87%
cases:1.12%
controls:0.34%
—
—
—
—
—
—
cases:1.27%
controls:0.30%
cases:4.28%
controls:1.41%
24
68
777
7763
9
27
796
7841
—
—
—
10
23
775
7721
31
101
693
7065
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 [3043924]
40987-0 [3043924]
7.2e-01
1.4e+00
—
—
—
1.3e+00
1.1e+00
cases:1.87%
controls:0.92%
cases:1.37%
controls:0.33%
—
—
—
—
—
—
cases:1.53%
controls:0.41%
cases:4.28%
controls:1.45%
15
72
786
7759
11
26
794
7842
—
—
—
12
32
773
7712
31
104
693
7062
Care involving use of rehabilitation procedure, unspecified
Z50.9 [45595525]
Z50.9 [45595525]
1.7e+00
2.1e+00
—
—
—
2.2e+00
1.4e+00
cases:1.00%
controls:0.19%
cases:0.62%
controls:0.08%
—
—
—
—
—
—
cases:1.15%
controls:0.13%
cases:1.10%
controls:0.27%
8
15
793
7816
5
6
800
7862
—
—
—
9
10
776
7734
8
19
716
7147
Folate [Moles/volume] in Red Blood Cells
14731-4 [3019309]
14731-4 [3019309]
1.1e+00
1.5e+00
—
—
—
1.1e+00
1.2e+00
cases:3.87%
controls:1.30%
cases:1.49%
controls:0.33%
—
—
—
—
—
—
cases:0.89%
controls:0.28%
cases:2.62%
controls:0.81%
31
102
770
7729
12
26
793
7842
—
—
—
7
22
778
7722
19
58
705
7108
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
6.4e-01
1.3e+00
—
—
—
1.1e+00
7.4e-01
cases:5.12%
controls:2.76%
cases:3.85%
controls:1.12%
—
—
—
—
—
—
cases:3.57%
controls:1.18%
cases:6.91%
controls:3.40%
41
216
760
7615
31
88
774
7780
—
—
—
28
91
757
7653
50
244
674
6922
Sensorineural hearing loss, bilateral
H90.3 [45576850]
H90.3 [45576850]
1.1e+00
1.1e+00
—
—
—
1.0e+00
1.5e+00
cases:2.75%
controls:0.93%
cases:1.74%
controls:0.57%
—
—
—
—
—
—
cases:1.66%
controls:0.61%
cases:4.97%
controls:1.10%
22
73
779
7758
14
45
791
7823
—
—
—
13
47
772
7697
36
79
688
7087
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
1.1e+00
7.9e-01
—
—
—
1.6e+00
1.1e+00
cases:4.49%
controls:1.61%
cases:1.12%
controls:0.51%
—
—
—
—
—
—
cases:1.53%
controls:0.32%
cases:4.01%
controls:1.34%
36
126
765
7705
9
40
796
7828
—
—
—
12
25
773
7719
29
96
695
7070
levothyroxine sodium; oral, parenteral
H03AA01 [21602754]
H03AA01 [21602754]
6.2e-01
6.9e-01
1.0e+00
—
8.1e-01
7.0e-01
7.0e-01
cases:7.12%
controls:3.97%
cases:7.95%
controls:4.14%
cases:3.11%
controls:1.12%
—
—
cases:2.37%
controls:1.07%
cases:8.15%
controls:4.24%
cases:9.94%
controls:5.21%
57
311
744
7520
64
326
741
7542
25
88
780
7780
—
19
84
784
7782
64
328
721
7416
72
373
652
6793
Examination of ears and hearing
Z01.1 [45547279]
Z01.1 [45547279]
1.2e+00
3.8e-01
—
—
-1.0e+50
1.4e+00
1.1e+00
cases:5.74%
controls:1.79%
cases:0.87%
controls:0.60%
—
—
—
—
cases:0.00%
controls:0.06%
cases:1.91%
controls:0.46%
cases:4.42%
controls:1.51%
46
140
755
7691
7
47
798
7821
—
—
0
5
803
7861
15
36
770
7708
32
108
692
7058
tolterodine; oral
G04BD07 [21602640]
G04BD07 [21602640]
1.9e+00
—
—
—
—
—
1.8e+00
cases:1.00%
controls:0.15%
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.15%
8
12
793
7819
—
—
—
—
—
7
11
717
7155
Periodontal treatment, brief
SDA02 [2001310327]
SDA02 [2001310327]
8.7e-01
7.4e-02
2.1e+00
—
—
6.8e-01
6.6e-01
cases:8.24%
controls:3.64%
cases:1.49%
controls:1.39%
cases:0.75%
controls:0.09%
—
—
—
—
cases:2.42%
controls:1.24%
cases:9.67%
controls:5.25%
66
285
735
7546
12
109
793
7759
6
7
799
7861
—
—
19
96
766
7648
70
376
654
6790
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 [3019800]
6598-7 [3019800]
5.3e-01
8.7e-01
2.9e+00
—
1.4e+00
8.7e-01
7.7e-01
cases:4.00%
controls:2.40%
cases:2.24%
controls:0.95%
cases:1.12%
controls:0.06%
—
—
cases:0.75%
controls:0.18%
cases:2.42%
controls:1.03%
cases:7.32%
controls:3.53%
32
188
769
7643
18
75
787
7793
9
5
796
7863
—
6
14
797
7852
19
80
766
7664
53
253
671
6913
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 [3044938]
34487-9 [3044938]
5.2e-01
1.2e+00
—
—
—
1.3e+00
1.1e+00
cases:2.00%
controls:1.20%
cases:1.49%
controls:0.43%
—
—
—
—
—
—
cases:1.78%
controls:0.49%
cases:5.25%
controls:1.84%
16
94
785
7737
12
34
793
7834
—
—
—
14
38
771
7706
38
132
686
7034
Implementation of physical therapy rehabilitation plan
SPAT1223 [2001700324]
SPAT1223 [2001700324]
7.1e-01
1.1e+00
—
—
—
1.1e+00
7.5e-01
cases:4.37%
controls:2.20%
cases:2.36%
controls:0.81%
—
—
—
—
—
—
cases:2.29%
controls:0.79%
cases:5.11%
controls:2.48%
35
172
766
7659
19
64
786
7804
—
—
—
18
61
767
7683
37
178
687
6988
Bacteria [#/volume] in Urine by Automated count
51480-2 [3031040]
51480-2 [3031040]
3.3e-01
8.1e-01
1.1e+00
—
1.3e+00
8.8e-01
6.3e-01
cases:10.86%
controls:8.08%
cases:7.58%
controls:3.52%
cases:1.49%
controls:0.51%
—
—
cases:1.62%
controls:0.46%
cases:7.64%
controls:3.31%
cases:17.13%
controls:9.95%
87
633
714
7198
61
277
744
7591
12
40
793
7828
—
13
36
790
7830
60
256
725
7488
124
713
600
6453
haloperidol; oral, parenteral
N05AD01 [21604516]
N05AD01 [21604516]
—
—
—
—
—
—
3.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.87%
controls:0.11%
—
—
—
—
—
—
28
8
696
7158
Abdominal pain localized other
D06 [2002000305]
D06 [2002000305]
5.4e-01
1.8e+00
—
—
—
1.7e+00
6.5e-01
cases:1.25%
controls:0.73%
cases:0.87%
controls:0.14%
—
—
—
—
—
—
cases:1.15%
controls:0.21%
cases:1.52%
controls:0.80%
10
57
791
7774
7
11
798
7857
—
—
—
9
16
776
7728
11
57
713
7109
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
5.4e-01
8.6e-01
—
—
—
1.2e+00
9.2e-01
cases:6.37%
controls:3.82%
cases:3.60%
controls:1.55%
—
—
—
—
—
—
cases:2.93%
controls:0.90%
cases:8.29%
controls:3.49%
51
299
750
7532
29
122
776
7746
—
—
—
23
70
762
7674
60
250
664
6916
hydrocortisone
D07XA01 [21602180]
D07XA01 [21602180]
6.3e-01
1.2e+00
—
—
—
1.4e+00
9.3e-01
cases:4.00%
controls:2.17%
cases:1.99%
controls:0.61%
—
—
—
—
—
—
cases:2.42%
controls:0.62%
cases:4.97%
controls:2.02%
32
170
769
7661
16
48
789
7820
—
—
—
19
48
766
7696
36
145
688
7021
hydrocortisone and antiseptics
D07BA04 [21602146]
D07BA04 [21602146]
6.3e-01
1.2e+00
—
—
—
1.4e+00
9.3e-01
cases:4.00%
controls:2.17%
cases:1.99%
controls:0.61%
—
—
—
—
—
—
cases:2.42%
controls:0.62%
cases:4.97%
controls:2.02%
32
170
769
7661
16
48
789
7820
—
—
—
19
48
766
7696
36
145
688
7021
chlorhexidine
D09AA12 [21602275]
D09AA12 [21602275]
5.6e-01
1.2e+00
—
—
—
1.4e+00
9.3e-01
cases:3.75%
controls:2.17%
cases:1.99%
controls:0.61%
—
—
—
—
—
—
cases:2.42%
controls:0.62%
cases:4.97%
controls:2.02%
30
170
771
7661
16
48
789
7820
—
—
—
19
48
766
7696
36
145
688
7021
other antifungals for topical use - combinations; ointment
D01AE20 [21601959]
D01AE20 [21601959]
5.6e-01
1.2e+00
—
—
—
1.4e+00
9.3e-01
cases:3.75%
controls:2.17%
cases:1.99%
controls:0.61%
—
—
—
—
—
—
cases:2.42%
controls:0.62%
cases:4.97%
controls:2.02%
30
170
771
7661
16
48
789
7820
—
—
—
19
48
766
7696
36
145
688
7021
chlorhexidine, combinations
D08AC52 [21602208]
D08AC52 [21602208]
5.6e-01
1.2e+00
—
—
—
1.4e+00
9.3e-01
cases:3.75%
controls:2.17%
cases:1.99%
controls:0.61%
—
—
—
—
—
—
cases:2.42%
controls:0.62%
cases:4.97%
controls:2.02%
30
170
771
7661
16
48
789
7820
—
—
—
19
48
766
7696
36
145
688
7021
chlorhexidine
S03AA04 [21605193]
S03AA04 [21605193]
5.6e-01
1.2e+00
—
—
—
1.4e+00
9.3e-01
cases:3.75%
controls:2.17%
cases:1.99%
controls:0.61%
—
—
—
—
—
—
cases:2.42%
controls:0.62%
cases:4.97%
controls:2.02%
30
170
771
7661
16
48
789
7820
—
—
—
19
48
766
7696
36
145
688
7021
chlorhexidine
S02AA09 [21605155]
S02AA09 [21605155]
5.6e-01
1.2e+00
—
—
—
1.4e+00
9.3e-01
cases:3.75%
controls:2.17%
cases:1.99%
controls:0.61%
—
—
—
—
—
—
cases:2.42%
controls:0.62%
cases:4.97%
controls:2.02%
30
170
771
7661
16
48
789
7820
—
—
—
19
48
766
7696
36
145
688
7021
triamcinolone and antiseptics
D07BB03 [21602150]
D07BB03 [21602150]
5.4e-01
1.2e+00
—
—
—
1.4e+00
9.1e-01
cases:3.75%
controls:2.21%
cases:1.99%
controls:0.61%
—
—
—
—
—
—
cases:2.42%
controls:0.62%
cases:4.97%
controls:2.07%
30
173
771
7658
16
48
789
7820
—
—
—
19
48
766
7696
36
148
688
7018
Lamotrigin and topiramate
183 [2001600182]
183 [2001600182]
3.5e+00
—
—
—
—
—
—
cases:2.37%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
19
6
782
7825
—
—
—
—
—
—
Support of social functional capacity
SPAT1234 [2001700335]
SPAT1234 [2001700335]
1.8e+00
—
—
—
—
—
1.6e+00
cases:0.87%
controls:0.14%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.22%
7
11
794
7820
—
—
—
—
—
8
16
716
7150
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 [3018251]
14771-0 [3018251]
3.8e-01
6.4e-01
7.4e-01
—
1.3e+00
6.5e-01
4.4e-01
cases:14.98%
controls:10.78%
cases:10.81%
controls:6.00%
cases:1.61%
controls:0.78%
—
—
cases:2.49%
controls:0.67%
cases:10.70%
controls:5.88%
cases:22.79%
controls:15.94%
120
844
681
6987
87
472
718
7396
13
61
792
7807
—
20
53
783
7813
84
455
701
7289
165
1142
559
6024
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
5.8e-01
6.3e-01
9.5e-01
—
6.7e-01
6.1e-01
6.2e-01
cases:14.48%
controls:8.63%
cases:9.81%
controls:5.45%
cases:2.61%
controls:1.03%
—
—
cases:1.74%
controls:0.90%
cases:9.55%
controls:5.42%
cases:19.61%
controls:11.61%
116
676
685
7155
79
429
726
7439
21
81
784
7787
—
14
71
789
7795
75
420
710
7324
142
832
582
6334
Pulmonary Disease
29 [38004472]
29 [38004472]
8.3e-01
8.4e-01
1.3e+00
1.0e+50
—
8.8e-01
8.0e-01
cases:6.12%
controls:2.77%
cases:3.11%
controls:1.36%
cases:0.99%
controls:0.28%
cases:0.87%
controls:0.00%
—
—
cases:3.82%
controls:1.61%
cases:8.29%
controls:3.89%
49
217
752
7614
25
107
780
7761
8
22
797
7846
7
0
798
7868
—
30
125
755
7619
60
279
664
6887
Carboxyhemoglobin/Hemoglobin.total in Blood
20563-3 [3023081]
20563-3 [3023081]
2.0e+00
—
—
—
—
—
1.4e+00
cases:1.25%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.43%
10
14
791
7817
—
—
—
—
—
12
31
712
7135
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
3.6e-01
6.3e-01
1.2e+00
—
9.7e-01
8.3e-01
6.1e-01
cases:11.99%
controls:8.68%
cases:7.95%
controls:4.38%
cases:1.99%
controls:0.61%
—
—
cases:1.49%
controls:0.57%
cases:8.66%
controls:3.96%
cases:17.40%
controls:10.27%
96
680
705
7151
64
345
741
7523
16
48
789
7820
—
12
45
791
7821
68
307
717
7437
126
736
598
6430
doxepin; oral, parenteral
N06AA12 [21604699]
N06AA12 [21604699]
1.4e+00
—
—
—
—
1.7e+00
1.8e+00
cases:1.50%
controls:0.36%
—
—
—
—
—
—
—
—
cases:0.76%
controls:0.14%
cases:1.66%
controls:0.28%
12
28
789
7803
—
—
—
—
6
11
779
7733
12
20
712
7146
Methemoglobin/Hemoglobin.total in Blood
2614-6 [3007930]
2614-6 [3007930]
1.8e+00
—
—
—
—
—
1.4e+00
cases:1.12%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.42%
9
14
792
7817
—
—
—
—
—
12
30
712
7136
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
1.2e+00
2.0e+00
—
—
—
1.6e+00
3.3e-01
cases:1.50%
controls:0.43%
cases:0.99%
controls:0.14%
—
—
—
—
—
—
cases:0.64%
controls:0.13%
cases:0.83%
controls:0.60%
12
34
789
7797
8
11
797
7857
—
—
—
5
10
780
7734
6
43
718
7123
Evaluation of communicative skills
R1260 [2001310179]
R1260 [2001310179]
3.2e+00
2.3e+00
—
—
—
—
—
cases:1.87%
controls:0.08%
cases:0.62%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
15
6
786
7825
5
5
800
7863
—
—
—
—
—
hydrocortisone
S02BA01 [21605166]
S02BA01 [21605166]
5.0e-01
9.1e-01
—
—
1.6e+00
9.8e-01
7.6e-01
cases:9.36%
controls:5.87%
cases:4.35%
controls:1.80%
—
—
—
—
cases:0.75%
controls:0.15%
cases:4.46%
controls:1.72%
cases:11.88%
controls:5.94%
75
460
726
7371
35
142
770
7726
—
—
6
12
797
7854
35
133
750
7611
86
426
638
6740
Telehealth
OMOP5556618 [722455]
OMOP5556618 [722455]
3.4e-01
4.7e-01
1.0e+00
—
6.5e-01
7.4e-01
5.9e-01
cases:21.35%
controls:16.19%
cases:9.44%
controls:6.10%
cases:2.61%
controls:0.98%
—
—
cases:1.62%
controls:0.85%
cases:11.34%
controls:5.76%
cases:25.14%
controls:15.64%
171
1268
630
6563
76
480
729
7388
21
77
784
7791
—
13
67
790
7799
89
446
696
7298
182
1121
542
6045
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
2.6e-01
4.2e-01
1.2e+00
—
1.3e+00
5.7e-01
2.8e-01
cases:10.99%
controls:8.71%
cases:9.44%
controls:6.39%
cases:4.60%
controls:1.39%
—
—
cases:4.61%
controls:1.27%
cases:11.85%
controls:7.08%
cases:19.75%
controls:15.73%
88
682
713
7149
76
503
729
7365
37
109
768
7759
—
37
100
766
7766
93
548
692
7196
143
1127
581
6039
hydrocortisone buteprate
D07AB11 [21602115]
D07AB11 [21602115]
4.6e-01
9.1e-01
—
—
1.4e+00
1.0e+00
7.2e-01
cases:9.99%
controls:6.55%
cases:4.72%
controls:1.96%
—
—
—
—
cases:0.75%
controls:0.19%
cases:5.10%
controls:1.90%
cases:12.71%
controls:6.63%
80
513
721
7318
38
154
767
7714
—
—
6
15
797
7851
40
147
745
7597
92
475
632
6691
hydrocortisone butyrate
D07AB02 [21602106]
D07AB02 [21602106]
4.6e-01
9.1e-01
—
—
1.4e+00
1.0e+00
7.2e-01
cases:9.99%
controls:6.55%
cases:4.72%
controls:1.96%
—
—
—
—
cases:0.75%
controls:0.19%
cases:5.10%
controls:1.90%
cases:12.71%
controls:6.63%
80
513
721
7318
38
154
767
7714
—
—
6
15
797
7851
40
147
745
7597
92
475
632
6691
hydrocortisone
D07AA02 [21602102]
D07AA02 [21602102]
4.6e-01
9.1e-01
—
—
1.4e+00
1.0e+00
7.2e-01
cases:9.99%
controls:6.55%
cases:4.72%
controls:1.96%
—
—
—
—
cases:0.75%
controls:0.19%
cases:5.10%
controls:1.90%
cases:12.71%
controls:6.63%
80
513
721
7318
38
154
767
7714
—
—
6
15
797
7851
40
147
745
7597
92
475
632
6691
hydrocortisone aceponate
D07AC16 [21602135]
D07AC16 [21602135]
4.6e-01
9.1e-01
—
—
1.4e+00
1.0e+00
7.2e-01
cases:9.99%
controls:6.55%
cases:4.72%
controls:1.96%
—
—
—
—
cases:0.75%
controls:0.19%
cases:5.10%
controls:1.90%
cases:12.71%
controls:6.63%
80
513
721
7318
38
154
767
7714
—
—
6
15
797
7851
40
147
745
7597
92
475
632
6691
Administration of medicine
SPAT1254 [2001700355]
SPAT1254 [2001700355]
7.5e-01
8.8e-01
1.7e+00
—
1.5e+00
1.5e+00
8.1e-01
cases:4.24%
controls:2.04%
cases:1.49%
controls:0.62%
cases:0.62%
controls:0.11%
—
—
cases:0.75%
controls:0.17%
cases:2.80%
controls:0.62%
cases:4.70%
controls:2.14%
34
160
767
7671
12
49
793
7819
5
9
800
7859
—
6
13
797
7853
22
48
763
7696
34
153
690
7013
hydrocortisone
C05AA01 [21601608]
C05AA01 [21601608]
4.5e-01
9.1e-01
—
—
1.4e+00
1.0e+00
7.2e-01
cases:9.99%
controls:6.60%
cases:4.84%
controls:2.01%
—
—
—
—
cases:0.75%
controls:0.19%
cases:5.10%
controls:1.94%
cases:12.85%
controls:6.68%
80
517
721
7314
39
158
766
7710
—
—
6
15
797
7851
40
150
745
7594
93
479
631
6687
hydrocortisone
A07EA02 [21600654]
A07EA02 [21600654]
4.5e-01
9.1e-01
—
—
1.4e+00
1.0e+00
7.2e-01
cases:9.99%
controls:6.60%
cases:4.84%
controls:2.01%
—
—
—
—
cases:0.75%
controls:0.19%
cases:5.10%
controls:1.94%
cases:12.85%
controls:6.68%
80
517
721
7314
39
158
766
7710
—
—
6
15
797
7851
40
150
745
7594
93
479
631
6687
Other generalized epilepsy and epileptic syndromes
G40.4 [45557231]
G40.4 [45557231]
3.1e+00
—
—
1.0e+50
—
—
—
cases:1.37%
controls:0.06%
—
—
—
—
cases:0.62%
controls:0.00%
—
—
—
—
—
—
11
5
790
7826
—
—
5
0
800
7868
—
—
—
Counselling related to known health issue
SPAT1310 [2001700411]
SPAT1310 [2001700411]
5.2e-01
9.2e-01
1.7e+00
—
1.3e+00
9.2e-01
7.2e-01
cases:6.74%
controls:4.14%
cases:3.11%
controls:1.26%
cases:0.75%
controls:0.14%
—
—
cases:0.62%
controls:0.18%
cases:2.93%
controls:1.19%
cases:8.43%
controls:4.30%
54
324
747
7507
25
99
780
7769
6
11
799
7857
—
5
14
798
7852
23
92
762
7652
61
308
663
6858
Pediatric Cardiology
OMOP4821938 [45756805]
OMOP4821938 [45756805]
1.0e+00
1.2e+00
—
—
—
9.1e-01
9.1e-01
cases:4.87%
controls:1.85%
cases:2.61%
controls:0.84%
—
—
—
—
—
—
cases:1.91%
controls:0.77%
cases:3.18%
controls:1.30%
39
145
762
7686
21
66
784
7802
—
—
—
15
60
770
7684
23
93
701
7073
Occupational therapy
R4120 [2001310234]
R4120 [2001310234]
1.6e+00
1.4e+00
—
—
—
1.7e+00
1.0e+00
cases:2.37%
controls:0.47%
cases:1.37%
controls:0.33%
—
—
—
—
—
—
cases:0.64%
controls:0.12%
cases:1.38%
controls:0.50%
19
37
782
7794
11
26
794
7842
—
—
—
5
9
780
7735
10
36
714
7130
biperiden; oral, parenteral
N04AA02 [21604447]
N04AA02 [21604447]
3.1e+00
—
—
—
—
—
—
cases:2.12%
controls:0.10%
—
—
—
—
—
—
—
—
—
—
—
—
17
8
784
7823
—
—
—
—
—
—
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
9.1e-01
8.4e-01
—
—
—
1.1e+00
1.0e+00
cases:2.75%
controls:1.12%
cases:1.49%
controls:0.65%
—
—
—
—
—
—
cases:2.17%
controls:0.76%
cases:4.83%
controls:1.77%
22
88
779
7743
12
51
793
7817
—
—
—
17
59
768
7685
35
127
689
7039
Psychosis requiring demanding treatment
188 [2001600187]
188 [2001600187]
—
—
—
—
—
—
3.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.38%
controls:0.07%
—
—
—
—
—
—
10
5
714
7161
Natriuretic peptide B [Mass/volume] in Serum or Plasma
30934-4 [3011960]
30934-4 [3011960]
1.1e+00
1.2e+00
-1.0e+50
—
—
1.9e+00
1.2e+00
cases:2.00%
controls:0.65%
cases:0.99%
controls:0.31%
cases:0.00%
controls:0.06%
—
—
—
—
cases:1.15%
controls:0.18%
cases:1.24%
controls:0.39%
16
51
785
7780
8
24
797
7844
0
5
805
7863
—
—
9
14
776
7730
9
28
715
7138
Ketones [Presence] in Urine by Test strip
2514-8 [3035350]
2514-8 [3035350]
5.0e-01
8.9e-01
1.1e+00
—
1.5e+00
9.5e-01
6.5e-01
cases:7.37%
controls:4.62%
cases:5.84%
controls:2.49%
cases:0.99%
controls:0.34%
—
—
cases:1.00%
controls:0.23%
cases:6.11%
controls:2.47%
cases:14.64%
controls:8.21%
59
362
742
7469
47
196
758
7672
8
27
797
7841
—
8
18
795
7848
48
191
737
7553
106
588
618
6578
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
7.2e-01
1.2e+00
—
—
—
1.1e+00
5.0e-01
cases:4.37%
controls:2.18%
cases:2.61%
controls:0.80%
—
—
—
—
—
—
cases:1.91%
controls:0.67%
cases:4.01%
controls:2.47%
35
171
766
7660
21
63
784
7805
—
—
—
15
52
770
7692
29
177
695
6989
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 [3019902]
13317-3 [3019902]
4.8e-01
8.6e-01
—
1.0e+50
—
1.9e+00
1.1e+00
cases:1.37%
controls:0.86%
cases:0.87%
controls:0.37%
—
—
cases:0.62%
controls:0.00%
—
—
cases:1.15%
controls:0.18%
cases:2.07%
controls:0.70%
11
67
790
7764
7
29
798
7839
—
5
0
800
7868
—
9
14
776
7730
15
50
709
7116
Dizziness and giddiness
R42 [45568132]
R42 [45568132]
2.3e-01
1.3e+00
—
—
—
1.6e+00
6.1e-01
cases:1.37%
controls:1.10%
cases:1.61%
controls:0.44%
—
—
—
—
—
—
cases:1.66%
controls:0.35%
cases:2.62%
controls:1.44%
11
86
790
7745
13
35
792
7833
—
—
—
13
27
772
7717
19
103
705
7063
Pediatric Surgery
OMOP4822020 [45756819]
OMOP4822020 [45756819]
5.3e-01
7.0e-01
7.8e-01
—
—
9.1e-01
6.9e-01
cases:7.74%
controls:4.71%
cases:4.10%
controls:2.07%
cases:0.75%
controls:0.34%
—
—
—
—
cases:3.82%
controls:1.58%
cases:6.35%
controls:3.28%
62
369
739
7462
33
163
772
7705
6
27
799
7841
—
—
30
122
755
7622
46
235
678
6931
felodipine; oral
C08CA02 [21601748]
C08CA02 [21601748]
1.3e+00
1.5e+00
—
—
-1.0e+50
1.1e+00
6.6e-01
cases:1.62%
controls:0.43%
cases:1.24%
controls:0.28%
—
—
—
—
cases:0.00%
controls:0.08%
cases:0.89%
controls:0.28%
cases:1.10%
controls:0.57%
13
34
788
7797
10
22
795
7846
—
—
0
6
803
7860
7
22
778
7722
8
41
716
7125
Urinary tract infection, site not specified
N39.0 [45548665]
N39.0 [45548665]
1.0e+00
—
—
—
—
1.7e+00
1.1e+00
cases:1.50%
controls:0.55%
—
—
—
—
—
—
—
—
cases:1.66%
controls:0.30%
cases:3.59%
controls:1.24%
12
43
789
7788
—
—
—
—
13
23
772
7721
26
89
698
7077
flupentixol; oral, parenteral
N05AF01 [21604531]
N05AF01 [21604531]
2.8e+00
—
—
—
—
—
—
cases:1.25%
controls:0.08%
—
—
—
—
—
—
—
—
—
—
—
—
10
6
791
7825
—
—
—
—
—
—
Excessive ear wax
H81 [2002000536]
H81 [2002000536]
1.5e+00
7.1e-01
-1.0e+50
—
—
—
1.3e+00
cases:2.37%
controls:0.52%
cases:0.62%
controls:0.31%
cases:0.00%
controls:0.06%
—
—
—
—
—
—
cases:3.45%
controls:1.00%
19
41
782
7790
5
24
800
7844
0
5
805
7863
—
—
—
25
72
699
7094
Hyperkinetic disorder, unspecified
F90.9 [45533124]
F90.9 [45533124]
2.8e+00
—
—
—
—
—
—
cases:1.00%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
8
5
793
7826
—
—
—
—
—
—
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
3.3e-01
8.2e-01
7.4e-01
—
1.3e+00
6.3e-01
2.4e-01
cases:10.11%
controls:7.50%
cases:8.07%
controls:3.72%
cases:1.24%
controls:0.60%
—
—
cases:2.12%
controls:0.60%
cases:7.01%
controls:3.87%
cases:13.54%
controls:11.01%
81
587
720
7244
65
293
740
7575
10
47
795
7821
—
17
47
786
7819
55
300
730
7444
98
789
626
6377
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-1.1e+00
-1.4e+00
—
—
—
2.3e+00
2.9e+00
cases:10.49%
controls:26.22%
cases:2.73%
controls:10.17%
—
—
—
—
—
—
cases:3.06%
controls:0.32%
cases:12.98%
controls:0.78%
84
2053
717
5778
22
800
783
7068
—
—
—
24
25
761
7719
94
56
630
7110
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
3.2e-01
1.1e+00
—
—
—
1.6e+00
1.1e+00
cases:2.00%
controls:1.46%
cases:1.24%
controls:0.43%
—
—
—
—
—
—
cases:1.27%
controls:0.26%
cases:2.90%
controls:0.99%
16
114
785
7717
10
34
795
7834
—
—
—
10
20
775
7724
21
71
703
7095
Developmental disorder of scholastic skills, unspecified
F81.9 [45581474]
F81.9 [45581474]
2.7e+00
—
—
1.0e+50
—
—
—
cases:1.12%
controls:0.08%
—
—
—
—
cases:0.62%
controls:0.00%
—
—
—
—
—
—
9
6
792
7825
—
—
5
0
800
7868
—
—
—
Caries of dentine
K02.1 [45548134]
K02.1 [45548134]
3.6e-01
6.6e-01
8.4e-01
—
1.3e+00
4.3e-01
4.1e-01
cases:14.11%
controls:10.27%
cases:8.57%
controls:4.61%
cases:1.37%
controls:0.60%
—
—
cases:1.99%
controls:0.57%
cases:7.64%
controls:5.11%
cases:22.10%
controls:15.89%
113
804
688
7027
69
363
736
7505
11
47
794
7821
—
16
45
787
7821
60
396
725
7348
160
1139
564
6027
hydrocortisone and antiinfectives
S01CA03 [21603654]
S01CA03 [21603654]
6.8e-01
8.6e-01
—
—
—
1.6e+00
1.1e+00
cases:2.87%
controls:1.48%
cases:0.87%
controls:0.37%
—
—
—
—
—
—
cases:1.53%
controls:0.32%
cases:3.31%
controls:1.10%
23
116
778
7715
7
29
798
7839
—
—
—
12
25
773
7719
24
79
700
7087
Nausea and vomiting
R11 [45539317]
R11 [45539317]
8.2e-01
—
—
—
—
1.6e+00
1.1e+00
cases:2.37%
controls:1.06%
—
—
—
—
—
—
—
—
cases:1.27%
controls:0.27%
cases:2.76%
controls:0.91%
19
83
782
7748
—
—
—
—
10
21
775
7723
20
65
704
7101
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
5.2e-01
7.6e-01
—
—
—
1.4e+00
1.3e+00
cases:5.87%
controls:3.59%
cases:2.61%
controls:1.23%
—
—
—
—
—
—
cases:2.17%
controls:0.56%
cases:5.52%
controls:1.56%
47
281
754
7550
21
97
784
7771
—
—
—
17
43
768
7701
40
112
684
7054
antibiotics in combination with corticosteroids
D01AA20 [21601918]
D01AA20 [21601918]
6.8e-01
8.3e-01
—
—
—
1.6e+00
1.1e+00
cases:3.12%
controls:1.61%
cases:0.87%
controls:0.38%
—
—
—
—
—
—
cases:1.66%
controls:0.35%
cases:4.14%
controls:1.41%
25
126
776
7705
7
30
798
7838
—
—
—
13
27
772
7717
30
101
694
7065
Erythrocytes [Presence] in Urine by Automated
53292-9 [3041096]
53292-9 [3041096]
5.8e-01
9.1e-01
1.4e+00
—
—
9.6e-01
7.9e-01
cases:4.49%
controls:2.57%
cases:2.86%
controls:1.17%
cases:0.62%
controls:0.15%
—
—
—
—
cases:3.06%
controls:1.19%
cases:8.15%
controls:3.87%
36
201
765
7630
23
92
782
7776
5
12
800
7856
—
—
24
92
761
7652
59
277
665
6889
zuclopenthixol; oral, parenteral
N05AF05 [21604535]
N05AF05 [21604535]
2.6e+00
—
—
—
—
—
—
cases:1.25%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
—
—
10
7
791
7824
—
—
—
—
—
—
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
4.8e-01
7.0e-01
—
—
—
1.1e+00
1.0e+00
cases:9.61%
controls:6.17%
cases:3.48%
controls:1.75%
—
—
—
—
—
—
cases:2.68%
controls:0.88%
cases:8.84%
controls:3.34%
77
483
724
7348
28
138
777
7730
—
—
—
21
68
764
7676
64
239
660
6927
Other problems related to lifestyle
Z72.8 [45609965]
Z72.8 [45609965]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.07%
—
—
—
—
—
—
7
5
717
7161
Intentional self-harm by sharp object
X78 [45756450]
X78 [45756450]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.07%
—
—
—
—
—
—
7
5
717
7161
OLANZapine [Moles/volume] in Serum or Plasma
39484-1 [3040370]
39484-1 [3040370]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.97%
controls:0.07%
—
—
—
—
—
—
7
5
717
7161
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.8e-01
8.6e-01
1.0e+00
1.0e+50
5.2e-01
6.9e-01
5.0e-01
cases:8.74%
controls:5.10%
cases:5.84%
controls:2.55%
cases:1.61%
controls:0.58%
cases:0.75%
controls:0.00%
cases:1.00%
controls:0.60%
cases:5.35%
controls:2.75%
cases:10.77%
controls:6.81%
70
399
731
7432
47
201
758
7667
13
46
792
7822
6
0
799
7868
8
47
795
7819
42
213
743
7531
78
488
646
6678
Metabolic syndrome
E66.00 [2000501500]
E66.00 [2000501500]
—
—
—
—
—
2.6e+00
1.3e+00
—
—
—
—
—
—
—
—
—
—
cases:0.89%
controls:0.06%
cases:1.38%
controls:0.36%
—
—
—
—
—
7
5
778
7739
10
26
714
7140
Diffusion capacity of lung
54715006 [4182985]
54715006 [4182985]
2.6e+00
—
—
—
—
—
—
cases:0.87%
controls:0.06%
—
—
—
—
—
—
—
—
—
—
—
—
7
5
794
7826
—
—
—
—
—
—
moclobemide; oral
N06AG02 [21604727]
N06AG02 [21604727]
1.2e+00
2.6e+00
—
—
—
1.6e+00
1.2e+00
cases:0.87%
controls:0.26%
cases:0.87%
controls:0.06%
—
—
—
—
—
—
cases:0.64%
controls:0.13%
cases:0.97%
controls:0.28%
7
20
794
7811
7
5
798
7863
—
—
—
5
10
780
7734
7
20
717
7146
amitriptyline; oral, parenteral
N06AA09 [21604696]
N06AA09 [21604696]
7.4e-01
5.6e-01
—
—
—
1.2e+00
6.9e-01
cases:3.37%
controls:1.63%
cases:1.61%
controls:0.93%
—
—
—
—
—
—
cases:2.55%
controls:0.80%
cases:4.28%
controls:2.19%
27
128
774
7703
13
73
792
7795
—
—
—
20
62
765
7682
31
157
693
7009
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
4.0e-01
5.0e-01
5.9e-01
—
8.3e-01
5.3e-01
3.4e-01
cases:22.10%
controls:15.97%
cases:17.64%
controls:11.49%
cases:3.98%
controls:2.24%
—
—
cases:4.73%
controls:2.11%
cases:17.71%
controls:11.21%
cases:30.11%
controls:23.49%
177
1251
624
6580
142
904
663
6964
32
176
773
7692
—
38
166
765
7700
139
868
646
6876
218
1683
506
5483
Recording of ECG
SPAT1097 [2001700198]
SPAT1097 [2001700198]
1.4e+00
1.6e+00
—
—
—
—
1.2e+00
cases:1.75%
controls:0.45%
cases:0.62%
controls:0.13%
—
—
—
—
—
—
—
—
cases:2.07%
controls:0.61%
14
35
787
7796
5
10
800
7858
—
—
—
—
15
44
709
7122
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 [3038288]
40982-1 [3038288]
7.6e-01
1.5e+00
—
—
—
1.3e+00
1.1e+00
cases:2.00%
controls:0.94%
cases:1.37%
controls:0.32%
—
—
—
—
—
—
cases:1.40%
controls:0.40%
cases:4.42%
controls:1.47%
16
74
785
7757
11
25
794
7843
—
—
—
11
31
774
7713
32
105
692
7061
Place of Employment-Worksite
18 [581475]
18 [581475]
1.3e+00
—
—
—
—
—
1.3e+00
cases:1.75%
controls:0.47%
—
—
—
—
—
—
—
—
—
—
cases:1.93%
controls:0.56%
14
37
787
7794
—
—
—
—
—
14
40
710
7126
Social assessment of need and possibilities of rehabilitation
R1240 [2001310177]
R1240 [2001310177]
2.6e+00
1.0e+50
—
—
—
—
—
cases:1.00%
controls:0.08%
cases:0.62%
controls:0.00%
—
—
—
—
—
—
—
—
—
—
8
6
793
7825
5
0
800
7868
—
—
—
—
—
sulpiride; oral, parenteral
N05AL01 [21604548]
N05AL01 [21604548]
2.6e+00
1.0e+50
—
—
—
1.0e+50
—
cases:1.00%
controls:0.08%
cases:0.87%
controls:0.00%
—
—
—
—
—
—
cases:0.89%
controls:0.00%
—
—
8
6
793
7825
7
0
798
7868
—
—
—
7
0
778
7744
—
miconazole
D01AC02 [21601921]
D01AC02 [21601921]
1.3e+00
1.9e+00
—
—
—
1.7e+00
1.3e+00
cases:1.87%
controls:0.54%
cases:0.75%
controls:0.11%
—
—
—
—
—
—
cases:0.76%
controls:0.14%
cases:2.21%
controls:0.61%
15
42
786
7789
6
9
799
7859
—
—
—
6
11
779
7733
16
44
708
7122
fluvoxamine; oral
N06AB08 [21604716]
N06AB08 [21604716]
1.6e+00
—
—
—
—
—
2.6e+00
cases:0.62%
controls:0.13%
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.10%
5
10
796
7821
—
—
—
—
—
9
7
715
7159
Paranoid schizophrenia
F20.0 [45547694]
F20.0 [45547694]
—
—
—
—
—
—
2.6e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.24%
controls:0.10%
—
—
—
—
—
—
9
7
715
7159
Pruritus
S02 [2002000967]
S02 [2002000967]
2.5e+00
—
—
—
—
—
1.0e+00
cases:1.12%
controls:0.09%
—
—
—
—
—
—
—
—
—
—
cases:1.10%
controls:0.39%
9
7
792
7824
—
—
—
—
—
8
28
716
7138
Measurement of bone age from hand and elbow using X-ray
NK6MA [2001308495]
NK6MA [2001308495]
1.1e+00
1.3e+00
—
—
—
1.5e+00
1.4e+00
cases:2.25%
controls:0.75%
cases:1.24%
controls:0.33%
—
—
—
—
—
—
cases:0.89%
controls:0.19%
cases:1.38%
controls:0.33%
18
59
783
7772
10
26
795
7842
—
—
—
7
15
778
7729
10
24
714
7142
Audiology
64 [38004489]
64 [38004489]
1.4e+00
8.4e-01
—
—
1.1e+00
7.6e-01
1.1e+00
cases:6.49%
controls:1.71%
cases:2.24%
controls:0.98%
—
—
—
—
cases:0.62%
controls:0.20%
cases:1.91%
controls:0.90%
cases:5.11%
controls:1.69%
52
134
749
7697
18
77
787
7791
—
—
5
16
798
7850
15
70
770
7674
37
121
687
7045
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
4.9e-01
4.7e-01
1.6e+00
—
—
7.1e-01
9.2e-01
cases:4.49%
controls:2.80%
cases:2.61%
controls:1.65%
cases:1.61%
controls:0.33%
—
—
—
—
cases:2.55%
controls:1.27%
cases:4.97%
controls:2.04%
36
219
765
7612
21
130
784
7738
13
26
792
7842
—
—
20
98
765
7646
36
146
688
7020
zopiclone; oral
N05CF01 [21604654]
N05CF01 [21604654]
5.9e-01
8.5e-01
1.2e+00
—
1.3e+00
1.0e+00
6.1e-01
cases:4.49%
controls:2.55%
cases:3.11%
controls:1.35%
cases:1.12%
controls:0.33%
—
—
cases:1.25%
controls:0.34%
cases:3.95%
controls:1.42%
cases:6.08%
controls:3.40%
36
200
765
7631
25
106
780
7762
9
26
796
7842
—
10
27
793
7839
31
110
754
7634
44
244
680
6922
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
1.2e+00
9.0e-01
—
—
—
1.7e+00
1.3e+00
cases:3.50%
controls:1.07%
cases:0.87%
controls:0.36%
—
—
—
—
—
—
cases:0.64%
controls:0.12%
cases:2.21%
controls:0.61%
28
84
773
7747
7
28
798
7840
—
—
—
5
9
780
7735
16
44
708
7122
alprazolam; oral
N05BA12 [21604577]
N05BA12 [21604577]
1.0e+00
1.1e+00
-1.0e+50
—
—
1.2e+00
1.5e+00
cases:2.12%
controls:0.79%
cases:1.24%
controls:0.42%
cases:0.00%
controls:0.09%
—
—
—
—
cases:1.40%
controls:0.41%
cases:3.31%
controls:0.77%
17
62
784
7769
10
33
795
7835
0
7
805
7861
—
—
11
32
774
7712
24
55
700
7111
clotrimazole
D01AC01 [21601920]
D01AC01 [21601920]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.07%
—
—
—
—
—
—
6
5
718
7161
Optic atrophy
H47.2 [45543066]
H47.2 [45543066]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.07%
—
—
—
—
—
—
6
5
718
7161
In Home Supportive Care Agency
253Z00000X [38004206]
253Z00000X [38004206]
—
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:0.83%
controls:0.07%
—
—
—
—
—
—
6
5
718
7161
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
O99.3 [45606675]
O99.3 [45606675]
—
—
—
—
—
-1.0e+50
2.5e+00
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.06%
cases:0.83%
controls:0.07%
—
—
—
—
—
0
5
785
7739
6
5
718
7161
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
206
148
17.16
231.78
6.8
5.9
410.93
376.75
umol/l
1.74
193
136
34
30
11.69
32.82
3.4
3.4
31.79
36.88
umol/l
0.84
23
22
425
2479
2.22
32.55
3.3
2.8
47.23
61.70
u/l
5.74
409
2330
608
4109
2.18
31.71
5.6
7.0
11.38
12.03
umol/l
0.20
579
3904
597
4011
2.17
31.55
10.9
8.7
1.21
1.21
mmol/l
0.14
538
3545
34
34
10.31
30.17
2.6
2.0
25.77
17.34
umol/l
2.11
34
34
249
1218
2.38
28.44
2.3
1.9
—
—
—
0
0
214
987
2.48
27.79
1.7
1.6
1220.17
1143.33
nmol/l
0.50
185
768
114
379
3.26
27.43
2.1
1.4
—
—
—
0
0
667
4857
2.06
26.26
7.9
5.8
6.82
6.49
mmol/l
2.50
639
4552
507
3367
2.00
25.71
5.7
6.1
35.48
37.08
g/l
7.76
477
3198
533
3606
1.99
25.58
12.3
8.6
1.21
1.22
mmol/l
0.15
507
3387
485
3195
1.98
24.93
13.0
9.9
1.21
1.16
inr
1.27
415
2657
316
1792
2.10
24.63
3.7
2.8
9.84
6.23
e6/l
2.93
288
1620
467
3055
1.97
24.32
4.1
3.8
30.07
32.42
u/l
0.74
447
2905
786
6187
2.15
23.73
8.6
7.8
94.76
84.86
u/l
1.70
750
5879
194
917
2.38
23.55
2.3
1.9
—
—
—
0
0
187
888
2.35
22.39
2.3
1.9
—
—
—
0
0
168
792
2.34
20.33
9.6
10.5
2.61
0.50
mmol/l
5.90
139
666
244
1346
2.07
19.90
1.9
1.7
52315252.14
25385048.15
pmol/l
0.31
216
1170
207
1078
2.15
19.63
7.3
7.4
2.01
1.54
mmol/l
1.04
178
916
210
1101
2.14
19.56
7.2
7.3
6.04
5.83
kpa
1.96
201
1078
688
5327
1.88
19.56
7.5
4.1
2614.41
353.58
e6/l
0.86
22
69
402
2668
1.83
18.67
5.3
3.5
23.82
51.22
e6/l
1.56
334
2006
346
2216
1.85
17.86
4.4
4.4
10.64
9.89
mg/mmol
0.07
241
1468
188
994
2.09
16.94
7.2
7.0
5.07
4.82
kpa
0.54
179
973
591
4499
1.74
16.37
5.9
3.5
8.38
5.00
estimate
0.15
144
907
159
801
2.17
16.20
9.9
10.4
10.72
13.03
kpa
8.21
154
772
159
801
2.17
16.20
9.9
10.4
5.64
5.13
kpa
6.47
154
770
147
718
2.22
16.18
10.3
11.1
95.10
95.81
%
0.86
141
698
355
2353
1.78
16.00
6.2
3.5
0.00
0.01
estimate
1.08
136
857
342
2247
1.78
15.85
3.0
2.2
357.77
230.31
u/l
0.99
329
2154
581
4459
1.70
15.09
5.9
3.5
0.00
0.00
estimate
0.50
143
904
586
4527
1.69
14.68
5.9
3.6
0.03
0.36
estimate
0.45
133
846
122
586
2.23
13.92
2.9
2.5
0.72
0.31
e6/l
0.92
116
558
285
1833
1.77
13.90
3.4
3.6
1359.23
1035.35
ng/l
0.41
237
1508
311
2055
1.74
13.78
6.3
3.3
1.02
1.02
kg/l
0.07
240
1334
433
3170
1.63
12.77
6.5
4.2
191.99
65.89
e6/l
1.00
333
2139
147
786
2.02
12.65
10.5
10.7
1.32
1.31
mmol/l
0.05
140
774
645
5224
1.63
12.44
20.1
10.5
4.20
3.91
e9/l
2.64
585
4505
144
769
2.01
12.43
8.0
6.1
2.44
1.33
mmol/l
2.62
109
565
450
3347
1.61
12.31
5.9
3.2
0.01
0.01
estimate
0.21
112
759
26
54
4.91
11.95
6.4
5.3
317.43
158.47
umol/l
0.64
15
32
19
14
13.80
11.48
1.0
1.0
—
—
—
0
0
387
2811
1.60
11.46
4.5
3.8
7.14
8.58
mmol/l
6.72
355
2467
369
2651
1.61
11.43
3.0
3.3
2.36
2.36
mmol/l
0.29
330
2448
372
2683
1.61
11.31
4.2
3.3
45.82
64.38
ng/l
0.30
261
1650
938
8534
2.14
10.96
27.6
15.1
139.47
139.66
mmol/l
1.28
923
8356
331
2343
1.61
10.77
5.4
3.5
0.36
0.31
e6/l
0.30
271
1696
97
471
2.17
10.74
2.8
3.8
100.75
171.67
ng/l
1.72
90
427
790
6843
1.67
10.63
5.3
4.1
14.56
14.61
pmol/l
0.22
746
6331
937
8541
2.11
10.58
27.4
15.3
4.00
3.95
mmol/l
6.68
921
8331
104
529
2.07
10.21
2.1
1.7
—
—
—
0
0
291
2027
1.61
9.99
1.7
1.6
19.17
20.02
nmol/l
0.38
264
1753
423
3210
1.54
9.99
2.1
1.9
95.84
97.10
pmol/l
0.20
232
1695
61
251
2.52
9.86
1.8
2.0
2.36
2.28
ug/l
0.02
55
227
111
603
1.94
9.06
8.2
6.1
76.29
75.73
ng/l
0.02
101
560
198
1289
1.66
8.79
10.7
8.6
1.18
1.14
mmol/l
1.09
190
1216
212
1405
1.64
8.78
5.8
6.0
0.81
0.82
mmol/l
0.89
200
1349
33
107
3.15
8.31
7.0
6.7
7.73
6.82
mmol/l
0.61
27
93
52
217
2.47
8.19
1.2
1.4
—
—
—
0
0
85
439
2.02
8.01
7.1
5.8
0.64
0.60
%
0.52
85
439
48
196
2.52
7.92
3.1
2.8
130.04
133.89
g/l
0.52
48
162
81
418
2.02
7.66
2.1
1.7
—
—
—
0
0
68
1294
0.49
7.57
2.1
2.9
0.66
0.71
ug/l
0.22
43
726
17
24
7.18
7.49
6.1
3.4
10.06
10.48
kpa
0.25
17
24
17
24
7.18
7.49
6.1
3.4
5.39
4.75
kpa
1.52
17
24
876
8004
1.64
7.29
6.6
4.9
2.00
1.85
mu/l
3.60
826
7536
96
541
1.85
7.02
3.9
3.9
1.24
1.23
mmol/l
1.31
88
477
293
2205
1.46
6.60
2.6
2.6
2.70
2.68
mg/l
0.07
269
1937
205
1443
1.53
6.40
4.0
3.7
256.55
650.58
ng/l
1.81
142
979
133
846
1.66
6.38
2.8
3.4
0.22
0.22
g/l
0.18
126
806
469
3902
1.37
5.76
3.6
2.8
73.40
72.43
nmol/l
0.31
437
3620
9
7
12.96
5.58
1.6
1.1
51.72
58.19
nmol/l
—
9
7
6
271
0.22
5.42
1.7
1.7
—
—
—
0
0
9
325
0.27
5.39
1.4
1.5
—
—
—
0
0
30
120
2.55
5.24
1.2
1.5
288.09
285.78
mosm/kgh2o
0.14
22
92
132
1908
0.65
5.18
3.0
2.4
—
—
—
0
0
32
133
2.45
5.17
2.6
3.6
10.54
7.31
mmol/l
1.22
32
128
175
1255
1.48
4.93
3.6
2.8
2.39
2.39
g/l
0.02
162
1172
833
7692
1.44
4.91
6.1
4.2
6.24
5.79
mmol/l
10.56
784
7164
66
1112
0.57
4.86
2.8
2.4
—
—
—
0
0
185
1347
1.46
4.81
3.7
2.8
12.13
14.11
umol/l
4.03
174
1275
813
7487
1.41
4.76
8.2
5.4
40.14
38.16
mmol/mol
5.16
773
7135
188
1385
1.44
4.59
5.3
3.3
5.42
1.94
e6/l
2.91
108
678
108
710
1.58
4.54
4.6
2.9
—
—
—
0
0
314
2528
1.35
4.49
4.9
2.9
0.00
0.04
estimate
0.72
113
737
159
1146
1.46
4.35
3.8
2.9
21.39
23.77
%
1.50
149
1088
127
1781
0.67
4.22
2.9
2.3
—
—
—
0
0
32
644
0.48
4.19
2.1
2.4
—
18.51
—
0
59
211
2701
0.72
4.17
1.9
1.8
—
—
—
0
0
29
597
0.47
4.05
1.1
1.3
—
46.62
—
0
34
56
321
1.79
3.96
3.8
3.0
1.02
1.02
ratio
0.86
51
299
193
1466
1.39
3.93
5.3
3.1
1.26
0.87
e6/l
1.20
115
755
172
1283
1.41
3.90
2.6
3.9
30.05
29.73
s
0.18
165
1257
135
963
1.46
3.90
2.3
2.4
389.52
367.92
nmol/l
0.58
128
920
19
71
2.71
3.84
1.2
1.2
88.11
110.31
pmol/l
1.29
19
71
14
44
3.21
3.78
1.2
1.6
1.99
1.15
nmol/l
—
9
31
10
307
0.32
3.55
1.4
1.7
—
—
—
0
0
14
361
0.38
3.46
1.3
1.2
5.01
2.54
u/ml
—
7
235
138
1011
1.42
3.46
3.3
4.6
13.96
7.54
umol/l
0.61
112
896
18
415
0.42
3.43
1.4
1.2
0.81
3.46
u/ml
2.86
12
270
19
423
0.44
3.32
1.6
1.5
—
—
—
0
0
13
40
3.28
3.14
2.2
3.2
9.05
8.53
mmol/l
0.15
13
40
173
1339
1.35
3.12
2.5
2.8
2.44
2.43
mmol/l
0.52
145
1201
44
254
1.77
3.09
1.4
1.3
—
—
—
0
0
13
41
3.20
3.06
1.1
1.1
183.15
513.69
u/l
0.65
13
35
31
161
1.95
3.02
1.3
1.6
—
—
—
0
0
63
952
0.64
3.00
2.5
2.3
—
—
—
0
0
5
5
10.04
2.98
2.4
1.8
251.60
402.00
ug/l
—
5
5
0
77
0.00
2.97
0.0
1.4
—
180.64
—
0
77
119
1588
0.72
2.95
1.4
1.3
39.00
27.39
iu/ml
0.48
33
441
21
428
0.48
2.92
2.2
1.9
38.29
38.05
nmol/l
0.01
21
415
33
178
1.88
2.89
1.5
1.8
22.69
30.89
ng/l
0.55
33
178
31
164
1.92
2.88
1.3
1.5
—
—
—
0
0
19
396
0.47
2.82
1.9
1.6
8.03
3.58
mg/l
1.33
19
277
44
265
1.69
2.70
1.3
1.9
—
—
—
0
0
6
10
6.03
2.70
20.5
4.9
5.52
8.05
mmol/l
—
6
10
75
514
1.50
2.69
2.0
1.7
562.73
294.88
mu/l
3.00
67
469
68
987
0.67
2.69
3.2
2.3
9.06
13.05
nmol/l
2.90
62
915
14
321
0.43
2.68
3.1
1.9
146.50
218.07
pmol/l
2.31
14
303
42
251
1.70
2.66
1.3
1.8
—
—
—
0
0
132
1698
0.74
2.58
3.6
4.0
19.82
21.44
%
0.44
47
695
104
766
1.40
2.56
6.4
6.0
—
—
—
0
0
40
239
1.70
2.54
3.9
3.1
7.12
2.41
index
0.80
26
145
79
556
1.46
2.50
1.9
3.8
4.85
4.77
pmol/l
0.18
72
506
37
218
1.72
2.48
1.2
1.5
—
—
—
0
0
11
38
2.91
2.42
1.3
4.7
0.55
1.29
%
1.27
11
38
5
8
6.27
2.37
1.0
1.0
14.82
9.43
pmol/l
—
5
8
945
9152
1.41
2.32
26.9
15.9
72.33
72.77
umol/l
0.09
933
9045
13
53
2.47
2.28
2.3
2.3
2.14
1.65
u/field
—
7
34
21
106
2.00
2.26
3.2
4.2
—
—
—
0
0
718
7594
0.82
2.23
4.5
3.8
1.48
1.27
mmol/l
6.85
673
7148
26
143
1.84
2.20
1.8
1.4
13.59
19.21
u/l
0.63
21
121
76
547
1.42
2.16
3.7
2.5
3529.78
5052.42
u/l
0.32
25
211
38
235
1.64
2.16
2.2
1.8
—
—
—
0
0
11
42
2.64
2.14
8.5
7.6
—
188.83
—
0
6
114
1458
0.75
2.14
1.3
1.3
5.29
9.14
u/ml
0.67
39
567
37
228
1.65
2.14
2.9
2.7
—
—
—
0
0
5
10
5.02
2.07
1.4
2.9
0.40
0.50
u/field
—
5
10
7
20
3.52
2.05
7.0
7.6
—
—
—
0
0
16
76
2.12
2.03
1.6
2.7
104.44
105.22
mmol/l
0.15
16
76
99
1277
0.75
1.98
1.5
1.5
—
—
—
0
0
22
119
1.87
1.98
1.2
1.7
—
—
—
0
0
11
243
0.45
1.98
1.1
1.1
0.28
0.48
u/ml
—
5
103
27
157
1.74
1.94
5.0
4.6
7.80
7.62
pmol/l
0.05
27
157
12
253
0.47
1.91
1.2
1.6
—
—
—
0
0
16
78
2.07
1.91
1.6
2.7
4.09
4.03
mmol/l
0.18
16
78
935
9079
1.33
1.89
14.5
11.0
28.18
27.49
u/l
0.36
913
8866
0
51
0.00
1.89
0.0
1.1
—
—
—
0
0
664
6240
1.18
1.79
4.6
4.4
12.06
9.47
mm/h
5.71
624
5878
12
243
0.49
1.73
1.5
1.6
42.31
55.89
ug/l
0.58
12
243
7
24
2.93
1.72
5.6
6.0
—
—
—
0
0
69
514
1.37
1.66
2.0
1.7
0.22
0.30
mg/l
1.19
35
250
24
390
0.61
1.65
1.2
1.3
—
—
—
0
0
106
842
1.29
1.65
2.7
2.5
29.85
91.76
u/l
0.55
86
702
15
76
1.99
1.65
1.7
2.7
1.19
1.19
mmol/l
0.04
15
76
38
255
1.51
1.60
2.4
2.0
—
—
—
0
0
659
6946
0.86
1.58
3.3
3.5
—
—
—
0
0
411
4483
0.86
1.56
4.1
3.3
99.50
101.48
ug/l
0.10
392
4254
15
78
1.94
1.54
1.5
2.2
32.93
33.08
pg
0.04
15
78
18
100
1.81
1.53
1.7
1.3
—
—
—
0
0
29
187
1.57
1.47
1.4
2.1
—
—
—
0
0
16
87
1.85
1.46
3.4
3.7
14.82
14.83
index
0.00
11
71
32
212
1.53
1.44
1.4
1.6
—
—
—
0
0
902
8779
1.23
1.34
24.1
13.5
25.51
22.48
mg/l
2.00
809
6895
0
39
0.00
1.34
0.0
1.1
—
44.95
—
0
39
67
517
1.32
1.32
2.8
1.9
6.32
7.10
u/l
0.35
52
376
24
366
0.65
1.30
1.1
1.2
—
4.06
—
0
43
798
7691
1.17
1.29
19.6
12.1
96.29
90.86
ml/min/173m2
7.63
718
6808
19
114
1.68
1.29
4.1
3.9
522.21
469.16
e6/l
0.16
14
87
6
135
0.44
1.27
16.2
1.9
13.45
13.08
%
—
6
135
250
2227
1.16
1.26
5.3
5.3
90.83
90.94
%
0.02
242
2188
19
115
1.66
1.25
4.1
4.0
322.00
194.11
e6/l
0.59
14
91
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
31
212
1.48
1.24
4.7
10.2
0.29
0.34
iu/ml
0.38
15
109
19
116
1.65
1.22
1.2
1.3
—
—
—
0
0
5
19
2.64
1.21
1.6
1.5
—
—
—
0
0
8
39
2.06
1.15
1.3
1.3
—
—
—
0
0
11
58
1.91
1.12
3.5
2.2
530.36
946.09
u/ml
1.62
11
58
8
41
1.96
1.09
2.5
3.4
115.66
111.52
ug/l
—
8
41
35
254
1.39
1.05
2.3
1.9
—
—
—
0
0
158
1380
1.17
1.04
2.8
1.8
1.71
1.45
%
0.77
143
1241
25
172
1.46
1.00
1.2
1.3
—
—
—
0
0
25
172
1.46
1.00
1.2
1.3
—
—
—
0
0
72
585
1.25
1.00
2.5
4.6
135.42
19.96
ug/l
0.51
58
471
636
6085
1.12
0.99
4.9
3.6
57.22
42.27
u/l
1.36
605
5828
0
29
0.00
0.98
0.0
1.2
—
67.90
—
0
29
0
29
0.00
0.98
0.0
1.7
—
—
—
0
0
0
30
0.00
0.97
0.0
1.1
—
—
—
0
0
31
421
0.73
0.96
1.8
1.4
—
—
—
0
0
8
145
0.55
0.93
2.4
2.1
—
2080.00
—
0
8
9
52
1.74
0.92
1.3
1.6
—
—
—
0
0
964
9760
0.80
0.92
40.5
20.5
134.56
137.67
g/l
8.44
956
9675
8
42
1.91
0.88
1.1
1.1
—
81.67
%
—
0
6
22
152
1.46
0.88
1.8
2.5
7.18
109.74
ug/min
2.41
11
89
23
161
1.44
0.87
1.3
2.0
—
—
—
0
0
782
8032
0.89
0.86
5.0
4.4
1.27
1.42
mmol/l
26.49
730
7596
211
1912
1.13
0.85
2.3
2.5
1.31
1.13
mg/l
0.40
172
1435
964
9754
0.81
0.84
40.9
20.9
40.33
41.80
%
1.82
955
9668
964
9754
0.81
0.84
40.0
20.3
4.55
4.61
e12/l
3.05
940
9528
19
129
1.48
0.83
1.3
1.8
—
—
—
0
0
964
9751
0.81
0.81
39.9
20.3
89.56
89.62
fl
0.15
955
9670
0
26
0.00
0.78
0.0
1.3
—
—
—
0
0
6
34
1.77
0.76
1.2
1.7
—
—
—
0
0
964
9745
0.82
0.74
40.0
20.4
253.78
255.83
e9/l
0.42
943
9540
8
134
0.59
0.73
1.1
1.1
—
16.78
—
0
46
7
39
1.80
0.72
1.3
1.3
—
—
—
0
0
20
275
0.72
0.71
1.2
1.4
—
—
—
0
0
20
143
1.41
0.70
1.5
1.8
—
—
—
0
0
7
119
0.59
0.68
1.0
1.1
—
—
—
0
0
20
271
0.73
0.66
1.4
3.4
47.74
1322.04
u/ml
1.44
15
231
10
155
0.64
0.66
1.5
1.2
24.67
21.09
u/l
—
10
137
11
70
1.58
0.65
1.9
2.1
—
—
—
0
0
10
62
1.62
0.65
1.1
1.6
—
—
—
0
0
19
258
0.73
0.64
1.1
1.1
—
21.32
—
0
61
5
29
1.73
0.64
1.4
2.4
191.40
196.14
u/l
—
5
29
12
79
1.53
0.62
2.0
1.5
—
—
—
0
0
11
71
1.56
0.62
2.7
3.8
0.36
0.83
index
1.28
11
71
62
530
1.18
0.59
2.0
2.3
6.02
7.92
ug/l
0.36
56
468
30
237
1.27
0.58
1.2
2.3
60.23
10.10
e6/l
0.67
22
168
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
797
7806
1.09
0.57
33.3
17.1
13.77
13.34
%
14.23
787
7724
13
184
0.70
0.57
1.8
2.1
0.00
0.00
g/l
-0.00
13
168
198
2135
0.91
0.57
3.3
4.6
1.46
1.95
ug/l
1.44
176
1963
6
36
1.67
0.56
1.2
1.7
—
—
—
0
0
30
240
1.26
0.54
1.3
2.4
359.00
1013.76
e6/l
0.48
24
177
30
371
0.80
0.53
2.0
1.6
181.50
210.90
u/ml
0.59
12
188
17
226
0.75
0.52
1.1
1.2
—
—
—
0
0
792
8061
0.92
0.48
5.2
4.5
4.33
4.64
mmol/l
18.76
746
7659
21
267
0.78
0.48
1.4
1.2
4.04
3.06
u/ml
—
5
25
14
102
1.38
0.47
1.5
1.4
—
—
—
0
0
14
188
0.74
0.47
2.1
2.2
0.00
0.03
g/l
0.50
14
180
5
81
0.62
0.46
1.4
2.4
—
5.54
—
0
27
68
766
0.88
0.44
1.3
1.3
24.83
140.12
u/ml
13.68
25
297
16
208
0.77
0.44
2.1
2.4
0.41
1.02
g/l
0.65
16
194
5
32
1.57
0.42
1.2
1.3
—
—
—
0
0
5
32
1.57
0.42
1.2
1.3
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
181
1928
0.93
0.41
3.0
3.1
324.94
337.61
umol/l
0.94
160
1752
38
443
0.85
0.40
2.4
1.8
—
—
—
0
0
5
34
1.47
0.40
4.8
6.5
—
—
—
0
0
68
608
1.13
0.39
3.6
2.7
78.75
74.85
ml/min/173m2
0.24
32
247
5
36
1.39
0.38
1.0
1.0
7.68
7.07
kpa
—
5
24
5
36
1.39
0.38
1.0
1.0
3.12
3.38
kpa
—
5
24
9
68
1.33
0.37
1.0
1.8
—
—
—
0
0
9
68
1.33
0.37
1.0
1.8
—
—
—
0
0
9
68
1.33
0.37
1.0
1.8
—
—
—
0
0
8
114
0.70
0.37
1.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
37
1.35
0.37
1.0
1.1
—
73.71
—
0
7
22
267
0.82
0.36
1.4
1.2
1.90
9.89
u/ml
—
5
37
6
43
1.40
0.35
1.2
1.6
—
—
—
0
0
25
210
1.20
0.33
1.1
1.1
—
—
—
0
0
19
155
1.23
0.32
2.1
2.0
—
—
—
0
0
17
209
0.81
0.32
1.6
2.1
10.32
10.66
g/l
0.17
17
197
17
207
0.82
0.30
1.1
1.1
—
1.96
—
0
26
13
102
1.28
0.30
1.2
1.3
—
—
—
0
0
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
34
387
0.87
0.29
1.8
1.9
9.10
5.39
iu/ml
—
8
75
24
281
0.85
0.29
1.3
1.4
—
—
—
0
0
53
586
0.90
0.29
1.4
1.3
—
—
—
0
0
66
604
1.10
0.28
2.8
1.8
11.19
17.43
iu/l
2.24
57
469
9
119
0.75
0.27
2.1
1.7
—
—
—
0
0
13
104
1.25
0.26
1.2
1.4
0.59
0.57
nmol/l
0.06
13
98
20
170
1.18
0.24
1.7
1.4
—
—
—
0
0
12
96
1.25
0.24
1.6
1.4
—
—
—
0
0
12
96
1.25
0.24
1.6
1.4
—
—
—
0
0
21
244
0.86
0.24
1.6
1.5
271.69
300.54
ug/g
0.23
13
141
74
689
1.08
0.23
1.1
1.1
—
—
—
0
0
5
38
1.32
0.23
1.0
1.2
118.40
106.64
%
—
5
33
5
38
1.32
0.23
1.0
2.0
—
—
—
0
0
5
38
1.32
0.23
1.0
2.0
—
—
—
0
0
5
38
1.32
0.23
1.0
1.1
—
91.00
—
0
7
5
38
1.32
0.23
1.0
2.0
—
—
—
0
0
5
38
1.32
0.23
1.0
2.0
—
—
—
0
0
12
97
1.24
0.23
1.6
1.4
—
—
—
0
0
7
93
0.75
0.22
1.0
1.2
—
—
—
0
0
7
93
0.75
0.22
1.0
1.2
—
—
—
0
0
7
93
0.75
0.22
1.1
1.1
—
—
—
0
0
17
199
0.85
0.21
1.7
1.4
—
—
—
0
0
239
2468
0.96
0.21
1.7
1.6
2.11
2.15
g/l
0.13
144
1497
0
11
0.00
0.21
0.0
1.1
—
1.39
—
0
11
353
3445
1.04
0.21
2.2
1.9
1.55
1.39
mmol/l
1.96
306
3020
0
12
0.00
0.21
0.0
1.6
—
1.19
—
0
12
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
0.34
—
0
8
0
13
0.00
0.21
0.0
11.9
—
10.58
—
0
13
6
48
1.25
0.20
1.7
3.4
1953.17
1281.25
mg
—
6
48
6
50
1.20
0.19
1.3
1.2
—
—
—
0
0
21
239
0.88
0.19
1.9
2.2
3.80
3.75
g/l
0.07
21
228
21
239
0.88
0.19
1.9
2.2
7.60
7.17
g/l
0.72
21
228
21
239
0.88
0.19
1.9
2.2
4.46
4.27
g/l
0.56
21
228
29
322
0.90
0.19
2.0
1.6
1.20
1.20
g/l
0.01
29
311
10
81
1.24
0.18
1.2
1.0
—
—
—
0
0
26
290
0.89
0.18
2.7
1.9
171.57
124.29
au/ml
—
7
102
12
100
1.20
0.18
1.0
2.1
—
—
—
0
0
29
262
1.11
0.17
2.0
2.1
2.37
4.61
iu/l
1.84
17
108
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
63
1.11
0.17
1.0
1.1
—
—
—
0
0
5
67
0.75
0.17
1.6
1.6
—
—
—
0
0
20
224
0.89
0.15
1.9
2.2
2.83
2.94
g/l
0.27
20
213
10
119
0.84
0.15
1.0
1.2
86.60
96.52
%
—
10
111
12
102
1.18
0.15
1.6
1.4
—
—
—
0
0
7
86
0.81
0.14
1.3
1.3
—
—
—
0
0
7
87
0.80
0.14
1.3
1.3
—
—
—
0
0
7
90
0.78
0.14
1.0
1.2
—
—
—
0
0
7
90
0.78
0.14
1.0
1.2
—
—
—
0
0
8
98
0.81
0.13
1.0
1.2
—
—
—
0
0
13
149
0.87
0.13
1.0
1.2
118.08
113.68
%
0.18
13
138
9
107
0.84
0.13
1.0
1.2
—
—
—
0
0
9
107
0.84
0.13
1.0
1.0
—
—
—
0
0
28
303
0.92
0.12
2.5
1.8
—
—
—
0
0
149
1532
0.97
0.12
2.7
3.0
135.51
106.75
ug/g
0.81
123
1250
807
8115
0.97
0.11
5.8
5.0
2.56
2.78
mmol/l
10.97
758
7685
12
136
0.88
0.11
1.4
1.7
—
80.30
—
0
10
14
125
1.12
0.10
1.0
1.9
—
—
—
0
0
200
2039
0.98
0.10
3.0
2.6
—
—
—
0
0
5
46
1.09
0.09
1.0
1.4
—
32.00
—
0
5
45
428
1.05
0.09
1.6
1.7
—
—
—
0
0
29
309
0.94
0.09
2.0
1.7
0.24
0.23
g/l
0.22
29
300
13
144
0.90
0.08
1.2
1.4
—
—
—
0
0
5
63
0.79
0.08
1.0
1.1
—
—
—
0
0
7
67
1.05
0.08
3.7
2.3
—
—
—
0
0
7
68
1.03
0.08
1.1
1.2
—
—
—
0
0
16
174
0.92
0.07
1.7
1.4
84.50
151.46
pmol/l
0.49
16
168
6
75
0.80
0.07
1.3
1.1
—
83.50
—
0
8
12
132
0.91
0.06
1.4
1.4
—
—
—
0
0
13
142
0.91
0.06
1.2
1.1
—
1.88
—
0
9
14
152
0.92
0.06
1.3
1.5
—
—
—
0
0
26
274
0.95
0.06
1.2
1.1
—
—
—
0
0
26
274
0.95
0.06
1.2
1.1
—
—
—
0
0
18
168
1.07
0.06
1.3
1.3
—
—
—
0
0
278
2754
1.01
0.05
1.6
1.6
2.38
2.05
u/ml
0.11
85
697
11
101
1.09
0.04
1.6
1.4
—
—
—
0
0
17
161
1.06
0.03
1.2
1.2
—
—
—
0
0
17
162
1.05
0.02
1.0
1.1
—
—
—
0
0
17
163
1.04
0.01
1.2
1.2
1.38
4.53
u/ml
—
8
64
381
3802
1.00
0.01
3.5
2.9
—
—
estimate
—
0
0
16
156
1.03
0.00
1.1
1.3
5.64
4.95
u/ml
0.11
11
77
85
852
1.00
0.00
4.4
4.2
30.85
31.14
%
0.08
62
594
64
645
0.99
0.00
1.4
1.5
—
—
—
0
0
8
83
0.96
0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
8
82
0.98
-0.00
1.3
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
4.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
8.83
—
0
6
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
61
0.98
-0.00
1.3
1.1
—
43.20
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
52
0.96
-0.00
1.0
1.1
92.40
105.88
%
—
5
52
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
760.60
—
0
5
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
6
64
0.94
-0.00
1.2
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
65
0.92
-0.00
3.8
5.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
5.3
—
—
—
0
0
5
51
0.98
-0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
7.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
50
1.00
-0.00
1.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint F5_MILDRET and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_MILDRET | 4.33 [3.68, 5.1] | < 0.001 |
| Birth year | 0.997 [0.99, 1.01] | 0.518 |
During the follow-up period (1.1.1998 — 31.12.2019), 521 out of 5665 females with F5_MILDRET died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| F5_MILDRET | 3.08 [2.64, 3.6] | < 0.001 |
| Birth year | 0.989 [0.98, 1.0] | 0.02 |
During the follow-up period (1.1.1998 — 31.12.2019), 597 out of 7441 males with F5_MILDRET died.
Mortality risk
Mortality risk for people of age
years, who have F5_MILDRET.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.413% | 0.528% |
| 5 | 2.374% | 3.894% |
| 10 | 6.159% | 8.881% |
| 15 | 11.876% | 16.609% |
| 20 | 20.559% | 28.021% |
Relationships between endpoints
↥Index endpoint: F5_MILDRET – Mild mental retardation
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data